1.       Shoenfeld Y. The Skin and the Body (Hebrew). Akademon, The Hebrew University, Jerusalem, 1976. pp 400.

 

2.       Shoenfeld Y, Shapiro Y, Bar-Chama A. Physical Activity and Health. (Hebrew). Akademon, The Hebrew University, Jerusalem, 1977. pp. 380.

 

3.       Pick AI, Shoenfeld Y. Clinical Immunology: Diseases with Defects in the Humoral System. (Hebrew). Akademon, The Hebrew University, Jerusalem, 1979. pp 400.

 

4.       Shoenfeld Y. Scientific Editor. Living Well. (Hebrew). Yediot Aharonoth Pub. Tel-Aviv, 1979. pp. 167.

 

5.       Shoenfeld Y, Berliner S. Medicines and You. (Hebrew). Yediot Aharonoth Pub. Tel-Aviv, 1979. pp 207.

 

6.       Shoenfeld Y, Berliner S. Textbook of Physical Fitness. (Hebrew). Wingate Institute,. Ministry of Education, Natanya, 1979. pp. 177.

 

7.       Shoenfeld Y, Berliner S. Biological, Biochemical and Health Aspects in Physical Education. (Hebrew). Ministry of Education, The Hebrew University, Jerusalem, 1979. pp. 128.

 

8.       Shoenfeld Y. Cancer: Vital Information for all. (Hebrew). Yediot Aharonoth Pub. Tel-Aviv, 1980. pp. 240.

 

9.       Shoenfeld Y, Bar-Chama A, Shuman E. The Israeli Fitness Strategy. Morrow Pub. New-York (English) 1981. pp. 260.

 

10.     Shoenfeld Y. Arthritis (Hebrew). Yediot Aharonoth Pub. Tel-Aviv, 1982. pp. 271.

 

11.     Shoenfeld Y, Berliner S. Internal Medicine. Zerikover Inc. Tel-Aviv, (Hebrew) 1983. pp. 287.

 

12.     Shoenfeld Y. Scientific Editor - Encyclopedia - The Human Body. (Illustrated) 20 volumes (Hbrew Edition). Yediot Aharonoth, 1986.

 

13.     Shoenfeld Y. Scientific Edition - "Publish or Perish" - A guide for research planning and scientific article writings. Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel, 1986, pp. 244.

 

14.     Zehavi I, Shoenfeld Y, Isenberg DA. The Heart in Health and Diseases. (Hebrew). Hakibutz Hameuchad, Tel-Aviv, 1988. pp. 360.

 

15.     Shoenfeld Y, Isenberg DA (authors). The Mosaic of Autoimmunity. (English). Elsevier, Holland 1989, pp. 523.

 

16.     Zimlichman R, Shoenfeld Y. Hypertension. (Hebrew). Yediot Aharonoth Pub. pp. 339.

 

17.     Shoenfeld Y, Isenberg DA. Natural Autoantibodies: Their Physiological Role and Regulatory Significance. CRC Press. 2000 Boca Raton Florida, USA, 33431.

 

18.     Shoenfeld Y, Goldwasser B. Good Trip. A Directory for Travellers. Hebrew, 1992.

 

19.     Peter JB, Shoenfeld Y (Editors): Autoantibodies. Elsevier, Amsterdam, The Netherlands, pp. 1 - 880, 1996.

 

20.     Asherson RA, Cervera R, Piette JC, Shoenfeld Y (Editors). The Antiphospholipid Syndrome. CRC Press, Inc, 2000 Corporate Blvd., N.W., Boca Raton, Florida 33431, U.S.A.

 

21.     Special Editor: Israel Journal of Medical Sciences. Beilinson 60th Anniversary. Rabin Medical Center, 1st Anniversary 1936-1996, Vol. 32 no. 12 1996.

 

22.     Hebrew Translation of Harrison’s Principles of Internal Medicine, 13th edition. Editor and Scientific advisor: Shoenfeld Y. McGraw-Hill, Diunon, 1996.

 

23.     Shoenfeld Y, Bar-Dayan Y. (authors). The Complete Guide for Signs Symptoms and Diseases. (Hebrew) pp. 1-377, 1996. Prolog Pub., Tel-Aviv, Israel.

 

24.     George K, Shoenfeld Y (authors). Diseases of the Joints. (Hebrew) pp. 1-64, 1995. Prolog Pub., Tel-Aviv, Israel.

 

25.     George K, Shoenfeld Y (authors). Hypertension. (Hebrew) pp. 1-64, 1995. Prolog Pub., Tel-Aviv, Israel.

 

26. Amital H, Shoenfeld Y (authors). The Immune System. (Hebrew) pp. 1-95, 1996. Prolog Pub., Tel-Aviv, Israel.

 

27.     Lorber M, Aharon A, Shoenfeld Y (authors). Systemic Lupus Erythematosus (Hebrew) Prolog Pub., Tel-Aviv, Israel, pp. 1-86, 1997

 

28.     Zimlichman R, Shoenfeld Y (authors). Treatment of Hypertension (Hebrew) Prolog Pub., Tel-Aviv, Israel. pp. 1-70, 1997.

 

29.     Shoenfeld Y, Kennedy R, Ferrano S. (Editors). Idiotypes in Medicine: Autoimmunity, Infectious Diseases and Cancer. Elsevier Publ. Amsterdam, The Netherlands pp. 1-500, 1997.

 

30.     Conrad K, Humbel R.L., Meurer M, Shoenfeld Y, Tan E.M. (Editors). Pathogenic and Diagnostic Relevance of Autoantibodies. Report on the 4th Dresden Symposium on Autoantibodies held in Dresden on October 21-24, 1998. 450 pp. PABST science Pub. Berlin, Germany, 1998.

 

31.     Shoenfeld Y. (Editor). The Decade of Autoimmunity. Elsevier Publ Amsterdam, The Netherlands. pp. 1-500, 1999.

 

32.     Hebrew Translation of Harrison’s Principles of Internal Medicine, 14th edition. Editor and Scientific advisor: Shoenfeld Y. McGraw-Hill, Diunon, 2000.

 

33.     Shoenfeld Y, Gershwin Eric M. (Editors). Cancer and Autoimmunity. Elsevier Publ. Amsterdam- Lausanne- New Yorrk- Shannon- Singapore-Tokyo; The Netherlands, pp. 1 - 446, 2000.

 

34.     Conrad K, Humbel R.L., Meurer M., Shoenfeld Y., Tan E.M. (Editors). Autoantigens and Autoantibodies: Diagnostic Tools and Clues to Understanding Autoimmunity.

 

35.     Report on the 5th Dresden Symposium on Autoantibodies held in Dresden on October 18-21. 2000. pp: 1-766, PABST science Pub. Berlin, Germany.

 

36.     Shoenfeld Y, Harats D, Wick G. (Editors). Atherosclerosis and Autoimmunity. Elsevier Publ. Amsterdam- Lausanne- New Yorrk- Shannon- Singapore-Tokyo; The Netherlands, pp. 1 - 370, 2001.

 

37.     Shoenfeld Y. Autoimmune Diseases – "Shooting on our forces". Galey Zahal – Transmitted University.

 

38.     Ministry of Defence Publication. 2011. pp. 1- 94.

 

 

39.     Asherson RA, Cervera R, Piette JC, Shoenfeled Y. (Editors). The Antiphospholipid Syndrome II , Autoimmune Thrombosis. Elsevier Publ. Amsterdam- The Netherlands, pp 1-457, 2002

 

40.     Conrad K, Fritzler M, Meurer M, Shoenfeld Y, (Editors). From Proteomics to Molecular Epidemiology: Relevance of Autoantibodies (Report of the 6th Dresden Synposium on Autoantibodies Sept. 4-7, 2002). PABST Science Pub. , Germany, pp. 1-700, 2002.

 

41.     Shoenfeld Y, Zandman-Goddard G. (Authors). Autoimmune Diseases "The Enemy from Within". Published by Bio-Rad Laboratories, pp. 1-83, 2003.

 

42.     Sherer Y, Shoenfeld Y, (Authors). Antiphospholipid Syndrome. (Hebrew). Ramot - Tel-Aviv University Publ. pp. 1-64, 2004.

 

43.     Ferencik M, Rovensky J, Shoenfeld Y., Matha V. (Editors). Imunity system – dobry obranca, ale aj mozny diverzant. (Slovakian). Vydanie prve. Vydal SAP – Slovak Academic Press Publ, Bratislave, Slovakia, pp: 1-273, 2004.

 

44.     K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J. Fritzler, R.L. Humbel, U.Sack, Y.Shoenfeld (Editors).

 

45.     From animal models to human genetics: research on the induction and pathogenicity of autoantibodies. Report on the 7th Dresden symposium on autoantibodies, September 1-4, 2004. Pabst Science Publishers, Germany, pp: 1-610, 2004.

 

46.     Yehuda Shoenfeld, Noel R. Rose (Editors). Infection and Autoimmunity. Elsevier Publ. Amsterdam- The Netherlands, pp 1-747, 2004.

 

47.     M. Eric Gershwin, Yehuda Shoenfeld (Editors). Autoimmunity Concepts and diagnosis at the cutting edge. Annals of the New York Academy of Sciences, V volum 1050, 2005.

 

48.     Yehuda Shoenfeld, M. Eric Gershwin (Editors). Autoimmune Diseases and Treatment, Organ-specific and systemic disorders. Special issue of Annals of the New York Academy of Sciences, Volum 1051, 2005.

 

49.     Yehuda Shoenfeld, M. Eric Gershwin (Editors). Autoimmunity, Part D. Autoimmune Diseases, Annus Mirabilis. Annals of the New York Academy of Sciences, Volum 1108, 2007.

 

50.     K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany.

 

51.     Shoenfeld Y (Editor). The Israeli Medical Encyclopedia, 10 volumes, written by 1200 physicians. Yediot Achronot Publisahers, pp. 2370, 2007.

 

52.     Sherer Y, Shoenfeld Y (Editors). Autoantibodies Guide in Systemic Lupus Erythematosus. Published by: Bio-Rad Laboratories. 2007.

 

53.     Shoenfeld Y, Gershwin ME, Meroni PL (Editors). Autoantibodies 2nd Edition. Elsevier Publ. Amsterdam- The Netherlands, pp 1-838, 2007.

 

54.     Shoenfeld Y, Cervera R, Gershwin M.E. Diagnostic Criteria in Autoimmune Diseases. Humana Press, Springer Science + Business Media, LLC, USA. pp 1-593, 2008.

 

55.     Conrad K, Chan EKL, Fritzler MJ, Humbel RL, von Landenberg P, Shoenfeld Y (Editors). From pathogenesis to therapy of autoimmune diseases. Report on the 9th Dresden Symposium on Autoantibodies held in Dresden on September 2-5, 2009. PABST Science Publishers, 49525 Lengerich, Germany. Pp 1-568, 2009.

 

56.     Shoenfeld Y, M Eric Gershwin (Editors). Contemporary challenges in autoimmunity. Annals of the New York Academy of Sciences, Volume 1173. Blackwell Publishing on behalf of the New York Academy of Sciences Boston, Massachusetts, 2009.

 

57.     K Conrad, E.K.L. Chan, M.J Fritzler, R.L. Humbel, P. von Landenberg, Y. Shoenfeld (Editors). From Pathogenesis to therapy of autoimmune diseases. Report on the 9th Dresden Symposium on Autoantibodies, held in Dresden on September 2-5, 2009. Autoantigens, Autoantibodies, Autoimmunity Volume 6 – 2009. PABST Science Publishers, pp: 1-568.

 

58.     Shoenfeld Y, Youinou P, Gershwin EM. (Guest Editors). The environment geoepidemiology and autoimmune diseases. Elsevier Publ. Amsterdam- The Netherlands. Printed in the UK and The Netherlands. 2010.

 

59.     Shoenfeld Y, Agmon-Levin N. (Guest Editors). New Pearls on CTDs. In: Best KPractice & Research Clinical Rheumatology, Volume 26, No.1, February 2012. pp. 1-157. Elsevier Publ.

 

60.     Shoenfeld Y, Tincani A, Gershwin ME (Guests Editors). Gender sex hormones pregnancy and autoimmunity. This is a compilation of Separate Special Issues of Journal of Autoimmunity (Vol. 38/2.3) and Autoimmunity Reviews (Vol.11/6.7), 2012, pp. 1-544. Published for the 8th International Congress on Autoimmunity, Granada, Spain, 2012. Elsevier Publ.

 

61.     Shoenfeld Y. Meroni P.L. (Editors). The General Practice Guide to Autoimmune Diseases. PABST Science Publishers, Lengerich. 2012; pp. 1-331.

 

62.     Yehunda Shoenfeld, Pier Luigi Meroni, and Ricard Cervera (Editors). E-book: Immunotherapeutic Agents for SLE. 93 pages. February, 2012 Copyright © 2012 Future Medicine Ltd doi: 10.2217/9781780840529 eISBN.

 

63.     Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y (Editors). "Infection, Tumors and Autoimmunity. Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013". 2013 Pabst Science Publishers, 49525 Lengerich. PP.1-361

 

64.     Juan Manuel Anaya, Yehuda Shoenfeld, Adrian Rojas-Villarraga, Roger A. Levy, Ricard Cervera (Editors). Autoimmunity from bench to bedside. El Rosario University Press, Bogota, Colombia. PP. 1-839, 2014.

 

65.     Yehuda Shoenfeld, Nancy Agmon-Levin, Noel R. Rose (Editors). Infection and Autoimmunity- Second edition. Elsevier BV Academic Press Publication, 2015. PP. 1-1036.

  

66.     Yehuda Shoenfeld, Nancy Agmon-Levin, Lucija Tomljenovic (Editors). Vaccines & Autoimmunity. Published by Willey-Blackwell. Hoboken, New Jersey, USA, 2015. PP. 369.

1.       Sohar E, Shoenfeld Y. Medicine and medical forces. In: Israel Army and Defence (Hebrew). Editors: Schiff Z, Haber E and Bitan Z. Modan 1976.

 

2.       Shapiro Y, Sohar E, Magazanik A, Shoenfeld Y. Sweat studies in patients with plantar hyperhidrosis. (Chapt 71). In: Selected Topics in Environmental Biology. Editors: Bhatia B, China GS, Singh B, 1975. pp. 453-454.

 

3.       Shoenfeld Y, Shapiro Y. I. Adjustment to the climatic conditions in the cold dessert. pp. 128-133. II. Cold injuries in the dessert. In: The Dessert-Past, Present and Future. Editor: Sohar E, Reshafim, Tel-Aviv (Hebrew), 1977.

 

4.       Sohar E, Shoenfeld Y, Shapiro Y. The climate, condition and way of life in the Jordan Valley Judea and Samaria (Hebrew). Editors: Shmueli A, Grossman D and Zeevi R. Onaan, Jerusalem.

 

5.       Shoenfeld Y, Sohar E, Ohry A, Shapiro Y. Cardiovascular and pathophysiological effects of the sauna. In: Internal Medicine: Topics. Editors: Louhija A and Valtonen V. Karger S. New-York, 1977. pp. 322-330.

6.       Shvartz E, Meroz A, Magazanik A, Shoenfeld Y. An assessment of exercise and heat orthostatism. In: Physical Fitness Assessment: Principles, Practices and Application. Editors: Shepard RJ and Lavallee A. Charles C Thomas, Spirngfield, I11. 1978. pp. 102-110.

 

7.       Shoenfeld Y, Schwartz RS. Hamatologic manifestations of SLE. In: The Clinical Management of Systemic Lupus Erythematosus. Editor: Peter H. Schur, Grune & Stratton, N.Y. 1983. pp. 123-137.

 

8.       Shoenfeld Y, Schwartz RS. The production of monoclonal atnibodies by human-human hybridomas: Their application to studies of autoimmune diseases. In: Human Hybridomas and Monoclonal Antibodies. Editors: E.G. Engelman et al. Plenum Press N.Y. 1985. pp. 247-260.

 

9.       Shoenfeld Y, Schwartz JA, Schwartz RS, Stollar BD. Anti-DNA Antibodies in: Systemic Lupus Erythematosus. Editor: M. Lahita. Academic Press, N.Y. 1986.

 

10.     Keydar I, Tsarfaty I, Smoradinsky N, Sahar E, Shoenfeld Y. Human monoclonal antibodies directed against MuMTV antigens from human breast cancer cells. In: New Experimental Modalities in the Control of Neoplasia. Editor: P. Chandara. Plenum Press, 1987.

 

11.     Shoenfeld Y, Tomer Y, Ben-Yehuda O. Treatment of autoimmune diseases: New modalities. In: Prospective on Autoimmunity. Editor: IR Cohen. CRC Press, USA, 1987.

 

12.     Shoenfeld Y. Analyses of anti-DNA idiotypes. In: Perspective on Autoimmunity. Editor: IR Cohen. Academic Press, 1987.

 

13.     Shoenfeld Y, Cohen IR. Infection and autoimmunity. In: The Antigens, Editor: M. Sela. Academic Press, 1987. pp. 307-325.

 

14.     Isenberg DA, Shoenfeld Y, Schwartz RS. The importance of the study of monoclonal antibodies in SLE. In: SLE. Editor: Smolen JS & Zielinski CC. Springer-Verlag, Berlin, 1987.

 

15.     Shoenfeld Y, Tsarfaty I, Smoradinsky N, Keydar I. In vitro immuinization of PBL with HuMTV, and the production of human MAbs reacting with MMTV and HuMTV. In: In vitro Immunization in Hybridomas. Science Pub. Amsterdam, 1988.

 

16.     Smoradinsky N, Tsaarfaty I, Ghendler Y, Argov S, Bakimer R, Krup M, Shoenfeld Y. Human monoclonal antibodies directed against viral antigens. In: Breast Cancer: Scientific and Clinical Progress. Editors: Rice MA, Hagen JL, Lopez DN. Kluwes Academic Pub. N.Y. USA. 1988, pp. 174-184.

17.     Amital-Teplizki H, Shoenfeld Y. The human anti-DNA idiotype (16/6 idiotype). In: Monoclonal Antibodies, Cytokines and Arthritis. Editor: Kresina TF. Marcel Dekker, New-Yrok, 1991. pp. 435-464.

 

18.     Shoenfeld Y. Ageing and autoimmunity: lesosns learnt from the presence of autoantibodies in patient with malignant conditions. In: Immunotherapy with Intravenous Immunoglobulins. Editor: P. Imbach. Academic Press. 1991. pp. 307-318.

 

19.     Abu-Shakra M, Shoenfeld Y. Chapter 15. Chronic infection and autoimmunity. In: Molecular Immunobiology of Self - Reactivity. Editors: Bona CA, Kaushik AK. Marcel-Dekker. Inc. New-York 1992, pp. 284-313.

 

20.     Alkan M, Shoenfeld Y. BCG. In: Encyclopedia of Immunology. Editor: Roitt I. Academic Press. N.Y. USA 1992. pp. 221-222.

 

21.     Assali A, Shoenfeld Y. Benign familial neutropenia. In: Genetic Diversity Among Jews: Diseases and Markers at the DNA Level. Editors: Bone-Tamir B, Adan A. Oxford University Press N.Y. 1992. pp. 267-274.

22.     Shoenfeld Y. Autoimmunity and autoimmune diseases like SLE. In: Systemic Lupus Erythematosus (2nd Ed) Editor: R.G. Lahita. Churchil Livingston. N.Y. USA, 1992. pp. 1-14.

 

23.     Buskila D, Shoenfeld Y. Anti-DNA antibodies. In Idem. pp. 205-206.

 

24.     Tomer Y, Shoenfeld Y. Idiotypes, antinuclear antibodies anti-idiotypes and autoimmunity. In: Enfermedades Autoimmunes del Tejido Conectivo. Editors: Kamashta MA, Font J, Hughes GRV. Ediciones Doyma, Madrid, Spain. 1992. pp. 29-41.

 

25.     Cohen J, Bakimer R, David N, Shoenfeld Y. Early pregnancy loss and the anti-phospholipid syndrome. In: Implantation and Early Pregnancy in Humans. Editors: Barnea F, Check JH, Grudzinskas JG, Maruo T. The Parthenon Pub. Group. New-Yrok, USA. 1993, pp. 333-355.

 

26.     Buskila D, Shoenfeld Y. Experimental models of SLE. In: The Kidney in Collagen Vascular Diseases. Editors: Grishman E, Churg J, Needle MA, Venkatasehan VS. Raven Press 1993. pp. 5-22.

 

27.     Ehrenfeld M, Shoenfeld Y. Hematology and Oncology in Rheumatology. Chapter 1.3.8. In: Oxford Textbook of Rheumatology. Editors: Maddison PJ, Isenberg DA, Woo P, Glass DN. Oxford University Press, Oxford U.K. 1993. pp. 154-163.

 

28.     Buskila D, Shoenfeld Y. Anti-DNA idiotypes: Their pathogenic role in autoimmunity. In: Concept in Immunopathology Clinical and Molecular Aspects of Autoimmune Diseases 8:85-114, 1993.

 

29.     Buskila D, Shoenfeld Y. Manipulation of anti-DNA idiotypes: A possible treatment approach to autoimmune disease. In: Concept Immunopathol Clin and Molec Aspects of Autoimmune Dis. 8:114-128, 1993.

 

30.     Shoenfeld Y. Idiotypic induction of autoimmune diseases: In: The Impact of Biotechnology on Autoimmunity. Eds: Dalgleish AG, Albertini A, Paoletti R. Kluwer Academic Pub. 1994. pp. 73-80.

 

31.     Mozes E, Shoenfeld Y. Experimental systemic lupus erythematosus: Role of the idiotypic network. In: Autoimmune Disease Models: A Guidebook. Editors: Cohen IR, Miller A. Academic Press Inc. USA. pp. 245-253, 1994.

 

32.     George J, Shoenfeld Y: Actin autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 10-12, 1996.

 

33.     Youinou P, Maran R, Dueymes M, ShoenfeldY: Autoantibody subclasses. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 103 - 108, 1996.

 

34.     Lorber M, George J, Shoenfeld Y: Hidden Autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 357 - 363, 1996.

 

35.     Abu-Shakra M, Buskila D, Shoenfeld Y: Idiotypes and anti-idiotypic antibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 408 - 416, 1996.

 

36.     George J, Shoenfeld Y: Natural autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 534 - 539, 1996.

 

37.     Cervera R, Shoenfeld Y: Pathogenic mechanisms. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 607- 617, 1996.

 

38.     Fishman P, Merimsky O, Baharav E, Shoenfeld Y: Tyrosinase autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 842 - 845, 1996.

 

39.     Guest Editor: Shoenfeld Y: “The dead sea: A source of life” therapeutic and economic potential. Special issue of the Isr J Med Sci: 1996 Vol 32(Suppl).

 

40.     Shoenfeld Y, Ehrenfeld M: Hematologic Manifestations. In: The Clinical Management of Systemic Lupus Erythematosus (SLE). (2nd Ed.). Editor: Peter H. Schur. Lippincott-Raven, N.Y., U.S.A., pp. 95-108, 1996.

 

41.     Abu-Shakra M, Buskila D, Shoenfeld Y: Idiotypes and anti-idiotypes. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 53-65, 1997.

 

42.     Buskila D, Abu-Shakra M, Shoenfeld Y: Idiotypes and anti-DNA antibodies. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 75-89, 1997.

 

43.     Dayan YB, Amital H, Shoenfeld Y: Idiotypes of anti-Ro and anti-La. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 95-99, 1997.

44.     Bakimer R, Shoenfeld Y: Idiotypes of anti-phospholipid antibodies. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 119-129, 1997.

45.     Abu-Shakra M, Buskila D, Shoenfeld Y: Idiotypes of platelet associated antibodies (autoimmune thrombocytopenia). In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 165-169, 1997

46.     Buskila D, Abu-Shakra, Shoenfeld Y: Manipulation of autoantibody idiotypes in autoimmune diseases. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 203-215, 1997.

47.     Merimsky O, Fishman P, Shoenfeld Y: Cancer therapy with anti-idiotypic antibodies. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Editors: Yehuda Shoenfeld, Ron Kennedy, Soldano Ferrone. Pub. Elsevier, pp. 407-417, 1997.

48.     Levy Y, George J, Langewitch P, Lorber M, Bar-Dayan Y, Gilburd B, Zandman-Goddard G, Fabbrizzi F, Shoenfeld Y: Novel aspects of IVIG treatment in autoimmune diseases. In: Proceedings of the XIX ILAR Congress of Rheumatology. 456-458, Singapore, 8-13 June,1997.

49.     Shoenfeld Y: Autoantibodies - antigen driven or idiotypically induced. In Proceeding of the XIX ILAR Congress of Rheumatology. 230-233, Singapore, 8-13 June, 1997.

50.     Shoenfeld Y, Buskila D: Animal models for systemic lupus erythemathosus. In: Proceedings of the XIX ILAR Congress of Rheumatology. 186-187, Singapore, 8-13 June, 1997.

51.     Shoenfeld Y, Blank M, Ziporen L: Animal models for antiphospholipid syndrome (APS). In: Proceeings of the XIX Ilar Congress of Rheumatology , 420-423,Singapore,8-13 June, 1997.

52.     Ehrengeld M, Pras M, Shoenfeld Y. Is familial mediterranean fever an autoimmune disease or an immune mediated condition? In: Familial Mediterranean Fever. Sohar E, Gafni J, Pras M (Eds.) Freund Publishing House Ltd., London, 267-278, 1997.

53.     Abu-Shakra M, Buskila D, Shoenfled Y. Introduction – Idiotypes and Anti-idiotypes. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.53-63.

54.     Buskila D, Abu-Shakra M, Shoenfled Y. Idiotypes of Anti-DNA Antibodies. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier, Amsterdam, The Netherlands, 1997. Pp.75-88.

55.     Bar Dayan Y, Amital H, Shoenfled Y. Idiotypes of Anti-Ro and Anti-La. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.95-97.

56.     Bakimer R, Shoenfled Y. Idiotypes of Anti-Phospholipid Antibodies. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.119-128.

57.     Abu-Shakra M, Buskila D, Shoenfled Y. Idiotypes of Platelet Associated Antibodies (Autoimmune Thrombocytopenia). In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. pp.189-192.

58.     Abu-Shakra M, Buskila D, Shoenfled Y. Idiotypes of Natural Autoantobodies and Monoclanal Gammopathies. In: Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.193-203.

59.     Buskila D, Abu-Shakra M Shoenfled Y. Manipulation of Autoantibody Idiotypes In Autoimmune Diseases. In: Idiotypes in Medicine Autoimmunity, Infection and Cancer. Eds: Shoenfeld Y, Keneddy RC, Feronne S. Elsevier,Amsterdam, The Netherlands, 1997. Pp.227-238.

60.     Ehrenfeld M, Shoenfeld Y: Chapter 1.3.8 Oncology and Haematology. in: Oxford Textbook of Rheumatology (Maddison et al – Eds). Oxford University Press, 1998, Oxford U.K. pp. 288-298.

61.     Tincani A, Shoenfeld Y. Animal models of Anti-Phospholipid Syndrome. in: Reumatologia V Teorii a Praxi V. Eds: Josef Rovenski. 1998: pp. 217-227. Vydavatelstvo Osveta. Banska Bystriia. Slovakia.

62.     George J, Alkan M, Shoenfeld Y. BCG In: Encyclopedia of Immunology. Editor I Roitt, P. Delves. Academic Press. USA. p. 335-336, 1998.

 

63.     Shoenfeld Y, Shere Y, The idiotypic network in autoimmune diseases – Induction and Treatment. pp. 124-134 in: Pathogenic and Diagnostic Relevance of Autoantibodies. Eds: Conrad K, Humbel RL, Member M, Shoenfeld Y, Tan & N.

 

64.     Amital H, Shoenfeld Y, Autoimmunity and autoimmune Diseases such as SLE. In: Systemic Lupus Erythematosus, Ed: R.G.Lahita, Academic Press San-Diego, USA pp. 1-16, 1998.

 

65.     Sherer Y, Bar-Dayan Y, Shoenfeld Y. The Dual Relationship Between Thymectomy and Autoimmunity: The Kaleidoscope of Autoimmune Disease. Sudhir paul, University of Texas/Huston Medical Scholl, Houston, TX. pp. 1-448, 1998.

 

66.     Blank M, Ziporen L, Krause L, Shoenfeld Y. Immunomodulation of Experimental Antiphospholipid Syndrome: Lessons from Murine Models. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 81-84, 1999.

 

67.     Shoenfeld Y, Cervera R. Innovations in Autoimmunity in the Last Decade. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 7-18, 1999.

 

68.     Merimsky O, Shoenfeld Y, Fishman P. A Focus on Anti-Tyrosinase Antibodies in Melanoma and Vitiligo. In: The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 261-268, 1999.

 

69.     Zurgil N, Gerbat S, Langevitz P, Tishler M, Ehrenfeld M, Kaufmann M, Deutsch M, Shoenfeld Y. Detection of Cellular Activity in Autoimmune Disorders by the Cellscan System. In: The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 295-304, 1999.

 

70.     Barak V, Shoenfeld Y. Cytokines in Autoimmunity. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 313-322, 1999.

 

71.     Buskila D, Abu-Shakra M, Shoenfeld Y. Prolactin and Autoimmunity. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 339-346, 1999.

 

72.     Buskila D, Sikuler E, Shoenfeld Y. Hepartitis C virus and Autoimmunity. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 355-364, 1999.

 

73.     George J, Shoenfeld Y. Introduction: The immune system, the autoimmune state and autoimmune disease. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 1-18, 2000.

 

74.     Abu-Shakra M, Buskila D, Shoenfeld Y. Rheumatoid arthritis and cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 19-30, 2000.

 

75.     Abu-Shakra M, Buskila D, Shoenfeld Y. SLE and Cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 31-40, 2000.

 

76.     Aron-Maor A, Shoenfeld Y. PSS (Scleroderma) and Cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 45-48, 2000.

 

77.     Tishler M, Shoenfeld Y. Paraneoplastic Syndromes. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 121-132, 2000.

 

78.     Tomer Y, Shoenfeld Y. Autoantibodies, autoimmunity and cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 141-150, 2000.

 

79.     Sherer Y, Shoenfeld Y. Thymoma and autoimmune diseases. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 249-252, 2000.

 

80.     Prindiville T.P., Cantrell M.C., Shoenfeld Y, Gershwin E.M. Apoptosis: The relation between anti-fas antibodies, and immunosurveillance against cancer and autoimmunity. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 1-19, 2000.

 

81.     Buskila D, Sikuler E, Shoenfeld Y. Hepatitis C virus, autoimmunity and cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 285-298, 2000.

 

82.     George J, Shoenfeld Y. The smoking - cancer - autoimmunity connection. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 309-316, 2000.

 

83.     Buskila D, Abu-Shakra M, Shoenfeld Y. Anti-idiotypic in autoimmunity. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 365-378, 2000.

 

84.     Blank M, Krause I, Shoenfeld Y. The contribution of experimental models to our understanding of etiology, pathogenesis and novel therapies in the antiphospholipid syndrome. In: "Hughes Syndrome Antiphospholipid syndrome (Ed: M.A. Khamashta) Springer Publ : 379-385, 2000.

 

85.     Blank M, Krause I, Shoenfeld Y. Molecular mimicry: lessons from experimental models of systemic lupus erythematosus and antiphospholipid syndrome. (Chap. 16) in: Molecular Mimicry, Microbes, and Autoimmunity. (Editors: M.W. Cunningham, R.S. Fujinami), 2000, ASM Press, Washington, D.C. pp. 223-233.

 

86.     Fishman P, Shoenfeld Y. Intravenous immunoglobulin (IVIg) as an inhibitor of tumor growth: from autoimmunity to cancer. (Chap. 13 ) in: Old Herborn University Seminar Monogrph. (Editors: Peter J. Heidt, Volker D. Rusch, Dirk Van Der Waaij), 2001, Herborn Litterae, pp:93-107.

 

87.     Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin (IVIg) in autoimmune diseases - expanding indications and increasing specificity. (Chap. 13 ) in: Old Herborn University Seminar Monogrph. Editors: Peter J. Heidt, Volker D. Rusch; Dirk Van Der Waaij, 2001, Herborn Litterae, pp:85-91.

 

88.     Shoenfeld Y, Haratz D, Wick G. Introduction: autoimmunity an additional 'risk factor' for atherosclrosis. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 1-2, 2001.

 

89.     Goldkorn T, George J, Lavrentiadou S.N., Ravid T, Tsaba A, Shoenfeld Y, Haratz D. Ceramide pathway and apoptosis in autoimmunity and atherosclerosis. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 55-72, 2001.

 

90.     Watkins S.M., German G.J., Shoenfeld Y, Gershwin E. Lipid and immunity. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 87-111, 2001.

 

91.     Shoenfeld Y, George J, Sherer Y, Haratz D. Atherosclerosis: evidence for the role of autoimmunity. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 139-142, 2001.

 

92.     Matsuura E, Kobayashi K, Kasahara J, Shoenfeld Y, Koike T. Oxidized autoantigens in atherosclerosis. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 143-150, 2001.

 

93.     Sherer Y, Blank M, Vaarala O, Shaish A, Shoenfeld Y. Anti-prothrombin antibodies in thrombosis and atherosclerosis. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 185-190, 2001.

 

94.     Zurgil N, Levy Y, Gilburd B, Trubiankov E, Deutch M, Shagran Y, Shoenfeld Y. Detection of cellular activity in atherosclerosis by the novel cellscan system. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D. and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 191-200, 2001.

 

95.     Meroni PL, Raschi E, Testoni C, Riboni M, Praprotnik S, Shoenfeld Y. Functional heterogeneity of pathogenic anti-endothelial cell antibodies. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D. and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 211-220, 2001

 

96.     Rauova L, Chapman J, Shoenfeld Y. Brain vasculitis and antiphospholipid syndrome. In: Brain disease therapeutic strategies and repair. Publication: Martin Dunitz; pp: 193-200, 2001.

 

97.     Shoenfeld Y, Blank M. Infectious origin of antiphospholipid syndrome. In: From Proteomics to Molecular Epidemiology: Relevance of Autoantibodies (Report of the 6th Dresden Synposium on Autoantibodies Sept. 4-7, 2002). K Conrad, M. Fritzler, M. Meurer, U. Sack, Y Shoenfeld (Editors). PABST Science Pub. , Germany, 2002, pp: 149-160.

 

98.     Blank M, Sherer Y, Shoenfeld Y. Autoantibodies associated with reproductive failure. In: From Proteomics to Molecular Epidemiology: Relevance of Autoantibodies (Report of the 6th Dresden Synposium on Autoantibodies Sept. 4-7, 2002). K Conrad, M. Fritzler, M. Meurer, U. Sack, Y Shoenfeld (Editors). PABST Science Pub. , Germany, 2002, pp: 300-313.

 

99.     Blank M, Sherer Y, Shoenfeld Y. Novel perspectives in the treatment of the antiphospholipid syndrome - from anticoagulation to immunomodulation. In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: p. 421, 2002

 

100.   Shere Y, Shoenfeld Y. Antiphospholipid antibodies in human and murine atherosclerosis. In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 137-141, 2002.

 

101.   Zandman-Goddard G, Blank M, Shoenfeld Y. Antiphospholipid antibodies and infections-drugs. In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 343-358, 2002

 

102.   Asherson RA, Cervera R, Piette JC, Shoenfeld Y. Milestones in the antiphospholipid syndrome. In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 3-9, 2002.

 

103.   Shoenfeld Y, Sherer Y, Blank M. Systemic involvement in the antiphospholipid syndrome: lessons from animal models. In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 101-106, 2002.

 

104.   Ehrenfeld M, Amital H, Shoenfeld Y. Cytokines, Th1/Th2 and adhesion molecules in the antipholpholipid syndrome. In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 107-112, 2002

 

105.   Abu-Shakra M, Shoenfeld Y. Lessons from monoclonal antiphospholipid antibodies. In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Asherson RA, Cervera R, Pietter JC, Shoenfeld Y. (Editors). Elsevier Publ. Amsterdam, The Netherlands: pp. 113-118, 2002

 

106.   Chapman J, Shoenfeld Y. Neurological and Neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome. In: Neuroendocrine immune basis of the rheumatic diseases II. Cutolo M, Bijlsma J W.J, Lahita R G, Masi A T, Straub R H, Bradlow L (Editors) Annals of the New York Academy of Sciences, Volume 966, 2002.

 

107.   Sherer Y, Shoenfeld Y. Intravenous immunoglobulin as therapy for RA. In: Targeted Therapies in Rheumatology. Josef S Smolen, Peter E Lipsky (Editors). Martin Dunitz; Taylor & Francis Group, London and New York, 2003.

 

108.   Sherer Y, Shoenfeld Y. Intravenous immunoglobulin as an immunomodulatory agent in systemic lupus erythematosus and lupus nephritis. In: Intravenous Immunoglobulins in the Third Millennium. Marinos C Dalakas, Peter J Spath (Editors). The Parthenon Publishing Group. pp. 357, 2003.

 

109.   Krause I, Shoenfeld Y. Intravenous immunoglobulin for fibrosis, atherosclerosis and malignant conditions. In: Intravenous Immunoglobulins in the Third Millennium. Marinos C Dalakas, Peter J Spath (Editors). The Parthenon Publishing Group. pp. 361, 2003.

 

110.   Sherer Y, Pauletto P, Shoenfeld Y. Atherosclerosis and autoimmunity. In: The Heart in Systemic Autoimmune Diseases, volume 1. Andrea Doria, Paolo Pauletto (Editors). Roland A. Asherson (Series Editor). Elsevier Publ. Amsterdam, The Netherlands: pp. 89-95, 2003.

 

111.   Rattazzi M, Shoenfeld Y, Pauletto P. Innate Immunity, inflammation, and atherogenesis. In: The Heart in Systemic Autoimmune Diseases, volume 1. Andrea Doria, Paolo Pauletto (Editors). Roland A. Asherson (Series Editor). Elsevier Publ. Amsterdam, The Netherlands: pp. 77-88, 2003.

 

112.   Amital H, Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In: Systemic LUPUS Erythematosus 4th edition. Robert G. Lahita (Editor), Elsevier Publication, Amsterdam, The Netherlands) pp. 3-27, 2004.

 

113.   Amital H, Shoenfeld Y. The etiopathogenesis of autoimmunity. In: "Stem cell therapy for autoimmune disease". Eds: Richard K. Brut & Alberto M. Marmont. Laandes Bioschience Georgetown, Texas, USA, pp: 106-112, 2004

 

114.   Blank M., Shoenfeld Y. Autoimmune pregnancy loss – experimental models. In: "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K. Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 71-84, 2004.

 

115.   Blank M, Nur I, Meidler R, Bar L, Slutzki L, Gilburd B, Shoenfeld Y. Peptide mimetics of anti-dsDNA idiotypes as a tool for Lupus-specific IVIG preparation: specificity and efficacy in the treatment of experimental SLE. In: "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K. Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, p: 106, 2004.

 

116.   Meroni PL, Shoenfeld Y. Receptors of the innate immunity as targets for circulating autoantibodies: antiphospholipid syndrome as a paradigm. In: "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K. Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 118-125, 2004.

 

117.   Inagaki J, Kondo A, Lopez LR, Shoenfeld Y, Matsuura E. Anti-laminin-1 autoantibodies in reproductive failure: animal and human studies. In: "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K. Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 243-252, 2004.

 

118.   Zandman-Goddard G, Blank M, Langevitz P, Pras M, Levy Y, Witte T, Doria A, Rovensky J, Shoenfeld Y. Elevated anti-serum amyloid component P (SAP) antibodies in SLE patients correlate with disease activity. In: "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 259-260, 2004.

 

119.   Matsuura E, Kobayashi K, Shoenfeld Y, Lopez LR. Atherogenic role of protein-modified oxidized low-density lipoproteins and their autoantibodies. In: "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack, Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 388-405, 2004.

 

120.   Marai I, Shoenfeld Y. Autoantibodies and recurrent miscarriages. In: "From animal models to human genetics: research on the induction and pathodenicity of autoantibodies" report on the 7th Dresden symposium on autoantibodies September 1-4, 2004, Eds: K.Conrad, M.P. Bachmann, E.K.L. Chan, M.J.Fritzler, R.L.Humbel, U.Sack,Y.Shoenfeld. Pabst Science Publishers, Germany, pp: 406-421, 2004.

 

121.   Shoenfeld Y, Rose NR. Introduction: Infection and Autoimmunity. In: Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ.Amsterdam The Netherlands, pp:1-4,2004.

 

122.   Aron Maor-A, Shoenfeld Y. Vaccination and autoimmunity. In: Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 105-116, 2004.

 

123.   Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. In: Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 171-179, 2004.

 

124.   Severin M.C., Shoenfeld Y. Parvovirus B19 infection and its association to autoimmune disease. In: Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 181-188, 2004.

 

125.   Abu Shakra M, Shoenfeld Y. Parasitic infection and autoimmunity. In: Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 439-448, 2004.

 

126.   Blank M, Eosemsteom M, Asherson RA, Cervera R, Shoenfeld Y. The infectious origin of the antiphospholipid syndrome. In: Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 473-490, 2004.

 

127.   Zandman-Goddard G, Shoenfeld Y. SLE and infections. In: Infection and Autoimmunity. Yehuda Shoenfeld & Noel R. Rose (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 491-503, 2004.

 

128.   Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. In: AIDS vaccines and related topics, 2004. Aldar S. Bourinbaiar (Editor). Immunitor Corporation Co., Ltd , Thailand, 2004.

 

129.   Tsabari R, Chapman J, Shoenfeld Y, Schwammenthal Y. asculitides – miscellaneous vasculitides. In: Neurologic involvement in systemic autoimmune diseases, volume 3. Doruk Erkan, Steven R. Levine (Editors). Elsevier Publ. Amsterdam- The Netherlands, pp: 217-227, 2004.

 

130.   Krause I, Shoenfeld Y. Intravenous immunoglobulin treatment for fibrosis, atheros and malignant conditions. In: Adoptive Immunotherapy Methods and Protocols. Burkhard Ludewig & Matthias W. Hoffmann (Editors). Humana Press, Totowa, New Jersey, pp: 403-408, 2004.

 

131.   Tishler M, Shoenfeld Y. BCG vaccination, autoimmunity and bladder cancer. In: Progress in Bladder Cancer Research. A.M. Mallory (Editor). Horizons in Cancer Research Vol. 6 ISBN 1-59454-129-9 NOVA science Publishers, Inc., pp.: 147-153, 2005.

 

132.   Tishler M, Shoenfeld Y. Vaccines and autoimmunity. In: The Autoimmune diseases 4th Ed. Noel R. Rose & Ian R. Mackay (Editors). Elsevier Publ. Amstersan – The Netherlands, pp: 309 – 316, 2005.

 

133.   Meroni PL, Mondini M, Airo P, Riboldi P, Shoenfeld Y, Gariglio M, Landolfo S. The human interferon-inducible protein IFI16: a mediator of inflammation and a target for autoimmunity. In: From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany, pp. 210-215.

 

134.   Sherer Y, Shoenfeld Y. Anti-phospholipid antibodies as predictors of autoimmune disease manifestations. In: From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany, pp. 370-377.

 

135.   Shoenfeld Y. Prediction of autoimmunity – more than just autoantibodies. In: From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany., pp. 2-5.

 

136.   Shoenfeld Y. Toubi E. Protective autoantibodies: Role in homeostasis, clinical importance and therapeutic potential. In: From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publishers, Germany, pp. 62-76.

 

137.   Szyper Kravitz M, Shoenfeld Y. Clinical and pathological significance of autoantibodies against protective molecules. In: From Etiopathogenesis to the prediction of autoimmune diseases: Relevance of autoantibodies, report on the 8th Dresden symposium on autoantibodies held in Dresden on September 12-15,2007. K. Conrad, E.K.L Chan, M.J. Frizler, U. Sack, Y Shoenfeld, A.S. Wiik (Editors). Autoantigens, Autoantibodies, Autoimmunity Volume 5- 2007. Pabst Science Publisher, Germany, pp. 131-140.

 

138.   Blank M, Praprotnik S, Shoenfeld Y. Systemic vasculitis autoantibodies targeting endothelial cells. In: Endothelial Biomedicine. William C Aird (Editor). Cambridge University Press. 2007. pp: 1411.

 

139.   Twig G, Sherer Y, Blank M, Shoenfeld Y. Antiphospholipid syndrome – pathophysiology. In: Recurrent Pregnancy Loss causes, controversies and treatment. Howard JA Carp (Editor). Informa Healthcare, 2007. pp: 285.

 

140.   Papageorgiou N.P, Shoenfeld Y. Autoantibodies in gastrointestinal autoimmune diseases. In: Handbook of Systemic Autoimmune Diseases. Josep Font, Manuel Ramos-Casals and Juan Rodes (Editors). Elsevier B.V. 2008. Volume 8 Chapter 17.

 

141.   Peeva E, Zandman-Goddard G, Shoenfeld Y. Gender bias in murine lupus. In: Handbook of Systemic Autoimmune Diseases. Series Editor: Ronald A. Asherson..Endocrine Manifestations of systemic autoimmune diseases. Edited by: Sara E, Walker & Luis J. Jara. 2008. Volume 9; Chapter 3. pp: 21-27.

 

142.   Carp HJA, Ornoy A, Shoenfeld Y. Autoantibodies and infertility in autoimmune diseases. In: Handbook of Systemic Autoimmune Diseases. Series Editor: Ronald A. Asherson..Endocrine Manifestations of systemic autoimmune diseases. Edited by: Sara E, Walker & Luis J. Jara. 2008. Volume 9; Chapter 14. pp: 157-172.

 

143.   Arnson Y, Amital H, Shoenfeld Y. The immunoendocrine role of Vitamin D in autoimmunity. In: Handbook of Systemic Autoimmune Diseases. Series Editor: Ronald A. Asherson..Endocrine Manifestations of systemic autoimmune diseases. Edited by: Sara E, Walker & Luis J. Jara. 2008. Volume 9; Chapter 26. pp: 293 – 299.

 

144.   Rohan Willis, Yehuda Shoenfeld, Silvia S. Pierangeli, Miri Blank. What is the Origin of Antiphospholipid Antibodies? D. Erkan, S.S. Pierangeli (Editors). In: Antiphospholipid Syndrome Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies. Springer Publication, 2012. Part II pages: 23- 40.

 

145.   Maurizio Cutolo, M. Plebani, Yehuda Shoenfeld, Luciano Adorini, Angela Tincani. Vitamin D Endocrine System and the Immune Response in Rheumatic Diseases. Chapter 14 in Book: Vitamins and Hormons Vol. 86, Elslevier Publ. 2011; ISSN 0083-6729, DOI: 10.1016/B978-0-12-386960-9.00014-9.

 

146.   Michal Solomon, Yehuda Shoenfeld, Gisele Zandman-Goddard. Task force report on non-criteria manifestations: Skin. D. Erkan, S.S. Pierangeli (Editors). In: Antiphospholipid Syndrome Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies. Springer Publication, 2012. Part III pages: 235 – 246.

 

147.   Zolta´n Szekanecz, Gy€orgy Kerekes, and Yehuda Shoenfeld. Chapter 26: Anti-Inflammatory Therapeutic Approaches. PP. 513-528. In book: G. Wick and C. Grundtman (eds.), Inflammation and Atherosclerosis, DOI 10.1007/978-3-7091-0338-8_26, # Springer-Verlag/Wien 2012.

 

148.   Miri Blank, Tomer Bashi, Yehuda Shoenfeld. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases. Chapter 18 pp. 353-361, in book: Human monoclonal antibodies. Editor: Michal Steinitz. PP. 1-364, Humana Press, 2013.

 

149.   Moran Landau Rabbi, Ilan Ben-Zvi, Nancy Agmon-Levin, Yehuda Shoenfeld. Environment, immune dysfunction, and systemic lupus erythematosus. Chapter 8 pp. 193-213, in book: Immunotoxicity, immune dysfunction, and chronic disease. Editors: Rodney R. Dietert and Robert W. Luebke. PP. 1- 451. Humana Press 2012.

 

150.   Perricone C, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Chapter No. 1/1 in book: "Infection, Tumors and Autoimmunity. Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013". Editors: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y. 2013 Pabst Science Publishers, 49525 Lengerich. PP.1-361.

 

151.   Borella E, Shoenfeld Y. Vitamin D in infection and autoimmunity. Chapter No. 1/4 in book: "Infection, Tumors and Autoimmunity. Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013". Editors: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y. 2013 Pabst Science Publishers, 49525 Lengerich. PP.1-361.

 

152.   Rosario C, Shoenfeld Y. The hyperferritinemic syndrome in infection and autoimmunity. Chapter No. 1/6 in book: "Infection, Tumors and Autoimmunity. Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013". Editors: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y. 2013 Pabst Science Publishers, 49525 Lengerich. PP.1-361.

 

153.   Blank M, Jordan L, Bashi T, Shoenfeld Y. Harnessing parasitic infection to treat autoimmunity. Chapter No. 2/23 in book: "Infection, Tumors and Autoimmunity. Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013". Editors: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y. 2013 Pabst Science Publishers, 49525 Lengerich. PP.1-361.

 

154.   Gilburd B, Agmon-Levin N, Martins T, Petzold A, Matthias T, Shoenfeld Y. HELIOS, a bright future for ANA – automated indirect immunofluorescence (IIF) assay. Chapter No. 6.2/90 in book: "Infection, Tumors and Autoimmunity. Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013". Editors: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Steiner G, Shoenfeld Y. 2013 Pabst Science Publishers, 49525 Lengerich. PP.1-361.

 

155.   Anaya JM, Rojas-Villarraga A, Shoenfeld Y. From the mosaic of lautoimmunity to the autoimmune tautology. Chapter No. 14 in book: "Autoimmunity from bench to bedside", Editors: Juan Manuel Anaya, Yehuda Shoenfeld, Adrian Rojas-Villarraga, Roger A. Levy, Ricard Cervera.El Rosario University Press, Bogota, Colombia. PP. 1-839, 2014.

 

 

156.   Arango MT, Shoenfeld Y, Cervera R, Anaya JM. Infection and autoimmune diseases. Chapter No. 19 in book: "Autoimmunity from bench to bedside", Editors: Juan Manuel Anaya, Yehuda Shoenfeld, Adrian Rojas-Villarraga, Roger A. Levy, Ricard Cervera.El Rosario University Press, Bogota, Colombia. PP. 1-839, 2014.

 

157.   Blank M, Israeli E. Gertel S. Amital H, Shoenfeld Y. Molecular mimicry in autoimmunity and vaccination Chapter No. 21 in book: "Autoimmunity from bench to bedside", Editors: Juan Manuel Anaya, Yehuda Shoenfeld, Adrian Rojas-Villarraga, Roger A. Levy, Ricard Cervera.El Rosario University Press, Bogota, Colombia. PP. 1-839, 2014.

 

158.   Zandman Goddard G, Shoenfeld Y. Intravenous Immunoglobulin customized therapy. Chapter No. 41 in book: "Autoimmunity from bench to bedside", Editors: Juan Manuel Anaya, Yehuda Shoenfeld, Adrian Rojas-Villarraga, Roger A. Levy, Ricard Cervera.El Rosario University Press, Bogota, Colombia. PP. 1-839, 2014.

 

159.   Soriano A, Blank M, Shoenfeld Y. Genetics and origin of antiphospholipid syndrome. Chapter No in book: "Antiphospholipid antibody syndrome. From bench to bedside". Editor: Pierre Luigi Meroni. Springer publication. PP. 1-263, 2014.

 

160.   Agmon-Levin N, Shoenfeld Y. Systemic lupus erythematosus ank the environment. Chapter No.9 in book: "Systemic Lupus Erythematosus, Basic, Applied and Clinical Aspects". Editor: George C. Tsokos. Elsevier Publ., 2016; pp: 63-69. (see also No. 1886 in "Articles" section).

 

161.   Michael Ehrenfeld, Yehuda Shoenfeld (Authors). Hematologic manifestations of rheumatoid arthritis. Chapter in: 2016 UpToDate, Inc. Editors: Section Editor: Prof. Ravinder N Maini; Deputy Editor: Prof. Paul L Romain. 

1. Shoenfeld Y, Ehrenfeld NA, Fried A. Osteogenesis imperfecta. Harefuah 83:319-322, 1972.

 

2. Shoenfeld Y, Schreibman S, Pick AI. AFP in embryonal cell carcinoma of the testis. Harefuah 85:163-165, 1973.

 

3. Shoenfeld Y, Sclerovsky S. T wave changes in urticaria. Harefuah 85:359-362, 1973.

 

4. Shoenfeld Y, Pick AI, Frohlichman R, Schriebman S. Non-secretory multiple myelloma. Harefuah 86:540-543, 1974.

 

5. Sheonfeld Y, Shapiro Y, Harel O. Adjustment to climatic conditions of the Sinai desert. Harefuah 87:452-454, 1974.

 

6. Shoenfeld Y, Sclerovsky S. Patterns of T wave changes in ECG in urticaria. Brit J Drm 90:283-288, 1974.

 

7. Pick AI, Shoenfeld Y, Schriebman S, Frohlichman R, Pinkhas J. Multiple myeloma: A study of 40 patients. Isr J Med Sci 10:1371-1378, 1974.

 

8. Pick AI, Shoenfeld Y. IgA-heavy chain (alpha chain) disease. Harefuah 87:77-79, 1974.

 

9. Pick AI, Shoenfeld Y. Treatment of multiple myeloma. Harefuah 86:558-560, 1974.

 

10. Shoenfeld Y, Schreibman S, Pick AI. AFP in testicular carcinoma. Urol Int 30:162-171, 1975.

 

11. Shoenfeld Y, shapiro Y. Hyperhidrosis palmaris and plantaris. Harefuah 88:184-185, 1975.

 

12. Shoenfeld Y, Shapiro Y. Neurocirculatory asthenia. Harefuah 89:414-416, 1975.

 

13. Shoenfeld Y, Pick AI. Lymphocyte, plasma cell and the immune response. Harefuah 88:466-474, 1975.

 

14. Shoenfeld Y, Shapiro Y, Fischer BK, Dvoretzky I. Sweating in the "adhidrotic type" of congenital ectodermal dysplasia. Dermatology 180:277-282, 1975.

 

15. Shoenfeld Y, Fried A, Ehrenfeld EN. Osteogenesis imperfecta: Review of the literature and presentation of 29 cases. Amer J Dis Child 129:679-694, 1975.

 

16. Pick AI, Shoenfeld Y, Schreibman S, Weiss C, Ben-bassat M. AFP assay, signficance and clinical application. Ny St J Med 27:1403, 1975.

 

17. Liberman P, Shoenfeld Y. Malignant hyperthermia. Harefuah 89:120-131, 1975.

 

18. Shapiro Y, Shoenfeld Y. Methods in investigating physical fitness. Harefuah 88:578-579, 1975.

 

19. Pick AI, Shoenfeld Y, Schreibman S, Frohlichman R, Pinkhas J. The effectiveness of melphalan in multiple myeloma. Modern Medicine 5:117, 1975.

 

20. Shoenfeld Y, Koren G, Shapiro Y. Physiology and pathophysiology of exposure to cold. Harefuah 90:124-128, 1976.

 

21. Shoenfeld Y, Shapiro Y, Koren G. Superficial cold lesions. Harefuah 90:229-231, 1976.

 

22. Shoenfeld Y, Zohar E, Ohry A, Shapiro Y. Heat stress: Comparison of short exposure to wet and dry saunas. Arch Phys Med Rehab 57:126-131, 1976.

 

23. Shoenfeld Y, Kurchin A, Shapiro Y, Machtiger A, Adar R. Phenomena associated with sympathectomy following hyperhidrosis. Harefuah 90:309-311, 1976.

 

24. Shoenfeld Y. B lymphocyte activation. Harefuah 90:578-581, 1976.

 

25. Shoenfeld Y, Pick AI, Schreibman S, Kessler H, Dintzman M. Alpha-feto-protein in a 3 year old child with hepatoma. Tumori 62:43-50, 1976.

 

26. Shoenfeld Y, Shapiro Y, Machtiger A, magazanik A. Sweat studies in hyperhidrosis palmaris and plantaris. Dermatologica 152:257-263, 1976.

 

27. Buchner A, Malinek A, Shoenfeld Y. Physiologic pigmentation of the gingiva. Harefuah 90:12-13, 1976.

 

28. Shapiro Y, Koren G, Shoenfeld Y, Sohar E. Accidental hypothermia in healthy adults. Harefua 90:164-167, 1976.

 

29. Koren G, Shoenfeld Y, Shapiro Y. II. Acidental hypothermia. Harefuah 90:175-180, 1976.

 

30. Pick AI, Shoenfeld Y. Disturbances in immunological mechanisms and development of malignancy. Harefuah 90:373-379, 1976.

 

31. Shilo S, Shoenfeld Y, Cabili S, Sohar E. Hypothermia secondary to endocrine dysfunction. Harefuah 90:419-421, 1976.

 

32. Drory Y, Shoenfeld Y, Shapiro Y, Hanne N. Athlete's heart syndrome. Harefuah 91:90-95, 1976.

 

33. Dvoretzky I, Shoenfeld Y, Fischer BK, Shapiro Y. Congenital ectodermal dysplasia: presentation of 7 cases. Harefuah 91:227-229, 1976.

 

34. Biernfeld C, Shapiro Y, Shoenfeld Y. Comparison of the climatic data in the west and east inclinations of the Judean mountains. Meteorology 1:34-37, 1976.

 

35. Sohar E, Shoenfeld Y, Shapiro Y, Ohry A, Cabili S. Effects of exposure to Finnish sauna. Isr J Med Sci 12:1275-1282, 1976.

 

36. Drory Y, Shoenfeld Y, Hanne N, Kellerman JJ. ECG changes in top athletes. Cardiology 61:267-278, 1976.

 

37. Shoenfeld Y, Shapiro Y. Physical activity, physical fitness and health. Harefuah 91:125-128, 1977.

 

38. Shoenfeld Y, Shapiro Y, Drory Y, Hanne N, Kellerman J. Aerobic work capacity in 1200, 18-60 year old men and 400 athletes. Isr J Med Sci 13:240-244, 1977.

 

39. Shoenfeld Y, Shapiro Y, Maechtiger A, Portugeeze D, Sohar E. Aerobic work capacity in male and female high school students. Isr J Med Sci 13:245-252, 1977.

 

40. Shoenfeld Y, Shapiro Y. Orthostatism in healthy people and spinal cord injury. Harefuah 92:219-222, 1977.

 

41. Shoenfeld Y, Djaldetti M, Weinberger A, Asherow J, Pinkhas J. A family with hereditary ovalocytosis. Harefuah 92:351-352, 1977.

 

42. Shoenfeld Y, Berliner S, Weinberger A, Pinkhas J. Hereditary ovalocytosis. (Editorial) Harefuah 92:358-359, 1977.

 

43. Shoenfeld Y, Shapiro Y, Sohar E. TheF and its influence on the human body. Harefuah 92:512-514, 1977.

 

44. Shoenfeld Y, Coffee drinking and myocardial infarction. Harefuah 93:44-45, 1977.

 

45. Shoenfeld Y, Weinberger A, Ben-bassat M, Pinkhas J. Generalized pruritus in metastatic adenocarcinoma of the stomach. Dermatologia 155:122-124, 1977.

 

46. Shoenfeld Y, Pick AI, Danziger Y, Kalazci I, Frohlichman R, Pinkhas J. Immunoglobulin changes in SLE. Ann Allergy 39:99-102, 1972.

 

47. Shoenfeld Y, Pick AI, Schreibman S, Zelikovsky A, Wollach Y, Mintz U, Udassin R, Pinkhas J. Our experience with the carcinoembryonic antigens (CEA and AFP). Harefuah 93:177-181, 1977.

 

48. Shoenfeld Y, Weinberger A, Pinkhas J. Hereditary benign leukopenia. harefuah 93:203-204, 1977.

 

49. Shoenfeld Y, Shapiro Y, Protugeeze D, Modan M, Sohar E. Maximal backpack load for long distance hiking. J Sport Med 17:147-153, 1977.

 

50. Shoenfeld Y, Shapiro Y, glazevsky Y, drory Y, Kellermann JJ, Sohar E. Rehabilitation of patients with NCA (neurocirculatory asthenia) through a short term training program. Amer J Phys Med 56:1-5, 1977.

 

51. Pick AI, Varsano D, Ben-Bassat M, Shoenfeld Y. Agammaglobulinemia, plasma cell dyscrasia and amyloidosis in a 12 year old child. Amer J Dis Child 131:682-686, 1977.

 

52. Nord E, Shoenfeld Y, Pinkhas J, DeVries A. Cytomegalovirus mononucleosis. Harefuah 92:466-467, 1977.

 

53. Pick AI, Shoenfeld Y, Schreibman S, Frohlichman R. Asymptomatic (benign) monoclonal gammopathy - a study of 100 patients. Ann Clin Lab Sci 7:335-343, 1977.

 

54. Pick AI, Shoenfeld Y, Zelikovsky A, Wollach Y, Mintz U. Diagnostic significance of CEA concentration - A study of 61 patients with malignancies. Amer J Protocol 28:37-43, 1977.

 

55. Shapiro Y, Shoenfeld Y. Physiological changes of the cardiovascular system on exertion. Harefuah 93:155-156, 1977.

 

56. Udassin R, Shoenfeld Y, Shapiro Y, Birenfeld C, Sohar E. Serum glucose and lactic concentrations during prolonged strenuous exercise in man. Amer J Phy Med 56:249-256, 1977.

 

57. Shvartz E, Meroz A, Magazanik A. Shoenfeld Y, Shapiro Y. Exercise and heat orthostatism and the effect on heat acclimatization and physical fitness. Avi Space Environ Med 48:836, 1977.

 

58. Shoenfeld Y, Udassin R, Ohry A, Shapiro Y, Sohar E. Age and sex differences in short exposure to extreme heat. J Appl Physiol 44:1-4, 1978.

 

59. Shoenfeld Y, Miraz D, Pick AI. Tumors of the urinary bladder and the immunological system. Harefuah 94:193-195, 1978.

 

60. Shoenfeld Y, Berliner S. Crohn's disease and the immunological system. Harefua 94:240-241, 1978.

 

61. Shoenfeld Y, Shapiro Y, Ohry A, Levy Y, Udassin R, Drory Y, Rozin Y, Sohar E. Orthostatic hypotension in amputees and subjects with spinal cord injuries. Arch Phys Med Rehab 59:138-141, 1978.

 

62. Shoenfeld Y, Pick AI, Weinberger A, Ben-Bassat M, Pinkhas J. Pleural effusion as a presenting sign in multiple myeloma. Respiration 36:160-164, 1978.

 

63. Shoenfeld Y, Avidor E, Eldar M, Vidne B, Levy M, Pinkhas J. Squamos cell carcinoma associated with sarcoidosis in the lung. Oncology 35:112-113, 1978.

 

64. Shoenfeld Y, Udassin R, shapiro Y, Bierenfeld C, Magazanik A. Optimal backpack load for short distances. Arch Phys Med rehab 59:281-285, 1978.

 

65. Shoenfeld Y. CPC - Sezary syndrome and bacterial endocarditis. Harefuah 95:95-100, 1978.

 

66. Shoenfeld Y, Pick AI, Gura V, Frohlichman R, Pinkhas J. Systemic lupus erythematosus associated with mixed cryoglobulinemia and circulating anticoagulant. South Afr J Med 54:1056-1058, 1978.

 

67. Shoenfeld Y, Weinberger A, Avishar R, Zamir R, Gazit E, Joshua H, Pinkhas J. Familial leukopenia among Yemenite Jews. Isr J Med Sci 14:1271-1274, 1978.

 

68. Shoenfeld Y, Udassin R, Bierenfeld C, Sohar E. The work capacity in high school students in the "kibbutz" in Israel. J Sport Med 18:385-390, 1978.

 

69. Delpre G, Shoenfeld Y, Weinberger A, Avidor I, Rousso I, Kadish U, Pinkhas J. Infiltration lymphocytaire lecemique et ulcere chronique simulant und cancer de l'estomac. Gastroenterol Clin Biol 2:71-76, 1978.

 

70. Berliner S, Shoenfeld Y, Weinberger A, Pinkhas J. Polyarteritis nodosa - Survey of 26 patients. Rheumatologica 36:137-143, 1978.

 

71. Pick AI, Shoenfeld Y, Hershkovitz M, Ben-bassat M, Ducziminer M, Schreibman S, frohlichman R, Sheinberg A. Macroglobulinemia - a survey of 33 patients. Harefuah 94:253-263, 1978.

 

72. Glanz I, Eldar M, Shoenfeld Y, Pitlik S, Tchernilas I, Pinkhas J. Chronic eosinophilic pneumonia. Harefuah 96:66-69, 1978.

 

73. Neeman A, Shoenfeld Y, Eldar M, Pinkhas J. Eosinophilic gastroenteritis. Harefuah 95:108, 1978.

 

74. Sohar E, Bierenfeld C, Shoenfeld Y, Shapiro Y. Description and forecast of summer climate in physiologically significant terms. Int J Biometerol 22:75-81, 1978.

 

75. Eldar M, Shoenfel Y, Pinkhas J. Diagnostic parameters in SBE. Harefuah 95:271-272, 1978.

 

76. Shapiro A, Shoenfeld Y, Shapiro Y. The effect of standardized submaximal work load on intraocular pressure. Brit J Ophtahlmol 62:679-681, 1978.

 

77. Sohar E, Udassin R, Shoenfeld Y, Magazanik A, Revach Z. Cold induced profuse sweating on back and chest. Lancet 2:1073-1075, 1978.

 

78. Avisar R, Savir H, Shoenfeld Y. Prevalence of pterygium in Israel. Harefuah 95:161-162, 1978.

 

79. Livne P, Eldar M, Shoenfeld Y, Dintsman m, Pinkhas J. Recurrent gastrointestinal bleeding associated with aortic stenosis. Harefuah 95:395-396, 1978.

 

80. Berliner S, Shoenfeld Y, Shaklai M, Sidi Y, Pick AI, Pinkhas J. Transient mixed cryoglobulinemia associated with chronic myelocitic leukemia. Biomedicine 29:259, 1978.

 

81. Shoenfeld Y, Pick AI. Hyperviscosity syndrome in plasma cell dyscrasia. Harefuah 96:161-163, 1979.

 

82. Shoenfeld Y. Inbar O. The anaerobic capacity. Harefuah 96:557-558, 1979.

 

83. Shoenfeld Y. Clinico-pathological conferences: CPC, progressive dyspnea, dry cough, syncope, hemoptysis, loss of weight, death. Harefuah 97:313-317, 1979.

 

84. Pick AI, Shoenfeld Y, Frohlichman R, Weiss H, Vana D, Schreibman S. Plasma cell dyscrasia: Analysis of 423 patients. JAMA 241:2275-2278, 1979.

 

85. Weinberger A, Shoenfeld Y, Zamir R, Gazit E, Joshua H, Pinkhas J. HLA antigens in genetic neutropenia of Yemenite Jews. Vox Sang 36:105-108, 1979.

 

86. Shapiro A, Shoenfeld Y, Shapiro Y. The effect of exposure to heat on intraocular pressure. Grafe Archiv Ophthalmologie 210:183-185, 1979.

 

87. Berliner S, Shoenfeld Y, Zegenreich A, Meiraz D, Pinkhas J. Testicular lymphoma: Presentation of 6 patients. Harefuah 96:573-574, 1979.

 

88. Shapiro Y, Magazanik A, Udassin R, Shvartz E, Shoenfeld Y. Heat intolerance in former heatstroke patients. Ann Int Med 90:913-916, 1979.

 

89. Weitzman A, Eldar M, Shoenfeld Y, Hischorn M, Wijsenbeek H, Pinkhas J. Hypercalcemia-induced psychopathology in malignant disease. Brit J Psychiat 135:363-366, 1979.

 

90. Aderka D, Shoenfeld Y. The interferon: Mode of action and therapeutic action. Harefuah 96:299-300, 1979.

 

91. Eldar M, Shoenfeld Y, Zaizov R, Fogel R, Asherov G, Liban E, Pinkhas J. Pulmonary alveolar proteinosis associated with Fanconi's anemia. Respiration 38:177-180, 1979.

 

92. Pick AI, Eldar M, Douer D, Levo Y, Weiss C, Shoenfeld Y, Pinkhas J. Depressed PHA transformation and acute leukemia in macrolobulinemia. Cancer 44:1741-1744, 1979.

 

93. Aderka D, Eldar M, Shoenfeld Y, Ravid M, Feuerman E, Pimkhas J. Epidermal ridge disarrangement and Hamman-Rich syndrome. Dermatology 160:21-24, 1980.

 

94. Berliner S, Shoenfeld Y, Livni E, Pinkhas J. Allergic purpura following intravenous administration of interferon. Acta Hematol 62:178, 1979.

 

95. Ravid M, Shoenfeld Y. The use of the reference list. Harefuah 97:141-142, 1979.

 

96. Epstein Y, Udassin R, Shapiro Y, Shoenfeld Y. Anthropological and physiological characteristics of the different Jeweish ethnic groups in Israel. S Afric J Phys Sports Phys Educ Rec 2:5-8, 1979.

 

97. Shoenfeld Y, Mor R, Avidor E, Weinberger A, Pinkhas J. Diagonal ear lobe crease and coronary risk factors. J Amer Ger Soc 28:184-188, 190.

 

98. Shoenfeld Y, Keren G, Shimoni T, Sohar E. Walking - a quick method for improving physical fitness. JAMA 243:2062-2063, 1980.

 

99. Shoenfeld Y, Eldar M, Bedazovsky B, Levy M, Pinkhas J. Aortic stenosis associated with gastrointestinal bleeding: A survey of 612 patients. Amer Heart J 137:179-182, 1980.

 

100. Shoenfeld Y, Shaulian E, Shaklai M, Krugliak Y, Feuerman E, Pinkhas J. Circulating anticoagulant and serological tests for syphilis. Acta Dermatovener 60:365-367, 1980.

 

101. Shoenfeld Y, berliner S, Pinkhas J, Beutler E. Gaucher's disease and dysproteinemia. Acta Haematol 64:241-243, 1980.

 

102. Shoenfeld Y, Livni E, Shaklai m, Pimkhas J. Sensitization to ibuprofen in SLE. JAMA 244:547-548, 1980.

 

103. Shoenfeld Y, Shaulian E, Berliner S, Shaklai M, Krugliak y, Pinkhas J. Thromboembolic phenomeon in patients with "lupus type circulating anticoagulant". Rheumatologica 51:417-424, 1980.

 

104. Beldegrin A, Shoenfeld Y, Pick AI, Vana D. Age related distribution of serum immunoglobulin concentrations in 1003 healthy children and adults. Biomedicine 33:8-12, 1980.

 

105. Eldar M, Neeman A, Shoenfeld Y, Pinkhas J. Transient mixed cryoglobulinemia associated with typhoid hepatitis. New Instanbul Contro Cli Res 13:55-57, 1980.

 

106. Berliner S, Neeman A, Shoenfeld Y, Eldar M, rousso I, Kadish U, Pinkhas J. Salazopyrin induced eosinophilic pneumonia. Respiration 39:119-120, 1980.

 

107. Neeman A, Berliner S, Shoenfeld Y, Kadish U, Pinkhas J. Salazopyrine induced tachycardia. Biomedicine 33:1-2, 1980.

 

108. Udassin R, Keren G, Shoenfeld Y. Acclimatization to heat. Harefuah 98:3-33, 1980.

 

109. Eldar M, Shoenfeld Y, Douer D, Pinkhas J. Hypercalcemia in Hodgkin's disease. Hematologia 65:459-463, 1980.

 

110. Berliner S, Shoenfeld Y, Pinkhas J. Mixed connective tissue disease. Harefuah 98:475-477, 1980.

 

111. Eldar M, Carel R, Shoenfeld Y. Hypertension and obesity. Harefuah 93:427-428, 1980.

 

112. Berliner S, Shoenfeld Y, Pinkhas J. Splenectomy in myeloproliferative diseases. Harefuah 98:274-275, 1980.

 

113. Shoenfeld Y, Berliner S, Neeman A, Kadish M, Pinkhas J. Cryoglobulinemia in chronic liver diseases. Amer J Gastroenterol 74:439-440, 1980.

 

114. Berliner S, Shoenfeld Y, Eldar M, Pinkhas J. Inappropriate ADH secretion secondary to fibrothorax. Respiration 29:283-285, 1980.

 

115. Aderka D, Shoenfeld Y, Santo M, Berliner S, Pinkhas J. Life threatening hypophosphatemia in a patient with acute myeloid leukemia. Acta Haematol 64:117-119, 1980.

 

116. Garfunkel D, Shoenfeld Y, Gadoth N, Pinkhas J. Oculomotor nerve paresis-presenting sign of acute myeloid leukemia. Hamatologia 65:769-771, 1980.

 

117. Shoenfeld Y, Avidor I, Liban E, Levy M, Pinkhas J. Leiomyosarcoma of the pulmonary artery. Respiration 41:208-213, 1981.

 

118. Shoenfeld Y, Gurewich Y, Gallant LA, Pinkhas J. Prednisone-induced leukocytosis: The influence of dosage, method and duration of administration on the degree of leukocytosis. Amer J Med 71:773-778, 1981.

 

119. Shoenfeld Y, Hage S. The effect of hypophosphatemia on peripheral blood cells. Harefuah 101:126-127, 1981.

 

120. Berliner S, Shoenfeld Y, Pinkhas J. The leukomogenic action of cytotoxic drugs. Harefuah 100:44-45, 1981.

 

121. Shoenfeld Y, Aloni D, Keren G, Shaklai M, Djaldetti M, Pinkhas J. Effect of physical effort on the white blood cells in benign familial leukopenia. Acta Haematol 65:108-113, 1981.

 

122. Aderka D, Shoenfeld Y, Berliner S, Shaklai M, Pinkhas J. Spontaneous remission of erythroleukemia following interestitial pneumonia. NY St J Med 41:772-773, 1981.

 

123. Udassin R, Harari L, Shoenfeld Y, Keren G. Cholinergic urticaria: A seasonal disease. Arch Int Med 141:1029-1030, 1981.

 

124. Shoenfeld Y, Pinkhas J. Chronic benign neutropenia. Harefuah 100:198-199, 1981.

 

125. Avisar R, Shoenfeld Y, Pick AI, Creter D, Cohen A, Djaldetti M, Savir H. Plasma cell dyscrasia. part I: Fluorescein angiography findings in plasma cell dyscrasia. Metab Pediat Ophthal 5:171-175, 1981.

 

126. Berliner S, Shoenfeld Y, Shaklai M, Pinkhas J. Conservative treatment of Budd-Chiari syndrome in polycythemia vera. Hematologia 66:220-222, 1981.

 

127. Shapiro A, Shoenfeld Y, Konikoff F, Shapiro Y. The relationship between body temperature and intraocular pressure. Ann Ophthalmol 28:159-161, 1981.

 

128. Berliner S, Weinberger A, Shoenfeld Y, Pinkhas J. Autoimmune disease in mice. Harefuah 100:529-530, 1981.

 

129. Bogard CH, Shoenfeld Y, Pinkhas J. Passive smoking. Harefuah 100:345-347, 1981.

 

130. Shaulian E, Shoenfeld Y, Berliner S, Shaklai M, Pinkhas J. Surgery in patients with circulating anticoagulant. Int Surg 66:157-159, 1981.

 

131. Giller S, Berliner S, Shoenfeld Y, Pinkhas J. Surgery in patients with hepatitis. Medicine Int 19: 211-215, 1981.

 

132. Berliner S, Shoenfeld Y, Dean H, Pinkhas J. Pulmonary hypertension in a patient with Marfan's syndrome. Respiration 41:214-215, 1981.

 

133. Shoenfeld Y, Keren G, Birenfeld C, Sohar E. Age, weight, and heart rate at rest as predictors of aerobic fitness. J Sport Med 21:377-382, 1981.

 

134. Shoenfeld Y, Hager S, Berliner S, Gallant LA, Pinkhas J. Hypophosphatemia as a diagnostic aid in sepsis. NY St J Med 82:163-165, 1982.

 

135. Shoenfeld Y, Modan M, Berliner S, Yair V, Shaklai M, Shisky A, Pinkhas J. The mechanism of benign hereditary neutropenia. Arch Int Med 142:797-799, 1982.

 

136. Lavie G, Shoenfeld Y, Shaklai M, Aderka D, Pick AI, Pinkhas J. Homogeneous populations of macrophages from histiocytic lymphoma patients as a source for macrophage subpopulations which differ in immunoregulatory properties. Cancer 50:69-77, 1982.

 

137. Aderka D, Djaldetti M, Shoenfeld Y, Shaklai M, Berliner S, Weinberger A, Pinkhas J. Morphological platelet anomalies in thrombotic thrombocytopenic purpura. Acta Haematol 67:119-123, 1982.

 

138. Berliner S, Shoenfeld Y, Dean H, Avisar R, David M, Pinkhas J. Primary pulmonary hypertension: A fact of a diffuse angiopathic process. Respiration 43:76-79, 1982.

 

139. Shoenfeld Y, Schwartz RS. Hybridomas: A potent new biotechnology: The production and the use of monoclonal antibodies. Harefuah 102:479-481, 1982.

 

140. Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaldetti M, Pinkhas J. Gaucher's disease: A disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106:388-391, 1982.

 

141. Shoenfeld Y, Baruch n, Livni E, Santo M, Pinkhas J. Carbamazepine (Tegretol)-induced thrombocytopenia. Acta Haematol 68:74, 1982.

 

142. Silverberg DS, Carel RS, Shoenfeld Y, Snir C. Errors in blood pressure recording. Harefuah 102:76-78, 1982.

 

143. Shoenfeld Y, Hsu-Lin SC, Gabriel JE, Silberstein LE, Furie BC, Furie B, Stollar BD, Schwartz RS. Production of monoclonal autoantibodies by human-human hybridomas. J Clin Invest 70:205-208, 1982.

 

144. Aderka D, Shoenfeld Y, Pinkhas J. Central nervous system involvement in patients with lymphoma. Harefuah 102:124-125, 1982.

 

145. Shoenfeld Y, Rotenberg M, Berliner S, Gallant LA, Garfinkel D, Shaklai M, Pinkhas J. Absence of predictive parameters for CNS involvement in adult non-lymphocytic leukemia at time of diagnosis. Scand J Haematol 28:335-340, 1982.

 

146. Shoenfeld Y, Rauch J, Massicotte H, Datta SK, Schwartz JA, Stollar BD, Schwartz RS. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. New Eng J med 308:414-420, 1983.

 

147. Shoenfeld Y, Aderka D, Sandbank M, Gadoth N, Santo M, Pinkhas J. Fatal peripheral neurolymphomatosis following remission of histiocytic lymphoma. Neurology 33:243-245, 1983.

 

148. Isenberg DA, Shoenfeld Y. The rheumatologic complication of hematologic disorders. Semin Arthritis Rheum 12:348-358, 1983.

 

149. Shoenfeld Y, Isenberg DA, Rauch J, Madaio MP, Stollar BD, Schwartz RS. Idiotypic cross reactions of monoclonal human lupus autoantibodies. J Exp Med 158:718-730, 1983.

 

150. Shoenfeld Y, Shindel D, Neri A. Leukocytosis in pregnancy and labour. Harefuah 104:69-70, 1983.

 

151. Isenberg DA, Shoenfeld Y, and Schwartz RS. Multiple serological reactions and their relationship to clinical activity in systemic lupus erythematosus. A study of 56 patients. Arthritis Rheum 27:132-138, 1984.

 

152. Shoenfeld Y, Pinkhas J. Drug induced lupus. Harefuah 105:75-77, 1983.

 

153. Berliner S, Shoenfeld Y, Sidi Y, Weinberger A, Hazaz B, Pecht M, Zaizov R, Pinkhas J. SLE and lymphoma: A family study. Scand J Rheumatol 12:310-314, 1983.

 

154. Schwartz JA, Datta SJ, Shoenfeld Y, Isenberg DA, Stollar BD, Schwartz RA. Binding of cytoskeletal proteins by monoclonal anti-DNA lupus antibodies. Clin Immunol Immunopathol 31:261-271, 1984.

 

155. Fox H, McCarthy P, Schwartz JA, Shoenfeld Y, Miller KB. Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B cell proliferation? Cancer 54:312-314, 1984.

 

156. Shoenfeld Y, Berliner S, Ayalone A, SHaklai M, Djaldetti M, Pinkhas J. Monoclonal gammopathy in patients with chronic and acute myeloid leukemia. Cancer 54:280-283, 1984.

 

157. Isenberg DA, Shoenfeld Y, Madio M, Reichlin M, Stollar BD, Schwartz RS. Measurement of anti-DNA antibody idiotypes to monitor the course of SLE. Lancet 2:418-422, 1984.

 

158. Isenberg DA, Shoenfeld Y, Schwartz RS. The use of hybridomas to analyze autoimmunity. Brit Med Bull 40:262-266, 1984.

 

159. Carel RS, Shoenfeld Y, Eldar M, Silverberg DS, Eldar Z, Pinkhas J, Mor G. Casual blood pressure: Its relationship to several cardiovascular risk factors in middle-aged men. Pub Health (London), 98:209-215, 1984.

 

160. Shoenfeld Y, Schwartz RS. Genetic and immunologic factors in autoimmune diseases. New Eng J Med 311:1019-1029, 1984.

 

161. Massicotte H, Rauch J, Shoenfeld Y, Tannenbaum H. Influence of fusion cell ratio and cell plating density on the production of human-human hybridomas secreting anti-DNA autoantibodies from patients with SLE. Hybridoma 3::215-222, 1984.

 

162. Berliner S, Weinberger A, Shoenfeld Y, Sandbank M, Hazaz B, Joshua H, Rosen M, Pinkhas J. Ibuprofen causes meningitis in (NZB/W)F1 mice. Arthritis Rheum 28:104-107, 1985.

 

163. Shoenfeld Y. The production of human-hybridomas and their contribution to the research of autoimmune diseases. Harefuah 107:134-135, 1982.

 

164. Shoenfeld Y, Pinkhas J. Antibody activity of monoclonal immunoglobulin components in plasma cell dyscrasia. Harefuah 97:420-422, 1984.

 

165. Garfinkel D, Bogard H, Salomon F, Aderka D, Shoenfeld Y, Weinberger A, Pinkhas J. Polymyalgia rheumatica and temporal arteritis in a married couple. Am J Med Sci 287:48-49, 1984.

 

166. Shoenfeld Y, Birenmaum O, Livni E, Boimovitch B, Scheinberg A, Pinkhas J. Sensitization to ampicilin in infectious mononucleosis. Harefuah 97:174-176, 1984.

 

167. Shoenfeld Y, Ben-Tal O, Berliner S, Pinkhas J. The outcome of bacterial infection in subjects with benign familial leukopenia. Biomedicine 38:23-26, 1984.

 

168. Aderka D, Shoenfeld Y, Pinkhas J. The thymic hormones: their function and therapeutic potential. Harefuah 97:244-247, 1984.

 

169. Shoenfeld Y, Schwartz JA, Schwartz RS. Antibodies to cytoskeleton proteins in autoimmune diseases. Harefuah 107:291-193, 1984.

 

170. 1Ben-Yehuda O, Shoenfeld Y. The T-cell receptor. Harefuah 108:46-48, 1985.

 

171. Aderka D, Shoenfeld Y. Oncogenes in medicine. Harefuah 109:31-35, 1985.

 

172. Silberstein LE, Shoenfeld Y, Schwartz RS, Berkman EM. A combination of IgG and IgM autoantibodies in chronic cold agglutinin disease. Immunologic studies and response to splenectomy. Vox Sang 48:105-109, 1985.

 

173. El-Roeiy A, Shoenfeld Y. Autoimmunity and pregnancy. Amer J Rep Immunol Microbiol 9:25-32. 1985.

 

174. Shoenfeld Y, Smorodinsky NI, Lavie G, Hazaz B, Joshua HJ, Pinkhas J. Human human monoclonal autoantibodies bind to Raji cells. Immunol Lett 11:121-126, 1985.

 

175. Shoenfeld Y, Zamir R, Joshua H, Lavie G, Pinkhas J. Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies. Eur J Immunol 15:1024-1028, 1985.

 

176. Isenberg DA, Shoenfeld Y, Walport M, Brill S, Weinberger A, Pinkhas J. Detection of cross-reactive anti-DNA antibody idiotype in the serum of lupus patients and their relatives. Arthritis Rheum 28:999-1007, 1985.

 

177. Shoenfeld Y, Hareuveni M. The MuMTV and its relation to human and breast carcinoma. Harefuah 109:338-342, 1985.

 

178. El-Roiey A, Shoenfeld Y. Zinc, the immune system, and autoimmunity. Harefuah 109:406-408, 1985.

 

179. Shoenfeld Y, Tal A, Berliner S, Pinkhas J. Leukocytosis in non-hematological malignancies - A possible tumor-associated marker. J Cancer Res Clinical Oncol 111:54-58, 1986.

 

180. Shoenfeld Y. The analysis of common idiotypes of human monoclonal anti-DNA autoantibodies in SLE and related conditions. Clin Immunol Newsletter 7:70-72, 1986.

 

181. Molad Y, Shoenfeld Y. Q fever endocarditis. Harefuah 110:47, 1986.

 

182. El-Roiey A, Gross WL, Ludeman J, Isenberg DA, Shoenfeld Y. Preferential secretion of common anti-DNA idiotype (16/6 Id) and anti-polynucleotide antibodies by mononuclear cells, following stimulation with Klebsiella pneumonia. Immunol Lett 12:313-319, 1986.

 

183. Dudeney C, Shoenfeld Y, Jones M, Mackworth-Young C, Shall S, Isenberg DA. A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members. Ann Rheum Disease 45:502-507, 1986.

 

184. Shoenfeld Y, Ben-Yehuda O, Naparstek Y, Wilner Y, Frohlichman F, Schattner A, Lavie G, Joshua H, Pinkhas J, Kennedy RC, Schwartz RS, Pick AI. The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies. J Clin Immunol 6:194-204, 1986.

 

185. Progozin CH, Shoenfeld Y. Eaton-Lambert's syndrome - a new autoimmune condition. Harefuah 110:536-538, 1986.

 

186. Shoenfeld Y, Witz IP. Hybridomas from unimmunized individuals. Immunol Today 7:350-351, 1986.

 

187. Sukenik S, El-Roiey A, Shoenfeld Y. Lupus anticoagulant and anticardiolipin antibodies in SLE. Acta Hematol 76:86-89, 1986.

 

188. Shoenfeld Y, Hizi A, Tal R, Lavie G, Mor C, Shteren S, Mammon Z, Pinkhas J, Keydar I. Human monoclonal antibodies derived from lymph nodes of a female patient with breast carcinoma react with MuMTV polypeptides. Cancer 59:43-50, 1986.

 

189. Shoenfeld Y. How to determine the academic rank of physicians. Harefuah, 11: 579, 1986. כרך ק"י, חוב י"א 1.6.86 .

 

190. Kleiner-Baumgarten A, Keynan A, Shoenfeld Y. Scabies associated angioimmunoblastic lymphadenopathy. Acta Hematol 76:166-168, 1986.

 

191. Shoenfeld Y, Vilner Y, Coates ARM, Rauch J, Lavie G, Shaul D, Pinkhas J. Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp. Immunol 1986; 66: 255 – 261.

 

192. Piura B, Shoenfeld Y. Autoimmune disease in pregnancy. Harefuah 111:85-92, 1986.

 

193. Shoenfeld Y. The crisis in internal medicine. Can research solve the problem? Harefuah 111:100-101, 1986.

 

194. Konikoff F, Shoenfeld Y, Magazanik A, Shapiro Y. Effects of salt loading during exercise in a hot dry climate. Biomedicine 40:296-300, 1986.

 

195. Shoenfeld Y. Promotion in medical school: a suggestion. Harefuah 110:579-580, 1986.

 

196. Shoenfeld Y. Publishing articles in Harefuah. Harefuah 112: 36-37, 1987.

 

197. Shoenfeld Y, Brill S, Weinberger A, Pinkhas J, Isenberg DA. High levels of a common anti-DNA idiotype (16/6 Id), a genetic marker for SLE. Acta Hematol 76:107-109, 1986.

 

198. Sela O, El-Roeiy A, Isenberg DA, Kennedy RC, Colaco CB, Pinkhas J, Shoenfeld Y. A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 30:50-55, 1987.

 

199. Piura B, Shoenfeld Y. Sex hormones and autoimmune diseases. Harefuah 112:192-195, 1987.

 

 

200. Varticovsky L, Schattner A, Pick AI, Shoenfeld Y. Anti-platelet and anti-DNA IgM in Waldenstrom's macroglobulinemia and ITP. Amer J Hematol 24:351-355, 1987.

201. Arad-Dann H, Isenberg DA, Shoenfeld Y, Offer D, Sperling J, Sperling R. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis. J Immunol 138:2463-2468, 1987.

 

202. Shoenfeld Y, El-Roeiy A, Ben-Yehuda O, Pick AI. Detection of anti-histone activity in sera of patients with monoclonal gammopathies. Clin Immunol Immunopathol 42:250-258, 1987.

 

203. Shoenfeld Y, Isenberg DA. DNA antibody idiotypes: a review of their genetic, clinical and immunopathologic features. Semin Arthritis Rheum 16:245-252, 1987.

 

204. El-Roeiy A, Sela O, Isenberg DA, Kennedy RL, Shoenfeld Y. The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6 Id) and anti-polynucleotide activity. Clin Exp Immunol 67:507-515, 1987.

 

205. Neeman A, Shoenfeld Y, Kadish M. Does duodenal ulcer lead to an early diagnosis of gastric cancer? J Clinical Gastroenterol 9:37-39, 1987.

 

206. Shoenfeld Y, Segol G, Segol O, Stollar BD, Isenberg DA. Anti-histones antibodies in the serum of lupus patients and their relatives. Arthritis Rheum 30:169-175, 1987.

 

207. Isenberg DA, Maddison P, Swana G, Jones M, Dudeney C, El-Roeiy A, Shoenfeld Y. Profile of autoantibodies in the sera of patients with tuberculosis, Klebsiella and other gram-negative infections. Clin Exp Immunol 67: 516-523, 1987.

 

208. Sela O, Shoenfeld Y. Infecting agents and autoimmune diseases. Harefuah 112:285-288, 1987.

 

209. Avinoach I, Shonefeld Y. The lupus band test: its diagnostic value. Harefuah 112:554-556, 1987.

 

210. Konikoff F, Isenberg D, Kennedy RC, Kuperman O, Shoenfeld Y. Common anti-DNA idiotypes in chronic liver diseases. Clin Immunol Immunopathol 43:265-270, 1987.

 

211. Teplizki H, Buskila D, Isenberg DA, Coates ARM, Sukenik S, Horowitz J, Shoenfeld Y. Low serum anti-TB glycolipid antibodies titer in the sera of patients with SLE as an indicator of CNS involvement. J Rheumatol 14:507, 1987.

 

212. Sela O, El-Roeiy A, Pick AI, Shoenfeld Y. Immunoglobulin levels in Klebsiella and TB infection. Immunol Lett 15:117-220, 1987.

 

213. Buskila D, Shoenfeld Y. HLA system and autoimmunity. Harefuah 112:398-402, 1987.

 

214. Isenberg DA, Feldman R, Dudeney C, Konikoff F, Jones D, Erbinger A, Shoenfeld Y. A study of anti-polynucleotide antibodies, anti-Klebsiella (K30) antibodies and anti-DNA antibody idiotypes in ankylosing spondylitis. Brit J Rheumatol 26:168-171, 1987.

 

215. Sela O, baumgarten A, Shoenfeld Y. Ibuprofen induced asthmatic attacks. Harefuah 112:345-346, 1987.

 

216. El-Roeiy A, Gleicher N, Isenberg D, Kennedy RC, Shoenfeld Y. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with SLE. Clin Exp Immunol 68:528-534, 1987.

 

217. Shoenfeld Y, Shohat R. Myocardial infarction in Yemenite Jews and benign familial leukopenia neutropenia. Harefuah 112:484-450, 1987.

 

218. Slor H, Sobe T, Shoenfeld Y. Quantitation of antinuclear autoantibodies by ELISA: Specificity correlation with other methods and clinical significance. Quart Med Rev 1:6-10, 1987.

 

219. Konikoff F, Shoenfeld Y, Isenberg DA, Theodore E, Moroz CH. Placental type isoferritins in chronic liver diseases. J Hepato-Gastroenterol 34:65-67, 1987.

 

220. Tomer Y, Ben-yehuda O, Shoenfeld Y. Treatment of autoimmune diseases. Harefuah 112:608-612, 1987.

 

221. Shoenfeld Y, Vilner Y, Reshef T, Klajman A. Common anti-DNA idiotypes (32/15 and 16/6) in sera of patietns with drug-induced lupus. J Clin Immunol 7:410-417, 1987.

 

222. Teplizki H, Alkan M, Coates ARM, Shoenfeld Y. ELISA measurement of antibodies titer to PPD and mycobacteria derived phosphoglycolipids as an aiding tool to the diagnosis of active pulmonary tuberculosis. Isr J Med Sci 23:1121-1124, 1987.

 

223. Bakimer R, Kennedy R, Shoenfeld Y. Vaccination with anti-idiotypic antibodies. Harefuah 114:19-22, 1988.

 

224. Isenberg DA, Shoenfeld Y. The origin and significance of anti-DNA antibodies. Immunol Today 8:279-281, 1987.

 

225. Teplizki H, Shoenfeld Y. Vaccines against AIDS - difficulties and solutions. Harefuah 113:354-358, 1987.

 

226. Smorodinski NI, Argov S, Ghendler Y, bakimer R, Krup M, Lupu R, Keydar I, Shoenfeld Y. Human monoclonal antibodies derived from pleural effusion lymphocytes of a patient with breast carcinoma react with human breast cancer associated antigens (HMTV) and MMTV polypeptides. Exp Cell Biol 55:237-249, 1987.

 

227. Konikoff F, Shoenfeld Y, Isenberg DA, Barrison I, Sobe T, Theodor E, Slor H. Anti-RNP antibodies in chronic liver diseases. Clin Exp Rheumatol 5:359-361, 1987.

 

228. Ben-Yehuda O, Tomer Y, Shoenfeld Y. Advances in therapy of autoimmune diseases. Semin Arthritis Rheum 17:206-220, 1988.

 

229. Dror Y, Slor H, Shoenfeld Y. The clinical significance of anti-Sm and anti-RNP autoantibodies. Harefuah 114:140-144, 1988.

 

230. Isenberg DA, Shoenfeld Y. An analysis of autoimmunity through studies of DNA antibody idiotypes. Autoimmunity 1:67-75, 1988.

 

231. Teplizki H, Slor H, Shoenfeld Y. Anti-Ro and anti-La autoantibodies in autoimmune condition. Harefuah 114:88-92, 1988.

 

232. Hundert I, Shoenfeld Y. Autoimmune conditions in the eye. Harefuah 114:352-355, 1988.

 

233. Mendelovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, Mozes E. Induction of a SLE-like disease in mice by a common anti-DNA idiotype. Proc Nat Acad Sci (USA) 85:2260-2264, 1988.

 

234. Smorodinsky NI, Cahalon L, Argov S, Witz IP, Shoenfeld Y. Naturally occuring tumor-reactive autoantibodies: a monoclonal antibody from normal mice reacts with tumor cells and with DNA. Immunol Lett 18:43-50, 1988.

 

235. Shoenfeld Y, Ben-Yehuda O, Messinger Y, Bentwitch Z, Rauch J, Isenberg DA, Gadoth N. Autoimmune diseases other than lupus share common anti-DNA idiotypes. Immunol Lett 17:285-290, 1988.

 

236. Dang H, Takei M, Isenberg DA, Shoenfeld Y, Bakimer R, Rauch J, Talal N. Expression of an interspecies idiotype in sera of SLE patients and their first degree relatives. Clin Exp Immunol 71:445-450, 1988.

 

237. El-Roeiy A, Valesini G, Friberg J, Shoenfeld Y, Kennedy R, Gleicher N. Autoantibodies and common idiotypes in men and women with sperm antibodies. Amer J Obstet Gynecol 158:596-603, 1988.

 

238. Shoenfeld Y, Levene A, Blank M, Argov S, Krup M, Fleishmakher E, Sukenik S, Teplizki H. A human monoclonal anti-DNA antibody derived from a patient with polymyositis having the common lupus 16/6 idiotype. Immunol Lett 19:77-84, 1988.

 

239. Shoenfeld Y, Teplizki H, Buskila D, Leideman J, Gross W. Immunoglobulin secretion of mononuclear cells induced by various mitogens. Int J Immunopharmacol 10:352-367, 1988.

 

240. Mendlovic S, Shoenfeld Y, Bakimer R, Segal R, Dayan M, Mozes E. In vitro T cell function specific to anti-DNA idiotype and serological markers in patients with SLE. J Clin Immunol 8:178-198, 1988.

 

241. Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity. Immunology Today 9:178-181, 1988.

 

242. Avinoach I, Teplizki H, Shoenfeld Y. Serological markers in diagnosis of CNS involvement in SLE. Harefuah 114:387-390, 1988.

 

243. Tomer Y, Shoenfeld Y. Ageing and autoantibodies. Autoimmunity 1:141-149, 1988.

 

244. Asali A, Shoenfeld Y. More about benign familial neutropenia. Harefuah 114:192-194, 1988.

 

245. Chaim N, Sela O, Shoenfeld Y. Autoimmune syndrome in malignant diseases. Harefuah 114:239-242, 1988.

 

246. Shoenfeld Y. Autoimmune diseases: multiple factors involved in the etiology. Isr J Med Sci 24:351-352, 1988.

 

247. Mozes E, Mendlovic S, Bentwitch Z, Brautbar C, Shoenfeld Y. T cell-helper factors in autoimmunity. Isr J Med Sci 24:355-358, 1988.

 

248. Sela O, Shoenfeld Y. IgA deficiency and autoimmunity. Harefuah 114:560-564, 1988.

 

249. Chaim N, Shoenfeld Y. Autoantibodies in malignant states. Harefuah 114:615-619, 1988.

 

250. Shoenfeld Y, Alkan ML, Sali A, Carmeli Y, Katz M. Bengin familial leukopenia and neutropenia in different ethnic groups. Eur J Hematol 41:273-277, 1988.

 

251. Tomer Y, Shoenfeld Y. The significance of natural autoantibodies. Immunol Invest 17:389-424, 1988.

 

252. Sela O, Shoenfeld Y. Complement deficiencies and autoimmune diseases. Harefuah 115:129-135, 1988.

 

253. Firer MA, Shoenfeld Y, Isenberg DA, Slor H. The use of ELISA for the measurment of autoantibodies to nuclear antigens: comparison with other methodologies. Isr J Med Sci 24:747-750, 1988.

 

254. Zurgil N, Shafrir S, Slor H, Shoenfeld Y. Identification of anti-Sm and anti-RNP autoantibodies by immunoblotting and immunoassay. Isr J Med Sci 24:751-754, 1988.

 

255. Mozes E, Shoenfeld Y, Brocke S, Mendlovic S. Induction of experimental SLE in mice. Isr J Med Sci 24:741-744, 1988.

 

256. Piura B, Tauber E, Dror Y, Sarov B, Naggan L, Slor H, Shoenfeld Y. Antinuclear antibodies in pregnancy. Harefuah 115:360-363, 1988.

 

257. Teplizki H, Shoenfeld Y. Achievements and progress in medicine - 1987. Harefuah 115:394-397, 1988.

 

258. Shoenfeld Y, Rotem Y. 1988 Nobel Prize for Medicine and Physiology. Harefuah 115:404, 1988.

 

259. Shoenfeld Y, Zamir R. The significance of HLA studies in human-human hybridomas. Tissue Antigens 32:209-213, 1988.

 

260. Moroz CH, Landsberg L, Cohen Y, Goldstein J, Quastel MR, Shoenfeld Y. Radioimmunodetection of tumors with monoclonal antiplacental ferritin antibody: Preliminary results. Oncology 46:35-39, 1988.

 

261. Sela O, Shoenfeld Y. Cancer in autoimmune disease. Sem Arthritis Rheum 18:77-85, 1988.

 

262. Smordinsky NI, Ghendler Y, Bakimer R, Chaitchuk S, Keydar I, Shoenfeld Y. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies. Eur J Immunol 18:1713-1718, 1988

 

263. Isenberg DA, Williams W, Le Page S, Swana G, Feldman R, Addison I, Bakimer R, Shoenfeld Y. A comparison of autoantibodies and common DNA antibody idiotypes in SLE patients and their spouses. Brit J Rheumatol 27:431-435, 1988.

 

264. Sela O, Hertzanu I, Shoenfeld Y. Fulminant hepatic failure due to hepatitis A. Harefuah 116:95-96, 1989.

 

265. Swissa M, Shoenfeld Y. The clinical significance of anti-histone antibodies. Harefuah 117:117-119, 1989.

 

266. Piura B, tauber E, Sarov B, Naggan L, Shoenfeld Y. Antinuclear autoantibodies in sera of healthy pregnant women and their offspirng. Amer J Rep Immunol 18:116-119, 1988.

 

267. Abu-Shakra M, Sukenik S, Shoenfeld Y. Recurrent ischemic necrosis of the bones in young male with SLE. Harefuah 116:197-199, 1989.

 

268. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunology Today 10:123-126, 1989.

 

269. Eldar M, Shoenfeld Y. Harmful effects of smoking. Harefuah 116:283-287, 1989.

 

270. Blank M, Mendlovic S, Mozes E, Shoenfeld Y. Induction of SLE-like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying 16/6 Id. J Autoimmunity 1:683-691, 1988.

 

271. Goshen E, Livne A, Krupp M, Hammerstrom L, Dighiero G, Slor H, Shoenfeld Y. Antinuclear and related autoantibodies in sera of healthy subjects with IgA deficiency. J Autoimmunity 2:51-60, 1989.

 

272. Konikoff F, Swissa M, Shoenfeld Y. Autoantibodies to histones and their subfractions in chronic liver diseases. Clin Immunol Immunopathol 51:77-82, 1989.

 

273. Abu-Shakra M, Fritch E, Ben-Arosh D, Shoenfeld Y. Tuberculosis in a general hospital; is the incidence increasing? Harefuah 117:351-354, 1989.

 

274. Yadin O, Sarov B, Naggan L, Slor H, Shoenfeld Y. Natural autoantibodies in the serum of healthy woman-a five year follow-up. Clin Exp Immunol 75:402-406, 1989.

 

275. Abu-Shakra M, Krupp M, Argov S, Buskila D, Slor H, Shoenfeld Y. The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies. Clin Exp Immunol 76:349-353, 1989.

 

276. Shoenfeld Y, Isenberg D. Anti-DNA antibody idiotypes: their pathogenic role and prognostic significance in SLE. Diagnostic and Clinical Testing 27:52-55, 1989.

 

277. Teplizki H, Buskila D, Alkan M, Coates ARM, Baumgarten A, Shoenfeld Y. Elisa measurments of antibody titer to purified protein derivative and mycobacteria-derived phosphoglycolipids: tool for diagnosing active pulmonary tuberculosis. Isr J Med Sci 23:1121-1124, 1988.

 

278. Buskila D, Shoenfeld Y. Subgroups of patients with SLE. Harefuah 117: 470-475, 1989.

 

279. Argov S, Jaffe C, Krupp M, Slor H, Shoenfeld Y. Autoantibody production by patients with Leishmania. Clin Exp Immunol 76:190-197, 1989.

 

280. Mendlovich S, Fricke H, Shoenfeld Y, Mozes E. The role of anti-idiotypic antibodies in the induction of experimental SLE in mice. Eur J Immunol 19:729-734, 1989.

 

281. Buskila D, Abu-Shakra M, Amital-Teplizki H, Coates ARM, Krupp M, Sukenik S, Shoenfeld Y. Serum monoclonal antibodies derived from patients with multiple myeloma react with mycobacterial phosphoinositides and nuclear antigens. Clin Exp Immunol 76:378-383, 1989.

 

282. Rotem Y, Amital-Teplizki H, Shoenfeld Y. Another encounter with an old foe: autobreak of poliomyelitis in Israel-1988. Viral Immunol 2:57-60, 1989.

 

283. Shoenfeld Y, Amital-Teplizki H, Mendlovic S, Blank M, Mozes E, Isenberg DA. The role of the human anti-DNA idiotype 16/6 in autoimmunity. Clin Immunol Immunopathol 51:313-325, 1989.

 

284. Malatzky-Goshen E, Shoenfeld Y. AIDS and autoimmunity. Autoimmunity 3:201-212, 1989.

 

285. Shoenfeld Y, Segol O. Anti-histone antibodies in SLE and other autoimmune diseases. Clin Exp Rheumatol 7:265-271, 1989.

 

286. Hundert I, Bakimer R, Amital-Teplizki H, Slor H, Yassur Y, Palestine A, Nussenblatt RB, Shoenfeld Y. Antinuclear autoantibodies in uveitis. Clin Exp Rheumatol 7:237-241, 1989.

 

287. Amital-Teplizki H, Shoenfeld Y. Chorea: A rare expression of neuropsychiatric manifestation of SLE. Isr J Med Sci 25:549-551, 1989.

 

288. Vardy DA, Khoury M, Ben-Meir P, Ben-Yakar Y, Shoenfeld Y. Full skin thickners burns caused by contact with the pavement in a heat stroke victim. Burns 15:115-116, 1989.

 

289. Zurgil N, Konikoff F, Bakimer R, Slor H, Shoenfeld Y. Detection of anti-mitochondrial antibodies characterization by ELISA and immunobloting. Autoimmunity 4:289-293, 1989.

 

290. Grunebaum E, Malatzky-Goshen E, Shoenfeld Y. Natural Killer cells and autoimmunity. Immunol Res 8:292-304, 1989.

 

291. Abu-Shakra M, Shoenfeld Y. Gm allotype system and autoimmune diseases. Immunol Res 8:282-291, 1989.

 

292. Shoenfeld Y. Experimental and induced animal models of SLE and Sjogren’s syndrome. Current Opinion in Rheumatology 1: 360-368, 1989.

 

293. Slor H, Shafrir S, Isenberg DA, Granados J, Alarcon-Segovia D, Shoenfeld Y. The genetic of autoimmunity: The familial tendency of SLE. Isr J Med Sci 25:678-682, 1989.

 

294. Shoenfeld Y. Why are autoimmune diseases so diversified? Pathogenic idiotypes-an additional etiological factor. Isr J Med Sci 25:667-669, 1989.

 

295. Shoenfeld Y. Is SLE an autoimmune disease? The role of pathogenic idiotypes. Harefuah 117:333-337, 1989.

 

296. Mozes E, Brocke S, Fricke H, Dayan M, Shoenfeld Y, Mendlovic S. New experimental autoimmune models. Isr J Med Sci 25:692-695, 1989.

 

297. Mozes E, Brocke S, Sheonfeld Y, Mendlovic S. The role of idiotype network in the induction of experimental SLE. J Cell Biochem 40:173-181, 1989.

 

298. Konikoff F, Isenberg DA, Barrison I, Theodor E, Shoenfeld Y. Antinuclear autoantibodies in chronic liver diseases. Hepatogastroenterol 36:341-345, 1989.

 

299. Yadin O, Sarov B, Naggan L, Shoenfeld Y. Familial studies on the occurrence of natural autoantibodies. Nat Immun Growth Regul 8:325-330, 1989.

 

300. Arad-Dann H, Isenberg J, Sperling R. Autoantibodies against a nuclear 56Kd protein: a marker for inflammatory muscle disease. J Autoimmunity 2:877-888, 1989.

 

301. Tomer Y, Shoenfeld Y. The significance of T-suppressor cells in the development of autoimmunity. J Autoimmunity 2:739-758, 1989.

 

302. Amital-Teplizki H, Avnoach I, Coates ARM, Kooperman O, Blank M, Shoenfeld Y. Binding of monoclonal anti-DNA and anti-TB glycolipid to brain tissue. Autoimmunity 4:277-287, 1989.

 

303. Blank M, Palestine A, Nussenblatt R, Shoenfeld Y. Down regulation of autoantibody levels by cyclosporine and bromocriptine in patients with uveitis. Clin Immunol Immunopathol 54:87-94, 1990.

 

304. Huminer D, Tomer Y, Pitlick S, Shoenfeld Y. Autoantibodies in cancer patients: are they tumor related or age related. Autoimmunity 5:232-233, 1990.

 

305. Page SH, Dudeney C, Hall S, Shoenfeld Y, Isenberg DA. Disease specificity of antibodies to poly (ADP-Ribose): Their relationship to anti-DNA antibodies and to disease activity in lupus. Autoimmunity 5:169-177, 1990.

 

306. Thomas MAB, Frampton G, Isenberg DA, Shoenfeld Y, Akinsola A, Ramzy M, Lilliywhite J, Williams DGA. Common anti-DNA idiotype and anti-phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmunity 2:803-812, 1989.

 

307. Blank M, Krup M, Mendlovic S, Fricke H Mozes E, talal N, Coates ARM, Shoenfeld Y. The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol 31:45-52, 1990.

 

308. Piura B, Shoenfeld Y. Recurrent abortions and the primary anti-phospholipid syndrome. Harefuah 118:158-161, 1990.

 

309. Konnikoff F, Pecht M, Theodore E, Shoenfeld Y. Primary biliary cirrhosis: lymphocyte subsets and function in a time frame. Hepatology 10:526-527, 1989.

 

310. Assali A, Shoenfeld Y. Renal crisis with normal blood pressure in a patient with scleroderma. Harefuah 118:319-320, 1990.

 

311. Blank M, Sredni B, Albeck M, Mozes E, Shoenfeld Y. The effect of the immuno modulator agent AS-101 on interleukin-2 production in SLE induced in mice by a pathogenic anti-DNA antibody. Clin Exp Immunol 79:443-447, 1990.

 

312. Swissa M, Shoenfeld Y. Immunological abnormalities in autoimmune liver diseases. Harefuah 118:264-268, 1990.

 

313. Mendlovic S, Brocke S, Fricke H, Shoenfeld Y, Bakimer R, Mozes E. The genetic regulation of the induction of experimental SLE. Immunology 69:228-236, 1990.

 

314. Goshen E, Livne A, Nagy J, Sarov I, Shoenfeld Y. Antinuclear autoantibodies in sera of patients with IgA nephropathy. Nephron 55:33-36, 1990.

 

315. Shoenfeld Y, Mozes E. Pathogenic idiotypes of antibodies and autoimmunity: A lesson from a new syndrome of experimental SLE. FASEB J 4:2646-2651, 1990.

 

316. Blank M, Mendlovic S, Fricke H, Mozes E, Talal N, Shoenfeld Y. Sex hormone involvement in the induction of expeirmental SLE by a pathogenic anti-DNA idiotype in naive mice. J Rheumatol 17:311-317, 1990.

 

317. Shoenfeld Y. Idiotypes and autoimmunity. Curr Opinion in Immunol 2:593-597, 1990.

 

318. Swissa M, Cohen Y, Shoenfeld Y. Autoantibodies in neoplasia: unresolved enigma. Cancer 65:2554-2558, 1990.

 

319. Abu-Shakra M, Shoenfeld Y. Human anti-DNA idiotype (16/6 idiotype): pathogenic role in autoimmunity. Human Ab hybridomas 1:10-14, 1990.

 

320. Avinoah I, Amital-Teplizki H, Kuperman O, Isenberg DA, Shoenfeld Y. Characteristics of anti-neuronal antibodies in SLE patients with and without CNS involvement: The role of mycobacterial cross-reacting antigens. Isr J Med Sci 26:367-373, 1990.

 

321. Avishar R, Cretzer D, Shoenfeld Y, Cohen A, Savir H. Hyperviscosity syndrome and eye involvement. Harefuah 118:696-699, 1990.

 

322. Mackworth-Young CG, Shoenfeld Y. Future directions in anti-DNA antibody idiotype research. J Autoimmunity 3:389-393, 1990.

 

323. Isenberg DA, Bakimer R, Diamond B, ebling F, Hahn B, Rauch J, Schwartz RS, Shoenfeld Y, Staines NA, Zouali M, Comparison of DNA antibody idiotypes in human sera: an international collaborative study of 19 idiotypes from 11 different laboratories. J Autoimmunity 3:393-415, 1990.

 

324. Shoenfeld Y. New autoimmune conditions. Isr J Med Sci 26:663-666, 1990.

 

325. Zurgil N, Bakimer R, Slor H, Kaplan M, Moutsopoulos H, Shoenfeld Y. Pyruvate dehydrogenase as an antigen to detect anti-mitochondrial antibodies. Isr J Med Sci 26:682-686, 1990.

 

326. Mozes E, Mendlovic S, Kalush F, Waisman A, Shoenfeld Y, Fricke H. Immunoregulation of autoimmune diseases. Isr J Med Sci 26:688-691, 1990.

 

327. Asali S, Shoenfeld Y. Vitamin D and the immune system. Harefuah 119:390-392, 1990.

 

328. Abu-Shakra M, Krup M, Slor Y, Shoenfeld Y. Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases. Clin Rheumatol 9:346-355, 1990.

 

329. Mendlovic S, Segal R, Shoenfel Y, Mozes E. Anti-DNA idiotype and anti-idiotype specific T cell responses in patients with SLE and their first degree relatives. Clin Exp Immunol 82:504-508, 1990.

 

330. Stein N, Tomer Y, Shoenfeld Y. High levels of bilirubin in hepatitis A infection of a patient with G6PD deficiency. Harefuah 119:126-130, 1990.

 

331. Shachar A, Shoenfeld Y. Additional applications to captopril. Harefuah 119:280-284, 1990.

 

332. Tomer Y, Kessler A, Many A, Shoenfeld Y. Superior vena cava occlusion in a patient with antiphospholipid syndrome. J Rheumatol 18:95-97, 1991.

 

333. Fricke H, Offen D, Mendlovic S, Shoenfeld Y, Bakimer R, Sperling J, Mozes E. Induction of experimental SLE in mice by immunization with a monoclonal anti-La autoantibody. Int Immunol 2:225-230, 1989.

 

334. Blank M, Smorodinsky NI, Keydar I, Chaitchik S, Shoenfeld Y. The production of human monoclonal anti-MMTV antibodies by in vitro immunization with anti-idiotypic antibodies. Immunol Lett 28:65-72, 1991.

 

335. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies. Proc Nat Acad Sci 88:3069-3073, 1991.

 

336. Shoenfeld Y. Ageing, autoantigen specific Ts cells, involution of the thymus, autoimmunity and autoimmune diseases. Autoimmunity 8:251-252, 1991.

 

337. Livneh A, Zemer D, Pras M, Shoenfeld Y. Activity scores in systemic lupus erythematosus. Harefuah 120:134-138, 1991.

 

338. Tomer Y, Shoenfeld Y. The erythrocyte sedimentation rate in modern medicine. Harefuah 120:199-203, 1991.

 

339. Buskila D, Shoenfeld Y, Averbuch Heller Z, Abramsky O. Neurologic complications in primary Sjogren’s syndrome. Harefuah 120:260-263, 1991.

 

340. Swissa M, Schul V, Korish S, Livneh A, Pras M, Shoenfeld Y. Determination of autoantibodies in patients with familial Mediterranean fever and their first degree relatives. J Rheumatol 18:606-608, 1991.

 

341. Weiss P, Shoenfeld Y. Shifts in autoimmune diseases: the kaleidoscope of autoimmunity. Isr J Med Sci 27:216-217, 1991.

 

342. Weiss P, Shoenfeld Y. Primary biliary cirrhosis is a multisystem disorder. Ann Med Intern 142:283-287, 1991.

 

343. Amital-teplizki H, Shoenfeld Y. Has schizophrenia an immunologic basis. Harefuah 120:392-394, 1991.

 

344. Tomer Y, Shoenfeld Y. The idiotypic network in autoimmunity. Giorn It Allergol Immunol Clin 1:3-15, 1991.

 

345. Asaly A, Shany S, Shoenfeld Y. Increased serum levels of vitamin D metabolites in black Bedouins with benign familial leukopenia. Eur J Int Medicine 2:55-61, 1991.

 

346. Shoenfeld Y, Khoury M, Ben-Yehuda O, Sela O, Abu-Shakra M, Goshen E. Hypophosphatemia in sepsis. Eur J Int Med 2:67-72, 1991.

 

347. Rahama D, Abu-Shakra M, Shoenfeld Y. Parasites and autoimmunity. Harefuah 121:104-108, 1991.

 

348. Rotem Y, Shoenfeld Y. Bibliography - the Achiles heel of medical articles. Harefuah 121:63-64, 1991.

 

349. Stein M, Reshef A, Shoenfeld Y. The significance of anti-neutrophil cytoplasmic antibody (ANCA). Harefuah 120-592-596, 1991.

 

350. Levy Y, Shoenfeld Y. Raynaud’s phenomenon-can we predict a systemic disease? Harefuah 120:660-663, 1991.

 

351. Abu-Shakra M, Shoenfeld Y. Parasitic infection and autoimmunity. Autoimmunity 9:337-344, 1991.

 

352. Fricke H, Mendlovic S, Blank M, Shoenfeld Y, Ben-bassat M, Mozes E. Idiotype specific T cell lines inducing experimental SLE in mice. Immunology 73:421-427, 1991.

 

353. Tomer Y, Cohen J, Shoenfeld Y. Clinical aspects of antiphospholipid antibody syndrome. Harefuah 120:514-520, 1991.

 

354. Grunebaum E, Chaitchuk S, Shoenfeld Y. Pancreatic carcinomas, sex hormones receptors and treatment with tamoxifen. Harefuah 120: 340-343, 1991.

 

355. Piura B, Tauber J, Slor H, Shoenfeld Y. Antinuclear autoantibodies in healthy nonpregnant and pregnant women and their offspring. Amer J Reproductive Immunol 26:28-31, 1991.

 

356. Buskila D, Shoenfel Y. Anti-DNA idiotypes. Their pathogenic role in autoimmunity. Clin Molecular Aspects of Autoimmune Diseases (Karger) 8:85-113, 1992.

 

357. Buskila D, Shoenfeld Y. Manipulation of anti-DNA idiotypes. A possible treatment approach to autoimmune diseases. Clin Molecular Aspects of Autoimmune Diseases (Karger) 8:114-129, 1992.

 

358. Shoenfeld Y. Pathogenic anti-DNA idiotype (16/6 Id) in SLE. Rheumatology 11:91-96, 1991.

 

359. Firer M, Spivak T, Shoenfeld Y, Slhor H. The effects of incubation temperature and coating procedure on the measurement of antibodies to cardiolipin. J Immunol Methods 143:31-39, 1991.

 

360. Zurgil N, Bakimer R, Kaplan N, Youinou P, Shoenfeld Y. Anti-pyruvate dehydrogenase in primary biliary cirrhosis. J Clin Immunol 11:239-245, 1991.

 

361. Argov S, Shattner Y, Burstein R, Handzel ZT, Shoenfeld Y. Autoantibodies in male homosexuals and HIV infection. Immunol Lett 30:31-36, 1991.

 

362. Blank M, Ben-Bassat M, Shoenfeld Y. Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA antibody idiotype. Cell Immunol 137:474-486, 1991.

 

363. Blank M, Mendlovic S, Mozes E, Coates ARM, Shoenfeld Y. Induction of SLE in naive mice with T cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculous antibody (TB/68) antibody (16/6 Id+). Clin Immunol Immunopathol 60:471-483, 1991.

 

364. Tomer Y, Mendlovic S, Kukulansky T, Mozes E, Shoenfeld Y, Globerson A. Effects of aging on the induction of SLE in mice. Mechanisms of Ageing and Development 58:233-244, 1991.

 

365. Vilarreal GM, Alarcon-Segovia D, Villa AR, Cabral AR, Shoenfeld Y. Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anti-cardiolipin antibodies of patients with primary antiphospholipid syndrome. J Rheumatol 18:1537-1541, 1991.

 

366. Buskila D, Sukenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Amer J Reprod 26:118-123, 1991.

 

367. Shoenfeld Y, Ferrone S, Bombardieri S. New aspects in the treatment of immunomediated diseases. Clin Exp Rheumatol 9:663-673, 1991.

 

368. Dannenberg Gh.D., Shoenfeld Y. Stress reaction and the immune system. Harefuah 120:455-459, 1991.

 

369. Shoenfeld Y. Primary biliary cirrhosis and autoimmune rheumatic diseases: Prediction and prevention. Isr J Med Sci 28:113-116, 1992.

 

370. Shoenfeld Y. Biochis H, Abramsky O. Will physicians-researchers vanish? Harefuah 122: 122-123, 1992.

 

371. Shoenfeld Y, Meroni PL. The beta-2 glycoprotein-I (b2-GP-I) and anti-phospholipid antibodies. Clin Exp Rheumatol 10:205-208, 1992.

 

372. Tomer Y, Neufeld MY, Shoenfeld Y. Coma with triphasic wave pattern in EEG as a complication of temporal arteritis. Neurology 42:439-440, 1992.

 

373. Shoenfeld Y, Rotem Y. Homeopathy: permit or forbid. Harefuah 122:195-196, 1992.

 

374. Levy Y, Shoenfeld Y. Viral and autoimmune mechanisms in the etiology of dilated idiopathic cardiomyopathy. Harefuah 122:245-249, 1992.

 

375. Tomer Y, Shoenfeld Y. The relationship between the lupus anticoagulant, anti-cardiolipin antibodies and anti-phospholipid antibodies. Isr J Med Sci 28:38-41, 1992.

 

376. Zurgil N, Bakimer R, Moutsopolous HM, Youinou P, Kaplan MM, Shoenfeld Y. Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J Clin Immunol 12:201-209, 1992.

 

377. Swissa M, Cohen Y, Shoenfeld Y. Autoantibodies in the sera of patients with lymphoma. Leukemia and Lymphoma 7:117-122, 1992.

 

378. Zandman-Goddard G, Shoenfeld Y. Leukomoid reaction in a patient with pulmonary edema. Isr J Med Sci 28:307, 1992.

 

379. Teplizki-Amital H, Sela B, Shoenfeld Y. Autoantibodies to brain pulynucleotides in patients with schizophrenia. Immunol Res 11:66-73, 1992.

 

380. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anti-cardiolipin antibody (H-3). J Clin Invest 89:1558-1663, 1992.

 

381. Krause I, Cohen J, Blank M, Bakimer R, Cartman A, Hohmann A, Valesini G, Asherson RA, Kamashta MA, Hughes GRV, Shoenfeld Y. Distribution of two common idiotypes of anti-cardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, SLE and monoclonal gammopathies. Lupus 1:91-96, 1992.

 

382. Shoenfeld Y, S;pr J. Shafrir S, Krause I, granados J, Villarreal GM, Alarcon-Segovia D. Diversity and pattern of inheritance of autoantibodies in families with multiple cases of SLE. Ann Rheum Dis 51:611-818, 1992.

 

383. Weiss P, Shoenfeld Y. Anti-mitochondrial autoantibodies in primary biliary cirrhosis: breaking the code. Giorn It Allergol Immunol Clin 1:583-592, 1991.

 

384. Tomer Y, Shoenfeld Y. Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 10:391-393, 1992.

 

385. Blank M, Krause I, Ben-Bassat M, Shoenfeld Y. Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmunity 5:495-509, 1992.

 

386. Fishman P, Shoenfeld Y, Hart J, Zigelman R, Shamir Y, Feldberg D, Inbar O, Sredni D, Djaldetti M. Interleukin-3 like activity levels in pregnant wome: possible modulation by progesterone. J Reprod Immunol 22:211-216, 1992.

 

387. Shoenfeld Y, Alarcon-Segovia D. The mosaic of SLE: Highlights of the third international conference on SLE. Lupus 1:269-283, 1992.

 

388. Amital-Teplizki H, Bearman JE, Miele JR, Sukenik S, Shoenfeld Y. A multidimentional autoantibody analysis specifying SLE patients with neuropsychiatric symptomatology. Isr J Med Sci 28:422-427, 1992.

 

389. Weiss P, Shoenfeld Y. Primary biliary cirrhosis: Increasing problem. Isr J Med Sci 28:726-728, 1992.

 

390. Schlesinger N, Ben-Bassat C, Shoenfeld Y. Complement profile in primary biliary cirrhosis. Immunol Res 11:98-103, 1992.

 

391. Shoenfeld Y, Meroni PL. The beta-2 glycoprotein I and antiphospholipid antibodies. Clin Exp Rheumatol 10:205-209, 1992.

 

392. Fishman P, Shoenfeld Y. Vitiligo as an autoimmune disease. Harefuah 123:339-341, 1992.

 

393. Fishman P, Bakimer R, Blank M, sredni D, Djaldetti M, Shoenfeld Y. The putative role of cytokines in the induction of primary anti-phospholipid syndrome. Clin Exp Immunol 90:266-270, 1992.

 

394. Buskila D, Weige D, Shoenfeld Y. The detection of anti-Ro/SS-A and anti-La/SS-B activity of human serum monoclonal immunoglobulins (monoclonal gammopathies). Hum Antibod Hybridoma 3:75-80, 1992.

 

395. Amital H, Klemperer I, blank M, Yassur Y, Palestine A, Nussenblatt RB, Shoenfeld Y. Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis. Int Arch Allergy Immunol 99:34-36, 1992.

 

396. Tomer Y, Shoenfeld Y. Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 10:391-393, 1992.

 

397. Shoenfeld Y. Pathogenic natural autoantibodies. Isr J Med Sci 29:142-145, 1992.

 

398. Fishman P, Shoenfeld Y. Cytokines, interleukin-3 and autoimmunity. Isr J Med Sci 29:159-164, 1992.

 

399. Shoenfeld Y. Induction of experimental primary and secondary anti-phospholipid syndrome in anive mice. Amer J Reproduct Immunol 28:219-222, 1992.

 

400. Blank M, Ben-Bassat M, Shoenfeld Y. The effect of cyclosporin A on early and late stages of experimental lupus. Arthritis Rheumat 35:1350-1355, 1992.

401. Vitali C, Bombardieri S, Moutsopoulos M, Shoenfeld Y, et al. Preliminary criteria for the classification of Sjogren’s syndrome. Arthritis Rheumat 36:340-347, 1993.

 

402. Finkelstein Y, Adler Y, Lorber M, Shoenfeld Y. Anti-phospholipid syndrome in young persons with acute myocardial infarction. Harefuah 124:146-149, 1993.

 

403. Shoenfeld Y. What is going to happen as for the prediction of autoimmune disorders is concerned. Ann Med Intern 143:525-526, 1992.

 

404. Levy Y, Shoenfeld Y. Treatment of Raynaud’s phenomenon. Harefuah 124:288-291, 1993.

 

405. Zarhari D, Shoenfeld Y. Polymyositis and anti-Jo-1 antibodies. Harefuah 124:206-210, 1993.

 

406. Tomer Y, Buskila D, Shoenfeld Y. Pathogenic significance and diagnostic value of lupus autoantibodies. Int Arch Allergy Immunology 100:293-306, 1993.

 

407. Gruschwitz MS, Shoenfeld Y, Krupp M, Gershwin ME, Penner E, Brezinshcek HP, Wick G. Antinuclear antibody profile in UCD line 200 chickens: A model for progressive systemic sclerosis. Int Arch Allergy Immunol 100:307-313, 1993.

 

408. Fishman P, Falach-Vaknine E, Zigelman R, Bakimer R, Sredni B, Djaldetti M, Shoenfeld Y. Prevention of fetal-loss in experimental anti-phospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 91:1834-1837, 1993.

 

409. Shoenfeld Y, Blank M, Aharoni R, Teitelbaum D, Arnon R. Manipulation of autoimmune diseases with T-suppressor cells: lesson from experimental SLE and EAE. Immunol Lett 36:109-116, 1993.

 

410. Shoenfeld Y. The pneumonia-urinary tract infection syndrome: Loss of diagnostic ability in medicine. Harefuah 124:590-592, 1993.

 

411. Krause I, Buskila D, Shoenfeld Y. Prolactin and bromocriptine in rheumatic and autoimmune diseases. Harefuah 124:775-779, 1993.

 

412. Shoenfeld Y. Pathogenic natural autoantibodies. Clin Immunol News Lett 13:13-36, 1993.

 

413. Dueymes M, barrier J, Shoenfeld Y, Youinou P. Relationship of interleukin-4 to isotypic distribution of anti-dsDNA antibodies in SLE. Int Arch Allergy Immunol 101:408-415, 1993.

 

414. Inbar Y, Zurgil N, gilburt C, Shoenfeld Y. Antimitochondrial antibodies and primary biliary cirrhosis. Harefuah 125:148-153, 1993.

 

415. Kra-Oz Z, Lorber M, Shoenfeld Y, Scharff Y. Inhibitions of natural anti-cardiolipin autoantibodies. Clin Exp Immunol 93:265-268, 1993.

 

416. Inbar O, Blank M, Faden D, Tincani A, Lorber M, Shoenfeld Y. Prevention of fetal loss in experimental antiphospholipid syndrome by low molecular weight heparin. Amer J Obstet Gynecol 169:423-426, 1993.

 

417. Krause I, Blank M, gilburd B, Shoenfeld Y. The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome. Am J Repro Immunol 29:155-161, 1993.

 

418. Shoenfeld Y. The kaleidoscope of autoimmunity. Autoimmunity 15:245-251, 1993.

 

419. Shurtz-Swirsky R, Inbar O, Blank M, Cohen J, Bakimer R, Barnea ER, Shoenfeld Y. In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Amer J Reproduc Immunol 29:206-210, 1993.

 

420. Grenbaum E, Lanfer M, Shoenfeld Y. Autoantibodies in systemic sclerosis. Harefuah 124:370-374, 1993.

 

421. Nesher G, Blank M, Shoenfeld Y. The perinuclear factor - a specific diagnostic marker for rheumatoid arthritis. Harefuah 124:415-419, 1993.

 

422. Maran R, Dueymes M, Pennec YL, Casburn-Budd R, Shoenfeld Y, Youinou P. Predominance of IgG subclass of anti-Ro/SS-A, but not anti-La/S-B antibodies in primary Sjogren’s syndrome. J Autoimmunity 6:379-387, 1993.

 

423. Shoenfeld Y. Car accident - a personal angle. Harefuah 1993; 124: 445 – 448.

 

424. Shoenfeld Y. Car accident - a personal angle. Isr J Med Sci 1993; 29:484 - 488.

 

425. Shoenfeld Y. Induction of experimental models in autoimmunity. Harefuah 123:528-534, 1992.

 

426. Fishman P, Azizi E, Shoenfeld Y, Sredni B, Yecheskel G, Ferrone S, Zigelman R, Chaitchik S, Djaldetti M. Vitiligo autoantibodies are effective against melanoma. Cancer 72:2365-2367, 1993.

 

427. Zandman-Goddard G, Ehrenfeld M, Shoenfeld Y. Silicone implants for breast augmentation and autoimmune diseases. Harefuah 125:360-364, 1993.

 

428. Benbassat C, Schlesinger M, Luderschmidt C, Valentini G, Tirri G, Shoenfeld Y. The complement system and systemic sclerosis. Immunol Res 12:312-315, 1993.

 

429. Bakimer R, Gilburd B, Zurgil N, Shoenfeld Y. The effect of intravenous gammaglobulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol 69:97-102, 1993.

 

430. Fishman P, Shoenfeld Y. Lessons from experimental anti-phospholipid syndrome. Semin Clin Immunol 6:39-46, 1993.

 

431. Zurgil N, Bakimer R, Tincani A, Faden D, Cohen J, Lorber M, Valesini G, Shoenfeld Y. Detection of anti-phospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus 2:233-238, 1993.

 

432. Cohen J, Bakimer R, Blank M, Valesini G, Shoenfeld Y. Pathogenic serum IgG anti-cardiolipin antibodies and the idiotypic network. Ann Rheumat Dis 52:742-748, 1993.

 

433. Amital H, Shoenfeld Y. Autoimmunity and schizophrenia: an epiphenomenon or an etiology. Isr J Med Sci 29:593-597, 1993.

 

434. Buskila D, Shoenfeld Y. Anti-DNA Idiotypes: Their Pathogenic Role in Autoimmunity. In: Concept in Immunopathol Clin and Molec Aspects of Autoimmune Dis. 8:85-114, 1993.

 

435. Buskila D, Shoenfeld Y. Manipulation of Anti-DNA Idiotypes: A Possible Treatment Approach to Autoimmune Disease. In: Concept in Immunopathol Clin and Molec Aspects of Autoimmune Dis. 8:114-128, 1993.

 

436. Cohen AD, Cohen Y, Shoenfeld Y. Ca 15-3 a tumor marker in breast cancer. Harefuah 125:484-488, 1993.

 

437. Gilburd B, Stein M, Tomer Y, tanne D, Abramski O, Chapman Y, Ahiron A, Blank M, Shoenfeld Y. Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic. Autoimmunity 16:23-27, 1993.

 

438. Shoenfeld Y. Idiotypic induction of autoimmunity: A new classification of autoimmune diseases. Isr J Med Sci 2:11-14, 1994.

 

439. Fishman P, Kamashta M, Ehrenfeld M, Vianna J, Hughes GRV, sredni D, Zigelman R, Sabo G, Shoenfeld Y. Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data. Int Arch Allergy Immunol 100:215-218, 1993.

 

440. Cohen JR, Luxman D, Bakimer R, Blank M, David MP, Shoenfeld Y. The antiphospholipid syndrome (APLS): obstetric and reproductive impacts. Isr J Obstet Gynecol 4:19-21, 1993.

 

441. Yativ N, Buskila D, Blank M, burek CL, rose NR, Shoenfeld Y. The detection of antithyroglobulin activity in human serum monoclonal immunoglobulins (monoclonal gammopathies). Immunol Res 12:330-337, 1993.

 

442. Shoenfeld Y. The significance of experimental models of systemic lupus erythematosus and anti-phospholipid syndrome induced by idiotypic manipulation. Isr J Med Sci 30:10-18, 1993.

 

443. Ben-Bassat K, Schlesinger M, Shoenfeld Y. The complement system in primary biliary cirrhosis. J Clin Lab Immunol 38:51-61, 1993.

 

444. Buskila D, Shoenfeld Y. Animal models of SLE in : G.S. Panayi (Ed): Immunoloty of the Connective tissue Diseases. Kluwer Academic Pub. Boston, USA 22:157-192, 1993.

 

445. Blank M, Tincani A, Shoenfeld Y. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 21:100-104, 1994.

 

446. Amital-Teplizki H, Shoenfeld Y. Early detection of autoimmune diabetes mellitus. Harefuah 126:211-214, 1994.

 

447. Cohen A. D, Shoenfeld Y, Gopas J, Cohen Y. Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels. Breast Cancer Research and Treatment 30: 197-200, 1994.

 

448. Shoenfeld Y. Idiotypic induction of autoimmune disease: in: The Impact of Biotechnology on Autoimmunity. Eds: Dalgleish AG, Albertini A, Paoletti R. Kluwer Academic Publishers. 1994 pp. 73-80.

 

449. Gilburd B, Stein M, Tomer Y, Tanne D, Abramsky O, Chapman Y, Ahiron A, Blank M, Shoenfeld Y. Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic? Autoimmunity 16:23-27, 1993.

 

450. Avidan B, Maran R, Shoenfeld Y. Early detection of micrometastases. Harefuah 126:268-271, 1994.

 

451. Cohen AD, Piura B, Cohen Y, Shoenfeld Y. CA-125 in the diagnosis and prognosis of epithelial ovarian cancer. Harefuah 126:283-285, 1994.

 

452. Yodfat O, Shoenfeld Y. Penicillamine - A friend or an enemy. Harefuah 126:328-334, 1994.

 

453. Gilburd B, Ziporen L, Zharhary D, Blank M, Zurgil N, Scheinberg MA, Guedes LH, Shoenfeld Y. Anti-mitochondrial (pyruvate dehydrogenase) antibodies in leprosy. J Clin Immunol 14:14019, 1994.

 

454. Asherson RA, Shoenfeld Y. The significance of antibodies to DNA in the primary antiphospholipid syndrome. Clin Exp Rheumatol 12:1-3, 1994.

 

455. Amital-Teplizki H, Shoenfeld Y. Early detection of autoimmune diabetes mellitus. Harefuah 126:211-214, 1994.

 

456. Ahmed AE, Peter JB, Shoenfeld Y. Autoimmune thrombocytopenia purpura. Clin Immunotherapeutics 1:348-357, 1994.

 

457. Shoenfeld Y. Idiotypic induction of autoimmune diseases: a new aspect of infection and autoimmunity. In: The Impact of Biotechnology on Autoimmunity. Edited Dalgleish AG, Albertini A, Paoleti R. Kluwer Acad Pub 1994 Boston, USA.

 

458. Adler Y, Goddard G, Tomer Y, Ravid M, Ehernfeld M, Shoenfeld Y, Zemer D. Usefulness of colchicine in preventing recurrences of pericarditis. Amer J Cardiol 73:916-917, 1994.

 

459. Valesini G, Shoenfeld Y. A new player in the antiphospholipid syndrome: The b2 glycoprotein I cofactor. Autoimmunity 14:105-110, 1992.

 

460. Reyes H, Dearing L, Shoenfeld Y, Peter JB. Anti-phospholipid antibodies: A critique of their heterogeneity and hegemony. Sem Thrombosis & Homostasis 20:89-100, 1994.

 

461. Rahima D, Tarrab-Hazdai R, Blank M, Arnon R, Shoenfeld Y. Anti-nuclear antibodies associated with schistosomiasis and anti-schistosomal antibodies associated with SLE. Autoimmunity 17:127-141, 1994.

 

462. Zandman-Goddard G, Weiss P, Avidan B, Bar-Meir S, Shoenfeld Y. Acute varicella infection heralding Wilsonian crisis. J Clin gastroenterol 18:265-266, 1994.

 

463. Adler Y, Salozhin K, tonqueze ML, Shoenfeld Y, Youinou P. Anti-endothelial cell antibodies: a need for standardization. Lupus 3:77-84, 1994.

 

464. Merimsky O, Shoenfeld Y, Yecheskel G, Chaitchik S, Aziz E, Fishman P. Vitiligo-and melanoma - associated hypopigmentation: a similar appearance but a different mechanism. Cancer Immunol Immunopathol 38:411-416, 1994.

 

465. Baharav M, Fishman P, Shoenfeld Y. Superantigens and autoimmunity. Harefuah 126:715-719, 1994.

 

466. Cohen J, Bakimer R, Blank M, valesini G, Shoenfeld Y. Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy. Clin Exp Immunol 97:181-186, 1994.

 

467. Tomer Y, Blank M, Shoenfeld Y. Suppression of experimental antiphospholipid syndrome and SLE in mice by anti-CD4 monoclonal antibodies. Arthritis Rheum 8:1236-1244, 1994.

 

468. Kronenberg A, Blank M, Kaufman S, Shoenfeld Y. Induction of tissue factor like activity in monocytes by anti-cardiolipin antibodies. J Immunology 153:1328-1332, 1994.

 

469. Tishler M, Aharon A, ehrenfeld M, Avni I, Bendet E, Bombardieri S, Yaron M, Shoenfeld Y. Sjogren’s syndrome in Israel: Primary versus secondary disease. Clin Rheumatol 13:438-441, 1994.

 

470. Shoenfeld Y, Fishman P. Role of Il-3 in the antiphospholipid syndrome. Lupus 3:259-261, 1994.

 

471. Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, gilburd B, Allegri F, Balestrieri G, Valesini G, Shoenfeld Y. Immunization with anticardiolipin cofactor (b2GP-I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmunity 7:441-455, 1994.

 

472. Buskila D, Shoenfeld Y. Anti-DNA antibodies: Their idiotypes and SLE. Clin Rev Allergy 12:237-253, 1994.

 

473. Tishler Y, Gilburd B, Shoenfeld Y, Yaron M. Anti-Ro (SSA) antibodies in patients with rheumatoid arthritis - a possible marker for gold induced side effects. J Rheumatol 21:1040-1042, 1994.

 

474. Bakimer R, Cohen JR, Shoenfeld Y. What really happens to fecundity in autoimmune diseases? Immunol Allergy Clinics North Amer 14:701-724, 1994.

 

475. Shoenfeld Y, Amital H, Ferrone S, Kennedy RC. Anti-idiotypes and their application under autoimmune, neoplastic and infections conditions. Int Arch Allergy Immunol 105:211-224, 1994.

 

476. Bendet E, Ehrnfeld M, Avni I, Tishler M, Nacadeziv S, Kronenberg J, Shoenfeld Y. Consensus: Diagnostic criteria for Sjogren’s syndrome. Harefuah 127:342-344, 1994.

 

477. Mozes E, Shoenfeld Y. Experimental systemic lupus erythematosus: Role of the idiotypic network. In: Autoimmune Disease Models: A Guidebook. Ed: Cohen IR, Miller A. Academic Press Inc. USA. Pp. 245-253, 1994.

 

478. Merimsky O, Shoenfeld Y, Chaitchik S, Yecheskel G, Fishman P. Antigens and antibodies in malignant melanoma. Tumor Biol 15:188-202, 1994.

 

479. Levy Y, Dueymes M, Pennec YL, Shoenfeld Y, Youinou P. IgA in Sjogren’s syndrome. Clin Exp Rheumatol 12:543-551, 1994.

 

480. Amital H, Shoenfeld Y. Thromboembolic events in heparin induced thrombocytopenia. Harefuah 127:448-450, 1994.

 

481. Maran R, Deuymes M, Adler Y, Shoenfeld Y. Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members. J Clin Immunol 14:723-326, 1994.

 

482. Lorber M, Gershwin ME, Shoenfeld Y. The coexistence of SLE with other autoimmune diseases: The kaleidoscope of autoimmunity. Sem Arthritis Rheum 24:105-113, 1994.

 

483. Blank M, Manosroi J, Tomer Y, Manosroi A, Kopolovic J, Charcon-Polak S, Shoenfeld Y. Suppression of experimental SLE with specific anti-idiotypic antibody-saporin conjugate. Clin Exp Immunol 98:434-441, 1994.

 

484. Shoenfeld Y, Blank M. Effect of long acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome. Lupus 3:397-400, 1994.

 

485. Aharon A, Zandman-goddard g, Shoenfeld Y. Autoimmune multiorgan involvement in elderly men, is it SLE? Clin Rheumatol 13:631-635, 1994.

 

486. Amital H, Schiby G, Rosenmann Y, Shoenfeld Y. Clinico-pathological conferences: When assumptions are insufficient: Sarcoidosis. Harefuah 127:564-568, 1994.

 

487. Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 8:1296-1301, 1994.

 

488. Hojnik M, Gilburd B, Ziporen L, Blank M, Tomer Y, Scheinberg MA, Tincani A, Rozman B, Shoenfeld Y. Anticardiolipin antibodies in infections are heterogeneous in their dependency on b2-glycoprotein I: Analysis of anticardiolipin antibodies in leprosy. Lupus 3:515-521, 1994.

 

489. Baudet-Pommel M, Albuisson E, Kemeny JL, Falvard F, Ristori JM, Fraysse MP, Sauvezie B, and the European Community study group on diagnostic criteria for Sjogren's syndrome (EEC COMAC), Clermont-Ferrand, Lille, Paris, and Brest, France; Pisa, Brescia, Padua, and Rome, Italy; Ioannina, Greece; Manchester, London, Bath, and Bristol, United Kingdom; Copenhagen, Denmark; Barcelona, Spain; Tel-Hashomer and Tel Aviv, Israel (Ehrenfeld M, and Shoenfeld Y); Erlangen, Germany; Utrecht, The Netherlands; Helsinki, Finland; Malmo, Sweden; and Vienna, Austria. Early dental loss in Sjogren's syndrome. Histologic correlates. Oral Surg Oral Med Pathol. 78: 181-6, 1994.

 

490. Shoenfeld Y, Tomer Y, Blank M. A new experimental model for Wegener’s granulomatosis. Isr J Med Sci 31:13-16, 1995.

 

491. Aron AL, Gharavi AE, Shoenfeld Y. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Int Arch Allergy Immunol 106:8-12, 1995.

 

492. Lorber M, Kra-Oz Z, Gilburd B, Shoenfeld Y. Natural (anti-phospholipid-PDH-DNA) autoantibodies and their physiologic serum inhibitors. Isr J Med Sci 31:31-35, 1995.

 

493. Zandman-Goddard G, Langevitz P, Shoenfeld Y. Anti-thymocyte globulin therapy in autoimmune diseases. Harefuah 128:104, 1995.

 

494. Cohen AD, Shoenfeld Y. Goodpasture’s syndrome as an autoimmune disease - identification of the autoantigen. Harefuah 128:100-103, 1995.

 

495. Paz Y, Shoenfeld Y. The treatment of a widespread cancer of the colon and rectum: quality of life vs pronlongation of life ? Harefuah 128: 231-233, 1995.

 

496. Blank M, Krauze I, Lanir N, Vardi P, Gilburd B, Tincani A, Tomer Y, Shoenfeld Y. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation, the importance of the T cell. Arth Rheum 1: 115-122, 1995.

 

497. Reyes H, Dearing L, Bick RL, Shoenfeld Y, Peter JB. Laboratory diagnosis of antiphospholipid syndrome. Clin Lab Med 15:85-109, 1995.

 

498. Amital H, Tur-Caspa I, Hendler I, Shoenfeld Y. Catalytic antibody-structure and possible applications. Harefuah 128:295-299, 1995.

 

499. Shoenfeld Y, Blank M, Fishman P. Antiphospholipid syndrome: from the laboratory bench to the patients’ bedside. Lupus 4 (suppl) 1:S33-S36, 1995.

 

500. Shoenfeld Y. Idiotypic induction of autoimmunity: do we need an autoantigen? Clin Exp Rheumatol 12 (suppl 11):S37-S40, 1994.

 

501. Buskila D, Shoenfeld Y. Disorders of the immune system leading to autoimmunity. In: Multi-Systemic Autoimmune Disease: An Integrated Approach. Eds: L. Kater Hb de la Faille. Elsevier, The Netherlands pp. 1-17, 1995.

 

502. Meroni PL, Khamashta MA, Youinou P, Shoenfeld Y. Mosaic of anti-endothelial antibodies: Review of the first international workshop on AECA. Clinical and pathological significance. Lupus 4:95-99, 1995.

 

503. Tishler M, Alosachie I, Chapman Y, Korcyn A, Lorber M, Mevorach D, Tane D, Barka N, Lin HC, Segovia DA, Youinou P, Peter JB, Shoenfeld Y. Anti-neuronal antibodies in antiphospholipid syndrome with central nervous system involvement: the difference from systemic lupus erythematosus. Lupus 4:145-147, 1995.

 

504. Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, Goldberg I, Shoenfeld Y. Bromocriptine immunomodulation of experimental SLE and primary anti-phospholipid syndrome via induction of nonspecific T suppressor cells. Cellular Immunol 162:114-122, 1995.

 

505. Cohen J, Bakimer R, David M, Shoenfeld Y. Early pregnancy loss and the antiphospholipid syndrome. In: Implantation and Early Pregnancy in Humans. Edited: Barnea ER, Check JH, Grudzinskas JG, Marno T. The Parthenon Pub Group, New-Yourk, USA, pp. 333-354, 1994.

 

506. Bar-Meir E, Teuber SS, Lin HC, Alosacie I, Goddard G, Terrybery J, Barka N, Shen B, Peter JB, Blank M, Gershwin ME, Shoenfeld Y. Multiple autoantibodies in patients with silicone breast implants. J Autoimmunity 8:267-277, 1995.

 

507. Gilburd B, Weiss P, Bakimer R, Shoenfeld Y. Identification and characterization of antimitochondrial autoantibodies in sera of patients with monoclonal gammopathies. Immunol Lett 45:163-166, 1995.

 

508. Waisman A, Shoenfeld Y, Blank M, Ruiz PJ, Mozes E. The pathogenic human monoclonal anti-DNA antibody that induces experimental SLE in mice is encoded by a VH4 gene segment. Int Immunol 7:689-696, 1995.

 

509. Shoenfeld Y. Anti-DNA antibodies: is DNA a self antigen or shelf antigen or are autoimmune rheumatic diseases immunogen driven? Rheumatol Europe 24:17-20 (supp 2), 1995.

 

510. Cohen J, Bakimer R, Shoenfeld Y. Fecundity in autoimmune diseases. Early Pregnancy Biology and Medicine. 1:93-105, 1995.

 

511. Bakimer R, Blank M, Kosashvilli D, Ichikawa K, Khamashta MA, Hughes GRV, Koike T, Shoenfeld Y. Antiphospholipid syndrome and the idiotypic network. Lupus 4:204-208, 1995.

 

512. Adler Y, Lamour A, Jamin C, Menez JF, Le Corre R, Shoenfeld Y, Youinou P. Impaired binding capacity of asialyl and agalactosyl IgG to Fc gamma receptors. Clin Exp Rheumatol 13:315-319, 1995.

 

513. Le Tonqueze M, Salozhin K, Dueymes M, Piette JC, Kovalev V, Shoenfeld Y, Youinou P. Role of b2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus 4:179-186, 1995.

 

514. Shoenfeld Y. Idiotypic network, pathogenic autoantibodies and autoimmunity. Clin Exp Immunol 101 (suppl):26-28, 1995.

 

515. Youinou P, Meroni PL, Khamashta MA, Shoenfeld Y. A need for standardization of the anti-endothelial-cell antibody test. Immunol Today 16:363-364, 1995.

 

516. Aron AL, Cuellar RL, Brey RL, Meceown S, Espinoza LR, Shoenfeld Y. Early onset of autoimmunity in MRL/++ mice following immunization with b2 glycoprotein I. Clin Exp Immunol 101:78-81, 1995.

 

517. Krause I, Blank M, Kopolovic J, Afek A, Goldberg I, Tomer Y, Shoenfeld Y. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin. J Rheumatol 22:1068-1074, 1995.

 

518. Fishman P, Falach-Vaknin E, Sredni B, Meroni PL, Rudniki C, Shoenfeld Y. Aspirin modulates interleukin-3 production: Additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome. J Rheumatol 22:1086-1090, 1995.

 

519. Buskila D, Berezin M, Gur H, Lin HC, Alosachie I, Terryberry JW, Barka N, Shen B, Peter JB, Shoenfeld Y. Autoantibody profile in the sera of women with hyperprolactinemia. J Autoimmunity 8:415-424, 1995.

 

520. Amital H, Tur-Kaspa I, Tashma Z, Hendler I, Shoenfeld Y. Catalytic antibodies: Structure and possible applications. In: Antibody Engineering Protocols. Ed. S. Paul Humana Press Totowa, New-Jersey 1995 pp. 203-210.

 

521. Zandmann-Goddard G, Lorber M, Shoenfeld Y. Systemic lupus erythematosus and thymoma - A double-edged swords. Int Arch Allergy Immunol 108:99-102, 1995.

 

522. Shoenfeld Y. Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome. Transplant Proc 26:3211-3213, 1994.

 

523. Blank M, Tomer Y, Slavin S, Shoenfeld Y. Induction of tolerance to experimental anti-phospholipid syndrome (APS) by syngeneic bone marrow cell transplantation. Scand J Immunol 42:226-234, 1995.

 

524. Cohen AD, Shoenfeld Y. Use and mechanism of action of IVIG in autoimmune diseases. Harefuah 129:123-126, 1995.

 

525. Adler Y, Finkelstein Y, Zandman-Goddard G, Blank M, Lorber M, Faden D, Shoenfeld Y. The presence of antiphospholipid antibodies in acute myocardial infarction. Lupus 4:309-313, 1995.

 

526. Blank M, Tomer Y, Stein M, Kopolovic J, Wiik A, Meroni PL, Conforti G, Shoenfeld Y. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 102:120-129, 1995.

 

527. Baharav E, Merimsky O, Altomonte M, Shoenfeld Y, Pavlovic M, Malo M, Ferrone S, Fishman P. Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen. Melanoma Res 5:337-343, 1995.

 

528. George J, Shoenfeld Y. Infections, idiotypes and SLE. Lupus 4:333-335, 1995.

 

529. Green L, Vinker S, Amital H, Amir T, Bar-Dayan Y, Levi Y, Shoenfeld Y. Pseudotumor cerebri in systemic lupus erythematosus. Sem Arthritis Rheum 25:103-108, 1995.

 

530. Yanai-Landau H, Amital H, Bar-Dayan Y, Levy Y, Gur H, Lin HC, Alosachie IJ, Peter JB, Shoenfeld Y. Autoimmune aspects of primary pulmonary hypertension. Pathobiology 63:71-75, 1995.

 

531. Gur H,. Shen G, Surjita M, Terryberry J, Alosachie I, Barka N, Lin HC, Peter JB, Meroni PL, Kaplan M, Gershwin E, Shoenfeld Y. Autoantibody profile of primary sclerosing cholangitis. Pathobiology 63:76-82, 1995.

 

532. Brik R, Tenenbaum G, Blank M, Shoenfeld Y, Barzilai D, Bloch K, Vardi P. D-penicillamine-induced autoantibodies in a mouse model. Clin Exp Rheumatol 13:483-488, 1995.

 

533. Tishler M, Alosachie I, Barak N, Lin HC, Gershwin ME, Peter JB, Shoenfeld Y. Primary Sjogren’s syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol 13:497-500, 1995.

 

534. Finkelstein Y, Adler Y, Levy Y, Youinou P, Shoenfeld Y. Viral myocarditis: are we dealing with an autoimmune phenomenon? Ann Med Intern 146:322-324, 1995.

 

535. Levy Y, George J, Shoenfeld Y. The occurrence of thromboembolic events following airplane flights - “The economy class syndrome”. Isr J Med Sci 31:621-623, 1995.

 

536. Terryberry J, Sutjita M, Shoenfeld Y, Gilburd B, Tanne D, Lorber M, Alosachie L, Barka N, Lin HC, Youinou P, Peter JB. Myelin-and microbe-specific antibodies in Guillain-Barre syndrome. J Clin Lab Analysis 9:308-319, 1995.

 

537. George J, Shoenfeld Y. Atherosclerosis as an autoimmune disease. Harefuah 129:257-259, 1995.

 

538. Shoenfeld Y, Blank M, Fishman P. Antiphospholipid syndrome: from the laboratory bench to the patients’ bedside. Lupus 4 (suppl 1):S33-S36, 1995.

 

539. Bar-Dayan Y, Levy Y, Shoenfeld Y. Cerebral infarction in Crohn’s disease. Harefuah 129:173-175, 1995.

 

540. Tomer Y, Gilburd B, Blank M, Lider O, Hershkoviz R, Fishman P, Zigelman R, Meroni PL, Wiik A, Shoenfeld Y. Characterization of biological active antineutrophil cytoplasmic antibodies induced in mice. Arthritis Rheum 38:1375-1381, 1995.

 

541. Cohen A, Shoenfeld Y. The viral autoimmunity relationship. Viral Immunology 8:1-9, 1995.

 

542. George J, Shoenfeld Y. The Hanta viruses - clinical syndromes. Harefuah 129:421-423, 1995.

 

543. George J, Adler Y, Shoenfeld Y. Apoptosis (programmed cell death) in autoimmunity - autoimmunological aspects. Harefuah 129:339-341, 1995.

 

544. Horoshovski H, Amital H, Katz M, Shoenfeld Y. Pseudotumour cerebri in SLE. Clin Rheumatol 14:708-710, 1995.

 

545. Cohen J, Bakimer R, Shoenfeld Y. Fecundity in autoimmune diseases. Early Pregnancy Biology and Medicine 1:93-105, 1995.

 

546. Levy Y, Shoenfeld Y. Images in allergy and immunology. Int Arch Allergy & Immunology 108:339, 1995.

 

547. Krause I, Hacham S, Gilburd B, Damianovitch M, Blank M, Shoenfeld Y. Absence of anti-idiotypic antibodies in IVIG preparations to autoantibodies of rare autoimmune diseases. Clin Immunol Immunopathol 77:229-235, 1995.

 

548. George J, Adler Y, Zhang J, Shoenfeld Y, Youinou P. Apoptosis and its association with autoimmunity. Clin Rheumatol 14:505-509, 1995.

 

549. Shoenfeld Y, Beresovski A, Zharhary D, Tomer Y, Swissa M, Sela E, Zimran S, Zevin S, Gilburd B, Blank M. Natural autoantibodies in sera of patients with Gaucher’s disease. J Clin Immunol 15:363-372, 1995.

 

550. Bean P, Sutphin MS, Liu YS, Anton R, Reynolds TB, Shoenfeld Y, Peter JB. Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. Clin Chem 41: 858-861, 1995.

 

551. Fishman P, Shoenfeld Y. Aspirin, interleukin-3 and the antiphospholipid syndrome. Isr J Med Sci 32:13-17, 1996.

 

552. Buskila D, Shoenfeld Y. Prolactin, bromocriptine and autoimmune diseases. Isr J Med Sci 32:23-27, 1996.

 

553. Shoenfeld Y. Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture’s syndrome. Isr J Med Sci 32:29-31, 1996.

 

554. Lerner A, Blank M, Shoenfeld Y. Celiac disease and autoimmunity. Isr J Med Sci 32:33-36, 1996.

 

555. George J, Avidan B, Shoenfeld Y. Iatrogenic damage. Harefuah 130:53-55, 1996.

 

556. Guedes L.S, Barbosa B, Gilburd B, Shoenfeld Y,Scheinberg M.A. Autoantibodies in leprosy sera, Clin Rheumatol 15:26-28, 1996.

 

557. Levy Y, George J, Hojnic M, Ehrenfeld M, Lorber M, Bombardieri S, Shoenfeld Y. Comparison of clinical and laboratory parameters for systemic lupus erythematosus activity in Israelis versus Europeans. Isr J Med Sci 32:100-104, 1996.

 

558. Peer O, Bar-Dayan Y, Shoenfeld Y. Satisfaction among patients of homeopathic clinic. Harefuah, 130:86-89, 1996.

 

559. George J, Levy Y, Shoenfeld Y. Mixed connective tissue disease: thirty three years of uncertainty. Harefuah, 130: 99-103, 1996.

 

560. Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunology Lett 48: 129-132, 1995.

 

561. Fishman P, Falach-Vaknin E, Sredni B, Meroni P.L, Tincani A, Dicker D, Shoenfeld Y. Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome. Amer J Reproduct Immunol 35: 80 - 84, 1996.

 

562. Tomer Y, Gilburd B, Sack J, Davies TF, Meshorer A, Burek CL, Rose NR, Shoenfeld Y. Induction of thyroid autoantibodies in naive mice by idiotypic manipulation. Clin Immunol Immunopathol 78: 180 - 187, 1996.

 

563. Yodfat O, Blank M, Krause I, Shoenfeld Y. The pathogenic role of anti-phosphatidylserine antibodies: Active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Clin Immunol Immunopathol 78: 14 - 20, 1996.

 

564. Shoenfeld Y, Gilburd B, Hojnik M, Damianovich M, Hacham S, Kopolovic Y, Polak-Charcon M, Goldberg I, Afek A, Hun-Chi L, Peter JB. Induction of Goodpasture antibodies to noncollagenous domain (NC1) of type IV collagen in mice by idiotypic manipulation. Hum Ab Hybridomas, 6: 122 - 128, 1995.

 

565. Shoenfeld Y, George J, Peter JB. Guillain-Barre as an autoimmune disease. Int Arch Allergy & Immunol 109: 318 - 326, 1996.

 

566. George J, Shoenfeld Y. Fungal infections and autoimmune diseases. Harefuah 130: 388 - 390, 1996.

 

567. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93: 1574 - 1587, 1996

 

568. Bar-Dayan Y, Amital H, Levy Y, Shoenfeld Y. Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci 32: 288 - 291, 1996

 

569. Barka N, Shen GQ, Shoenfeld Y, Alosachie IJ, Gershwin ME, Reyes H, Peter JB. Multireactive pattern of serum autoantibodies in asymptomatic individuals with immunoglobulin A(IgA) deficiency. Clin Diag Lab Immunol 2: 469 - 472, 1995.

 

570. Carp HJA, Achiron R, Mashiach S, Shoenfeld Y, Gazit E, Toder V. Intravenous immunoglobulin in women with five or more abortions. Amer J Reproductive Immunol 35: 360 - 362, 1996.

 

571. George J, Levy Y, Shoenfeld Y. Immune network and autoimmunity. Internal Medicine 35: 3 - 9, 1996.

 

572. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus (SLE). J Rheumatol 23 : 629 - 632, 1996.

 

573. Shoenfeld Y. Clinical practice today. Harefuah 130: 606 - 607, 1996.

 

574. Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, Balestrieri G, Radice A, Sinico RA, Meroni PL. Anti-endothelial cell IgG antibodies from patients with Wegener’s granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 39: 758 - 766, 1996.

 

575. George J, Shoenfeld Y. Pregnancy and antiphospholipid syndrome. A report and relevant abstracts from the 4th Int. Conference on SLE. Jerusalem March 1995. Early Pregnancy Biology and Medicine 2: 53 - 69, 1996.

 

576. George J, Shoenfeld Y. Actin autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 10-12, 1996.

 

577. Youinou P, Maran R, Dueymes M, Shoenfeld Y. Autoantibody subclasses. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 103 - 108, 1996.

 

578. Lorber M, George J, Shoenfeld Y. Hidden Autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 357 - 363, 1996.

 

579. Abu-Shakra M, Buskila D, Shoenfeld Y. Idiotypes and anti-idiotypic antibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 408 - 416, 1996.

 

580. George J, Shoenfeld Y. Natural autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 534 - 539, 1996.

 

581. Cervera R, Shoenfeld Y. Pathogenic mechanisms. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 607- 617, 1996.

 

582. Fishman P, Merimsky O, Baharav E, Shoenfeld Y. Tyrosinase autoantibodies. In: Autoantibodies. Editors: James B. Peter, Yehuda Shoenfeld. Elsevier, Amsterdam, The Netherlands, pp. 842 - 845, 1996.

 

583. Shoenfeld Y. Common infections, idiotypic dysregulation, autoantibody spread and induction of autoimmune diseases. J Autoimmunity 9: 235 - 239, 1996.

 

584. Damianovich M, Gilburd B, George J, Del Papa N, Afek A, Goldberg I, Kopolovic Y, Roth D, Barkai G, Meroni PL, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in vasculitis. J Immunol 156: 4946 - 4951, 1996.

 

585. Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilburd B, Yecheskel G, Youinou P, Fishman P. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105: 84 - 88, 1996.

 

586. Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, Blank M, Sandbank Y, Vilardell-Tarres M, de Torres I, Weinberger A, Asherson RA, Kopolovic Y, Shoenfeld Y. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5: 196 - 205, 1996.

 

587. Tomer Y, Shoenfeld Y. Finding a valid model for human Wegener’s granulomatosis: comment on the article by Tomer et al. Arthritis Rheum 39: 1262 - 1263, 1996.

 

588. Levy Y, George J, Shoenfeld Y. Severe blastocystis hominis in an elderly man. J Infection 33: 57 - 59, 1996.

 

589. Shoenfeld Y, Grunebaum E, Laufer M, Zurgil N, Bakimer R, Lunderschmidt A, Valentini G, Tirri G, Blank M. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma). Isr J Med Sci 32: 537-541, 1996.

 

590. Keusch J, Levy Y, Shoenfeld Y, Youinou P. Analysis of different glycosylation states in IgG subclasses. Clinica Chimica Acta 252: 147 - 158, 1996.

 

591. George J, Levy Y, Shoenfeld Y. Infections and autoimmunity - emerging clinical trials. Turk J Immunol 1: 11-13, 1996.

 

592. Swissa M, Lerner A, Sasaki T, Sela E. Blank M, Shoenfeld Y. The diverse pathogenic potential of anti-DNA antibodies from various sources to induce experimental systemic lupus erythematosus. Pathobiology 64: 32-39, 1996.

 

593. Tomer Y, Viegas OAC, Swissa M, Koh SCL, Shoenfeld Y. Levels of lupus autoantibodies in pregnant SLE patients: correlations with disease activity and pregnancy outcome. Clin Exp Rheumatol 14: 275-280, 1996.

 

594. Sukenik S, Shoenfeld Y. The dead sea is alive. Isr J Med Sci 32 (Suppl 3): 1-3, 1996.

 

595. Tishler M, Shoenfeld Y. The medical and scientific aspects of spa therapy. Isr J Med Sci 32: (suppl 3) 8-10, 1996.

 

596. Zandman-Goddard G, George J, Levy Y, Blank M, Slavin S, Shoenfeld Y. Modulation of experimental systemic lupus erythematosus with linomide. Lupus 5: 328-333, 1996.

 

597. Ehrenfeld M, Buskila D, Tishler M, Lorber M, Shoenfeld Y. Rheumatology in Israel. Brit J Rheumatol 35: 778-780, 1996.

 

598. Baharav E, Gur H, Fishman P, Ziporen L, Blank M, Aelion J, Kotb M, Shoenfeld Y. Superantigens and experimental SLE induced by idiotypic dysregulation. Clin Exp Rheumatol 14: 359 - 366, 1996.

 

599. Amital H, Swissa M, Bar-Dayan Y, Buskila D, Shoenfeld Y. New therapeutic avenues in autoimmunity. Res Immunol (Inst. Pasteur) 147: 361-376, 1996.

 

600. Amital H, Blank M, Shoenfeld Y. Th1/Th2 cells and autoimmunity. Harefuah 131: 189-193, 1996.

601. Krause I, Blank M, Shoenfeld Y. Immunomodulation of experimental APS: lessons from murine models. Lupus 5: 458-462, 1996.

 

602. Bar-Dayan Y, Shahar A, Rick J, Shoenfeld Y. Clinico-Pathological Conferences: Severe fatal shock after syncope in an old man. Harefuah 131: 360-363, 1996.

 

603. George J, Shoenfeld Y. Cellular immune responses in rheumatic fever. Harefuah 131: 321-323, 1996.

 

604. Galperin C, Shoenfeld Y, Gilburd B, Esterre P, Meroni PL, Del Papa N, Halpern GM, Andriantsimahavandy A, Gershwin ME. Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. Clin Exp Rheumatol 14: 479-483, 1996.

 

605. Amital H, Shoenfeld Y. Nucleosomes, DNA and SLE : Where is the starting point ? Clin Exp Rheumatol 14: 475-478, 1996.

 

606. Shoenfeld Y, Ehrenfeld M. Hematologic manifestations. In: The Clinical Management of Systemic Lupus Erythematosus (SLE). (2nd Ed.). Editor: Peter H. Schur. Lippincott-Raven, N.Y., U.S.A., pp. 95-108, 1996.

 

607. Leibovitch L, Levy Y, Shoenfeld Y. Pancreatitis induced by clarithromycin. Ann Int Med 125: 701. 1996.

 

608. Krause I, Blank M, Shoenfeld Y. Treatment of systemic lupus erythematosus and antiphospholipid syndrome: From experimental models to patients’ bedside. Int Arch Allergy Immunol 111: 355-361, 1996.

 

609. Aharon-Maor A, Shoenfeld Y. Interleukin 12 - polyfunctional cytokine. Harefuah 131: 501-505, 1996.

 

610. Bar-Dayan Y, Gurstein A, Zilinski I, Shoenfeld Y. Playing with fire. Harefuah 131: 474-476, 1996.

 

611. Levy Y, Sologov M, George J, Shoenfeld Y. “BCG itis” - sepsis following BCG treatment. Harefuah 131: 541-543, 1996.

 

612. Aharon-Maor A, Shoenfeld Y. Everything you wanted to know about magnesium and didn’t dare to ask. Harefuah 131: 556-558, 1996.

 

613. Shoenfeld Y. No Russian immigrants, no women, no Hebrew. Harefuah 131: 604-605, 1996.

 

614. George J, Harats D, Gilburd B, Shoenfeld Y. Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis. Immunol Res 15: 315 - 322, 1996.

 

615. Levy Y. George J, Eli Y, Shoenfeld Y. Partial lipodystrophy and complement dysfunction. Turk J Immunol 2: 43-45, 1996

 

616. Shoenfeld Y, Krause I. Immunosuppression and immunomodulation of experimental models of systemic lupus erythematosus and antiphospholipid syndrome. Transplantation Proceed 28: 3096-3098, 1996.

 

617. Tishler M, Shoenfeld Y. Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. Semin Arthritis Rheum 26: 558-563, 1996.

 

618. George J, Levy Y, Afek A, Yaniv R, Shoenfeld Y. Leucocytoclastic vasculitis after coronary bypass artery grafting. Brit J Dermatol 135: 1015 - 1016, 1996.

 

619. Zandman-Goddard G, George J, Blank M, Levy Y, Yanai P, Halperin T, Shoenfeld Y, Barak V. The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus. Immunol Lett 53: 77-82, 1996.

 

620. Amital H, Tur-Kospa I, Tashma Z, Hendler I, Shoenfeld Y. Catalytic antibodies: generation, nature and possible role as chemical warfare scavengers. Military Medicine 161: 1/1996, p. 7. Youinou P, Isenberg DA, Kalsi JK, Dugoujon JM, Ravirajan CT, Muller S, Blanco F, Piette JC, Guillevin L, Jouquan J, Semana G, Salmon D, Shoenfeld Y, Bach JF. Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spouses. J Autoimmunity 9: 767-775, 1996

 

621. Dopamine and kidneys - the protective efect on the kidneys - legend or reality.Yussim E, Yogev Y, Segal E, Shoenfeld Y. Harefuah, 130: 480-483, 1996.

 

622. Tishler M, Shoenfeld Y. Tuberculose et auto-immunite: ou en sommes - nous? Annales de L’ Institut Pasteur 7: 133-136, 1996.

 

623. Krause I, Blank M, Shoenfeld Y. Immunointerventions in experimental model for antiphospholipid syndrome. Ann Med Interne 147: 50-53 (suppl), 1997.

 

624. Levy Y, Ziporen L, Gilburd B, George J, Polak-Charcon S, Amital H, Cledes J, Youinou P, Shoenfeld Y. Membranous nephropathy in primary antiphospholipid syndrome: description of a case and
induction of renal injury in SCID mice. Hum Antibody Hybridomas 7: 91-96, 1996.

 

625. Dueymes M, Levy Y, Ziporen L, Piette JC, Shoenfeld Y, Youinou P. Do some antiphospholipid antibodies target endothelial cells? Ann Med Interne 147: 22-23 (suppl): 1997.

 

626. Shoenfeld Y, Krause I, Blank M. New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation. Ann Rheum Dis 56: 5-11, 1997.

 

627. Shoenfeld Y, Rotem Y. Physicians and the battle against road accidents. Harefuah 132: 183-184, 1997.

 

628. Ziporen L, Blank M, Shoenfeld Y. Animal models for antiphospholipid syndrome in pregnancy. Rheum Dis Clin of North America 23: 99-117, 1997.

 

629. George J, Levy Y, Shoenfeld Y. Smoking and immunity. An additional player in the mosaic of autoimmunity. Scand J Immunol 45: 1-6, 1997.

 

630. Shoenfeld Y. T cell help and antiphospholipid antibody immunogenesis (letter). Arthritis Rheumat 40: 196-197, 1997.

 

631. Shoenfeld Y. Why did the entity of effort syndrome disappear ? Harefuah 132: 266, 1997.

 

632. Bar-Dayan Y, Levy Y, Bar-Zohar D, Shoenfeld Y. Immunological aspects of endocarditis. Harefuah 132: 288-290, 1997.

 

633. Cohen AD, Shoenfeld Y. Vaccine-induced Autoimmunity. J Autoimmunity 9: 699-703, 1996.

 

634. George J,Gilburd B, Shoenfeld Y. The emerging concept of pathogenic natural antibodies. Human Antibodies Hybridoma 8: 70-75, 1997.

 

635. Bar-Zohar D, Bar-Dayan Y, Shoenfeld Y. Advances in immunotherapy and treatment of Bechet’s disease. Harefuah 132: 350-353, 1997.

 

636. Maran R, Dueymes M, Le Corre R, Renaudineau Y, Shoenfeld Y, Youinou P. IgG subclasses of human autoantibodies. Ann Med Interne 148: 29-38, 1997.

 

637. Sherer Y, Bar-Dayan Y, Shoenfeld Y. Selective inhibitors of cyclooxygenase-2: an upgrade in nonsteroidal anti-inflammatory drugs. Harefuah 132: 411-416, 1997.

 

638. Bar-Dayan Y, Blank M, Amital H, Afek A, Polak-Charcon S, Shoenfeld Y. Short term effect of high dose insulin on thymic morphology of ICR female mice. Diabetes Research 32: 27-35, 1997.

 

639. Zimlichman R, Shoenfeld Y. Calcium blockers and cancer - is there any link between them? Harefuah 132: 876-878, 1997.

 

640. Shoenfeld Y, George J. Induction of autoimmunity: A role for the idiotypic network in B lymphocytes and autoimmunity. (Ed:Chiorazzi N, Labrita RG, Ravelka K, Ferrarimi M) Ann N Y Acad Sci 815: 342-349, 1997.

 

641. Gruenbaum E, Shoenfeld Y. Pathogenesis of hemolytic uremic syndrome and thrombotic throbocytopenic purpura. Harefuah 32: 665-669; 1997.

 

642. Shovman O, George J, Shoenfeld Y. Ischemic hepatitis in congestive heart failure after an episode of hypotension. Harefuah 132: 459-460, 1997.

 

643. Gruenbaum E, Shoenfeld Y. Nucleosomes as an autoantigen in SLE. Harefuah 132:475-478, 1997.

 

644. Shoenfeld Y, Lorber M, Yucel T, Yazici H. Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: additional evidence for the kaleidoscope of autoimmunity. Lupus 6: 474-476, 1997.

 

645. Sherer Y, Bar-Dayan Y, Shoenfeld Y. Thymoma, thymic hyperplasia,thymectomy in autoimmune diseases. Int J Oncol 10:939-943, 1997.

 

646. Fishman P, Merimsky O, Shoenfeld Y. Autoimmunity and cancer-beneficial relationship: a new concept for the production of human monoclonal antibodies. Int J Oncol 10:901-904, 1997.

 

647. Merimsky O, Shoenfeld Y, Baharav E, Zigelman R, Fishman P. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo). Hum Antibody Hybridoma 7:151-156,1996.

 

648. Sherer Y, Bar Dayan, Shoenfeld Y. Vasaculitis: classification, mechanisms, animal models and treatment. Harefuah 132: 567-572, 1997.

 

649. Fishman P, Merimsky,O, Baharav E, Shoenfeld Y. Autoantibodies to tyrosinase-the bridge between melanoma and vitiligo. Cancer 79: 1461-1464, 1997.

 

650. Merimsky O, Shoenfeld Y, Baharav E, Altomonte M, Chaitchik S, Maio M, Ferrone S, Fishman P. Melanoma-associated hypopigmentation: Where are the antibodies? Am J Clin Oncol (CCT):19; 613-618,1996.

 

651. Shoenfeld Y. Anti-DNA Antibodies: Is DNA the self antigen or a shelf antigen, or are all autoimmune diseases immunogen driven? Immunoregulation in Health and Disease, Academic Press, New York, Lukic ML, Colic M, Stoikovic MM,Cuperlovic K (Eds.) pp.139-148, 1997.

 

652. ShoenfeldY, Wysenbeek AJ. Systemic lupus erythematoses in Israel. Harefuah 132:636-638,1997.

653. George J, Blank M,Hojnik M,Bar-Meir E, Koike E,Matsuura M,Lorber M, AviramM, Shoenfeld Y . Oxidized low-density lipoprotein (Ox LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS). Clin Exp Immunol: 108;227-233,1997

 

654. Blank M,Cines DB, Arepally G,Eldor A,Afek A, Shoenfeld Y. Pathogenicity of human anti-platelet factor 4(PF4)heparin in vivo: generation of mouse anti-PF4/ heparin and induction of thrombocytopenia by heparin. Clin Exp Immunol 108:333-339,1997.

 

655. Afek A, Ziporen L, Shoenfeld Y. Libman-Sacks endocarditis-a jubilee year. Harefuah 132:718-719,1997.

 

656. Shoenfeld Y. Finding a valid model for antineutrophil cytoplasmic antibody-related vasculitis. Letter (comment) Arthritis Rheum 5: 986-987,1997.

 

657. Aharon A, Levy Y, Bar Dayan Y, Afek A, Zandman-Goddard G, Skurnik Y, Fabrrizzi F, Shoenfeld Y. Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus 1997; 6: 408-411.

 

658. George J, Levy Y, Shoenfeld Y. The idiotypic network. Animal models and clinical implications. Japanese J Rheumatol 7 (invited article) : 75-82, 1997.

 

659. Tomer Y,Lider O, Gilburd B, Hershkoviz R, Meroni PL, Wiik A, Shoenfeld Y. Anti-neutrophil cytoplasmic antibody-enriched IgG induces adhesion of human T lymphocytes to extracellular matrix proteins. Clinical Immunol Immunophathol 83: 3; 245-253, 1997.

 

660. George J, Levy Y, Kallenberg CGM, Shoenfeld Y. Infections and Wegener’s granulomatosis - a cause and effect relationship? Q J Med 90: 367-373,1997.

 

661. Shoenfeld Y. Autoantibodies - antigen derived or idiotypically induced. In: Proceedings of the XIX ILAR Congress of Rheumatology.pp 230-233, Singapore 8-13 June, 1997.

 

662. Shoenfeld Y, Buskila D. Animal models for Systemic Lupus Erythemathosus. In: Proceedings of the XIX ILAR Congress of Rheumatology, pp 186-187, Singapore 8-13 June, 1997.

 

663. Shoenfeld Y, Blank M, Ziporen L. Animal models for antiphospohlipid syndrome (APS). In: Proceedings of the XIX ILAR Congress of Rheumatology. pp 420-423, Singapore, 8-13 June, 1997.

 

664. Levy Y, George J, Langewitch P, Lorber M, Bar-Dayan Y, Gilburd B, Zandman-Goddard G, Fabrizzi F, Shoenfeld Y. Novel aspects of IVIG treatment in autoimmune diseases. In: Proceedings of the XIX ILAR Congress of Rheumatology,pp 456-458 Singapore,8-13 June,1997.

 

665. Ziporen L. Shoenfeld Y. Levy Y, Korcyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid syndrome: a mouse model. J Clin Invest 100:613-619, 1997.

 

666. George J, Blank M, Gilburd B, Hojnik M, Shenkman B, Tamarin I, Varon D, Matssura E, Koike T, Shoenfeld Y. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human b2-glycoprotein I. Int Immunol 9: 6; 913-921, 1997.

 

667. Villarreal GM, Drenkard C, Villa AR, Slor H, Shafrir S, Bakimer R, Shoenfeld Y, Alarcón Segovia D. Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity. Lupus 6: 425-435, 1997.

 

668. Ehrenfeld M, Pras M, Shoenfeld Y. Is familial mediterranean fever an autoimmune disease or an immune mediated condition? In: Familial Mediterranean 669. Fever. Sohar E. Gafni J, Pras M. (Eds.) Freund Publlishing House Ltd. London, 267-278,1997.

 

670. Adler Y, Shoenfeld Y. Colchicine as therapy for recurrent pericarditis. Harefuah, 133: 100-102, 1997.

 

671. Sherer Y, Bar-Dayan Y, Shoenfeld Y. Hemorrhagic diathesis. Harefuah, 133: 98-99,1997

 

672. George J, Shoenfeld Y. Editorial. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 6: 559-560, 1997

 

673. Shoenfeld Y. Heparin-induced thrombocytopenia as an autoimmune disease - idiotypic evidence for the role of anti-heparin/PF4 autoantibodies. Israel Journal of Medical Sciences 33: 4; 243-245, April 1997.

 

674. Zurgil N, Gerbat S, Langevitz P, Tishler M, Ehrenfeld M, Shoenfeld Y. Intracellular fluorescence polarization measurements by the cellscan system:detection of cellular activity in autoimmune disorders. Isr J Med Sci 33: 4; 273-279, April 1997.

 

675. Sherer Y, Bar Dayan Y, Shoenfeld Y. Thymectomy and autoimmune diseases - The dual connection. Sem Clin Immunol 1: 5-11, 1997.

 

676. Konrad K, Humbel E T, Shoenfeld Y. Autoantibodies - diagnostic, pathogenic and prognostic relevance. Clin Exp Rheumatol 15: 457-465, 1997.

 

677. Shovman O, George J, Shoenfeld Y. Q fever endocarditis and bicuspid aortic valve. Harefuah 133: 281-283, 1997.

 

678. Moses S, Motro M, Sheonfeld Y. Blunt trauma causing emboli from friable atherosclerosis plaques. Harefuah 133: 355-357, 1977.

 

679. George J, Gilburd B, Levy Y, Afek A, Damianovich Y, Ghirardello A, Doria A, Todesco S, Shoenfeld Y. Autoantibody dominance pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies. Pathobiology 65: 204-209, 1997.

 

680. Bar-Dayan Y, Shoenfeld Y. Magnesium fortification of water a possible step forward in preventive medicine? Ann Med Interne 6:440-444, 1997.

 

681. Bar-Dayan Y, Levy Y, Amital H, Shoenfeld Y. Aspirin for prevention of myocardial infarction, a double edge- sword. Ann Med Interne 6: 148: 430-433, 1997.

 

682. Levy Y, George J, Abraham A, Afek A, Livneh A, Shoenfeld Y. Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents. Clin Rheumatol 16:606-608,1997.

 

683. Grunebaum E, Renandineau E, Shoenfeld Y. Anti-endothelial cell antibodies-clinical significance. Harefuah 133: 458-462, 1997.

 

684. Sherer Y, Shoenfeld Y. Tumor metastases: mechanisms and dissemination pathways. Harefuah 133:564-570,1997.

 

685. George J, Afek A, Gilburd B, Levy Y, Blank M, Kopolovic J, Harats D, Shoenfeld Y. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 6:723-729, 1997.

 

686. Tishler M, Maran R, Langevitz P, Livneh A, Gazit E, Gilburd P, Youinou P, Shoenfeld Y. Antiperinuclear factor – clinical, serological and genetic correlates in Israeli patients with rheumatoid arthritis. Rheumatol Int 17: 141-143.

 

687. Rotman P, Levy Y, Shoenfeld Y. Primary biliary cirrhosis – association or overlap with other autoimmune diseases. Isr J Med Sci 33: 823-825, 1997.

 

688. Buskila D, Sikuler E, Shoenfeld Y. Hepatitis C virus, autoimmunity and rheumatic disease. Lupus 6: 685-690, 1997.

 

689. Shovman O, George J, Shoenfeld Y. Primary subclavian vein thrombosis after physical exertion. Harefuah 133: 610-613, 1997.

 

690. Mendelovic S, Doron A, Shoenfeld Y. Schizophrenia – an autoimmune disease? Harefuah 133: 629-632, 1997.

 

691. Finkekstein Y, Adler Y, Nussinovitch M, Shoenfeld Y. Continuous infusion versus intermittent adminitration of furosemide in pediatric and adult pateints with severe congestive heart failure. Paddiatr. Grenzgeb. 36: 181-184, 1997.

 

692. Sherer Y, Shoenfeld Y. Tumor metastases – new experimental anti-metastatic therapies. Harefuah 133: 636-642, 1997

 

693. Aharon-Maor A, Shoenfeld Y. Cimetidine - an unexpected ally. Isr J Med Sci 33: 363-365, 1997.

 

694. Sherer Y, Shoenfeld Y. Infectious agents and atherosclerosis. Harefuah 134: 204-207, 1998.

 

695. Barak V, Schwartz A, Kalichman I, Nisman B, Gurman G, Shoenfeld Y. Prevalence of hypophosphatemia in sepsis and infection: The role of cytokines. Amer J Med 104: 40-47, 1998.

 

696. Blank M, George J, Fishman P, Levy Y, Toder V, Savion S, Barak V, Koike T, Shoenfeld Y. Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. Arthritis & Rheumatism 41: 224-232, 1998.

 

697. Amital H, Levi Y, Shoenfeld Y. Antiphospholipid syndrome and vasculitis – just a coincidence? Harefuah 134: 273-276, 1998.

 

698. Ehrenfeld M, Shoenfeld Y: Chapter 1.3.8 Haematology and Oncology in Rheumatology: Oxford Textbook of Rheumatology (Maddison et al – Eds). Oxford University Press, 1998, Oxford U.K. pp. 288-298.

 

699. Krause I, Blank M, Shoenfeld Y. Anti-DNA and antiphoshpholipid antibodies in IVIG preparations: In Vivo study in naive mice. J. Clin Immunol, 18, 52-60, 1998.

 

700. Aharon-Maor A, Levy Y, Shoenfeld Y. Fibrosarcoma after silicone breast augmentation: associated? Harefuah, 134: 339-441, 1998.

 

701. Ehrenfeld M, Shoenfled Y. Breast silicone implant and autoimmunity: coincidence or cause and effect relationship? Harefuah, 134: 361-364, 1998.

 

702. George J, Blank M, Levy Y, Meroni PL, Damianovich M, Tiniani A, Shoenfeld Y. Differential effects of anti-b-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 97: 900-906, 1998.

 

703. Levy Y, George J, Ziporen L, Cledes J, Amital H, Bar-Dayan Y, Afek A, Youinou P, Shoenfeld Y. Massive proteinuria as a main manifestation of primary antiphospholipid syndrome. Phatobiology 1998; 66: 49-52.

 

704. Sherer Y, Shoenfeld Y. Stem cells transplatation – a cure for autoimmune diseases. Lupus 7, 137-140, 1998.

 

705. Gafter A., Bar-Dayan Y., Shoenfeld Y.. Cow milk feeding in infancy: is it a predisposing factor to insulin-dependent diabetes mellitus? Harefuah 134; 489-492, 1998.

 

706. Tomer Y, Sherer Y, Shoenfeld Y. Autoantibodies, autoimmunity and cancer. Oncol Rep. 5:753-761, 1998.

 

707. Reifen R, Blank M, Afek A, Kopilowiz Y, Sklan D, Gershwin ME, German B, Yoshida S, Shoenfeld Y. Dietary polyunsaturated fatty acids decrease anti-dsDNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus. Lupus 7, 192-197, 1998.

 

708. Karsten C, Levy Y, Blank M, Jurgen M, Karl-Heinz F, Beate R, Shoenfeld Y, The pathogenic 16/6 idiotype in pateints with silica associated systemic lupus erythematosus (SLE) and in uranium miners with increased risk for development of SLE. J Rheumatol 1998; 25: 660-666, 1998.

 

709. Tincani A, Shoenfeld Y. Animal Models of Anti-Phospholipid Syndrome. in: Reumatologia V Teorii a Praxi V. Eds: Josef Rovenski. 1998: pp. 217-227. Vydavatelstvo Osveta. Banska Bystriia. Slovakia.

 

710. Levy Y, George J, Barak V, Shoenfeld Y, Early detection of recurrent mono-metastases of breast cancer to endocrine tissues by following CEA levels. Oncol Reports, 4: 623-624: 1997.

 

711. Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, Shoenfeld Y, Youinou PY. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest, 15; 101 : 2029-2035: 1998.

 

712. Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Sander DM, Shoenfeld Y, Ahmed A, Van de Water J, Gershwin ME, Garry RF. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet, 351: 1620-1624: 1998.

 

713. Sherer Y, Shoenfeld Y. Bone marrow transplantation for severe autoimmune diseases: treatment of choice or a treatment of no choice? Harefuah, 134: 785-787: 1998.

 

714. George J, Afek A, Gilburd B, Levkovitz H, Shaish A, Goldberg I, Kopolovic Y, Wick G, Shoenfeld Y, Harats D. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138; 147-152: 1998.

 

715. Adler Y, Finkelstein Y, Guindo J, Rodriguez de la Serna A, Shoenfeld Y, Bayes-Genis A,Sagie A, Bayes de Luna A, Spodick DH. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation, 97: 2183-2185: 1998.

 

716. Afek A, Kopulovic J, Shoenfeld Y. Cytomegalovirus and atherosclerosis. Harefuah 134: 869-871, 1998.

 

717. Levy Y, Gilburd B, George J, Del Papa N, Mallone R, Damianovich M, Blank M, Radice A, Renaudineau Y, Youinou P, Wiik A, Malavasi F, Meroni P.L., Shoenfeld Y. Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA. Int Immunol 10: 861-868, 1998.

 

718. Assouline-Dayan Y, Levi Y, Shoenfeld Y. Viagra, the first oral treatment for impotence. Harefuah 135; 1-2, 1998.

 

719. Shemer J, Shoenfeld Y. Viagra – utility and risk. Harefuah 135; 20-23, 1998.

 

720. Levy Y, George J, Yona E, Shoenfeld Y. Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation: An autoimmune phenomenon. Immunol Res 18: 55-60, 1998.

 

721. George J, Alkan M, Shoenfeld Y. BCG In: Encyclopedia of Immunology. Editor: I Roitt, P. Delves. Academic Press. USA. p. 335-336, 1998.

 

722. Shoenfeld Y, Sherer Y, Fishman P. Interleukin-3 and pregnancy loss in antiphospholipid syndrome. Scand J Rheumatol. 27 (suppl) 107: 19-22, 1998.

 

723. Shoenfeld Y, Sherer Y, Blank M. Antiphospholipid syndrome in pregnancy – animal models and clinical implications. Scand J Rheumatol. 27 (suppl) 107: 33-36, 1998.

 

724. Sherer Y, Shoenfeld Y. Anti-phospholipid autoantibodies – do they have a pathogenic role in infertility? Scand J Rheumatol. 27 (suppl) 107: 40-43, 1998.

 

725. Sherer Y, Blank M, Shoenfeld Y. Immunomodulation of experimental antiphospholipid syndrome. Scand J Rheumatol. 27 (suppl) 107: 48-52, 1998.

 

726. George J, Afek A, Gilburd B, Blank M, Levy Y, Aron-Maor A, Levkovitz H, Shaish A, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with b2-glycoprotein I. Circulation. 98: 1108-1115, 1998.

 

727. Krause I, Blumenfeld Z, Malchinsky M, Cohen S, Blank M, Eldor A, Weksler B, Schweitzer K, Shoenfeld Y. Anti-endothelial cell antibodies in the sera of hyperprolactinemic women. Lupus 7: 377-382. 1998.

 

728. Shoenfeld Y. Introduction: Autoantibodies as a clinical diagnostic tool. Clin Rev Allergy & Immunol 16: 205-206, 1998.

 

729. Ahmed AEE, Peter J B, Shoenfeld Y. Autoantibodies in angioneurotic edema. Clin Rev Allergy & Immunol. 16: 207-210, 1998.

 

730. Merimsky O, Shoenfeld Y, Fishman P. The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions. Clin Rev Allergy & Immunol 16: 227-236, 1998.

 

731. Terryberry JW., Shoenfeld Y., Peter J. B. Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants. Clin Rev Allergy & Immunol. 16: 265-273, 1998.

 

732. Alosachie IJ, Terryberry JW, Mevorach D, Chapman Y, Lorber M, Torre D, Youinou P, Peter JB, Shoenfeld Y. Central nervous System (CNS) involvement in SLE: The diagnostic role of antibodies to neuronal antigens. Clin Rev Allergy & Immunol. 16: 275-284, 1998.

 

733. Kollmeier A, Kreditor M, George J, Levy Y, Shoenfeld Y. Functional properties of antiendothelial cell antibodies. Clin Rev Allergy & Immunol. 16: 297-311, 1998.

 

734. Shen GQ, Shoenfeld Y, Peter JB. Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus. Clin Rev Allergy & Immunol. 16: 321-334, 1998.

 

735. George J, Patnaik M, Bakshi E, Levy Y, Ben-Daviv A, Ahmed A, B. Peter J, Shoenfeld Y. Hantavirus seropositivity in Israeli patients with renal failure. Viral Immunol. 11: 103-8, 1998.

 

736. Shoenfeld Y, Haratz D, George J. Atherosclerosis and the antiphospholipid syndrome: A link unravelled? Lupus 7: 140-143, 1998.

 

737. Shoenfeld Y, Ziporen L. Lessons from experimental APS models. Lupus 7: 158-161, 1998.

 

738. George J, Gilburd B, Hojnik M, Levy Y, Langevitz P, Matsuura, Koike Takao, Shoenfeld Y. Target recognition of b2-Glycoprotein (b2GPI)-dependent anticardiolipin antibodies: Evidence for involvement of the fourth domain of b2GPI in antibody binding. J Immunol, 160: 3917-3923, 1998.

 

739. Krause I, Blank M, Shoenfeld Y. Idiotypic induction of autoimmunity. J Biolo Reg d Homeost Agents, 12, 49-52, 1998.

 

740. Bordron A, Dueymes M, Levy Y, Jamin C, Ziporen L, Piette JC, Shoenfeld Y, Youinou P. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum, 41:1738-47, 1998.

 

741. Levy y, Afek A, Sherer Y, Bar-Dayan y, Shibi R, Kopolovic J, Shoenfeld Y. Malignant thymoma associated with autoimmune diseases: A retrospective study and review of the literature. Sem Arthritis Rheumat, 28: 73-80,1998.

 

742. Amital H, Shoenfeld Y., Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. System Lupus Erythematosus, AP-Academic press, 3rd Ed. 1-16,1998. (Editor R. Sahita).

 

743. Aharon-Maor, Shoenfeld Y., The role of ultraviolet light, and sun and fluoresent light, in the pathogenesis of systemic lupus erythematosus. Harefuah, 135:295-298, 1998.

 

744. Shoenfeld Y., Kleidoscopic Autoimmunity. Harefuah, 135, 262-263, 1998.

 

745. Abu-Shakra M, Buskila D, Shoenfeld Y. Idiotypes of autoantibodies. APLAR J Reumatol 2: 54-64; 1998.

 

746. Sherer Y, Shoenfeld Y, Environmental factors and scleroderma. Harefuah, Vol.135 No.9: 370-373, 11/1998.

 

747. Amital H, Levy Y, Blank M, Barak V, Langevitz P, Afek A, Nicoletti F, Kopolovic J, Gilburd B, Meroni PL, Shoenfeld Y. Immunomodulation of murine experimental SLE-like disease by interferon-Y. Lupus 7: 445-454, 1998.

 

748. Nezlin C, Alarcon-Segovia D, Shoenfeld Y. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. J Autoimmun 1998, 11:489-493.

 

749. Skurnik Y, Shoenfeld Y. Health effects of cigarette smoking. Clin Dermatol 1998,16:545-56.

 

750. Ziporen L, Li ZQ, Park KS, Sabnekar P, Liu WY, Arepally G, Shoenfeld Y, Kieber-Emmons T, Cines DB, Poncz M. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. Blood 1998, 92:3250-9.

 

751. Shoenfeld Y, Autoantibodies-antigen driven or idiotypically induced. Bratisl Lek Listy, 99:410-2, 1998.

 

752. Ahmed AE Peter JB, Shoenfeld Y, ANCA testing. New developments and clinical implications. Clin Rev. Allergy Immunol 16:303-11,1998.

 

753. Sherer Y, Bar-Dayan Y, Shoenfeld Y, The Dual Relationship Between Thymectomy and Autoimmunity. The Kaleidoscope of Autoimmune Disease. Autoimmune Reactions, Ch.23, pp.371-382,Edited by: Sudhir Paul, Human Press Inc., Totowa, New Jersey, U.S.A., 1998.

 

754. Sherer Y, Bakshi E, Rotman P, Levy Y, Shoenfeld Y, Comparative clinical study of cefonicid, chloramphenicol, and penicillin in community-acquired pneumonia., Int J Mol Med 2:343-348, 1998 .

 

755. Winder A, Shoenfeld Y, Hochman R, Keren G, Levy Y, Eldor A. High-Dose Intravenous γ g-globulins for herparin induced thrombocytopenia: A prompt response. J Clin Immunol, 18: 330-334; 1998.

 

756. Blank M., George J, Barak V, Tincany A, Koike T, Shoenfeld Y. Oral tolerance to low dose ß2-glycoprotein-I: immunomodulation of experimental antiphospholipid syndrome. J Immunol, 161: 5303-12, 1998.

 

757. Sherer Y, Shoenfeld Y, Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant, 22: 873-81, 1998.

 

758. Portugese S, Amital H,Tenenbaum A, Bar-Dayan Y, Levy Y, Afek A, Shemesh J, Shoenfeld Y. Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol; 21: 813-816, 1998.

 

759. Bar-Dayan Y, Gershwin M.E., Levy Y, Amital H, Soenfeld Y. Primary biliary cirrhosis: Is (and how much of) the patology preventible? Immunologic Research 18: 117-121, 1998.

 

760. Ziporen L, Shoenfeld Y, Anti-phospholipid syndrome:from patient's bedside to experimental animal models and back to the patient's bedside. Hematol Cell Ther 40: 175-82, 1998.

 

761. Galeazzi M, Bellisai F, Sebastiani GD, Marcolongo R, Houssiau F, Cervera R, Levy Y, George J, Sherer T, Shoenfeld Y. Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLE. Clin Exp Rheumatol 16: 717-20, 1998.

 

762. Tincani A, Spatola L, Cinquini M, Meroni P, Balestrieri G, Shoenfeld Y. Models animaux de syndrome antiphospholipides. Rev Rhumatisme. [Ed.Fr]: 65: 676-681, 1998. [Engl. Ed.]: 65:614-618, 1998.

 

763. Shoenfeld Y, Gharavi A, Koike T. ß2GP-I in the anti phospholipid (Hughes') syndrome - from a cofactor to an autoantigen - from induction to prevention of antiphospholipid syndrome. Lupus 7: 503-506, 1998.

 

764. Goldstein S.E, Levy Y, Shoenfeld Y. Pulmonary hypertension and multivalvular damage caused by anorectic drugs. Harefuah 135: 491, 1998.

 

765. Sherer Y, Shoenfeld Y, Report on the catalytic and super antibodies satellite meeting held in conjunction with the 10th International Congress of Immunology. WWW.rheuma21st.com, 15.11.98.

 

766. Afek A, George J, Shoenfeld Y, Gilburd B, Levy y, Shaish A, Keren P, Jankovic Z, Goldberg I, Kopolovic J, Haratz D. Enhancement of atherosclerosis in beta-2 glycoprotein I - immunized apolipoprotein E - deficient mice. Pathobiology 67: 19-25,1999

 

767. Bar-Dayan y, Blau A, Skurnik Y, Shoenfeld Y, Renal biopsy in the elderly - to do or not to do? Harefuah 135: 645, 1998.

 

768. Amital H, Shoenfeld Y. Cytokines, antibodies to cytokines and autoimmunity. Drug of Today 34: 825-835, 1998.

 

769. Amital H, Shoenfeld Y, Autoimmunity and Autoimmune Diseases such as SLE . Chapter in book: Systemic Lupus Erythematosus. Ed: R.G.Lahita, Academic Press San-Diego, USA pp. 1-16, 1998.

 

770. Nahum A, Levy Y, Shoenfeld Y. Ocular manifestations in the antiphospholipid syndrome. Harefuah 136: 50, 1999.

 

771. Ben-Ari T, Bar-Dayan Y, Shoenfeld Y. Low cholesterol, depression and unexplained deaths - the link and the mystery. Harefuah 136: 82, 1999.

 

772. Sherer Y, Bar-Zohar D, Levy Y, Shoenfeld Y. Thromboembolic phenomena in patients with hereditary factor XI deficiency. Ann Med Interne 149: 492-494, 1998.

 

773. Zandman-Goddard G, Blank M, Ehrenfeld M, Gilburd B, Peter J, Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol 26: 73-7, 1999.

 

774. Ehrenfeld M, Gur H, Shoenfeld Y. Rheumatologic features of hematologic disorders. Curr Opin Rheumatol . 11: 62-7, 1999.

 

775. Blank M, Eldor A, Tavor S, Ziporen L, Cines DB, Arepally G, Afek A, Shoenfeld Y. A mouse model for heparin - induced thrombocytopemnia. Semin Hematol 36: 12-16, 1999.

 

776. Bar-Meir E, George J, Shoenfeld Y. Hyperhomocysteinemia - a risk factor for vascular disease? Harefuah 136: 129, 1999.

 

777. Blank M, Ziporen L, Krause L, Shoenfeld Y. Immunomodulation of Experimental Antiphospholipid Syndrome: Lessons from Murine Models. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 81-84, 1999.

 

778. Shoenfeld Y, Cervera R. Innovations in Autoimmunity in the Last Decade. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 7-18, 1999.

 

779. Merimsky O, Shoenfeld Y, Fishman P. A Focus on Anti-Tyrosinase Antibodies in Melanoma and Vitiligo. In: The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 261-268, 1999.

 

780. Zurgil N, Gerbat S, Langevitz P, Tishler M, Ehrenfeld M, Kaufmann M, Deutsch M, Shoenfeld Y. Detection of Cellular Activity in Autoimmune Disorders by the Cellscan System. In: The Decade of Autoimmunity: (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 295-304, 1999.

 

781. Barak V, Shoenfeld Y. Cytokines in Autoimmunity. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 313-322, 1999.

 

782. Buskila D, Abu-Shakra M, Shoenfeld Y. Prolactin and Autoimmunity. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 339-346, 1999.

 

783. Buskila D, Sikuler E, Shoenfeld Y. Hepatitis C virus and Autoimmunity. In: The Decade of Autoimmunity. (Ed: Y. Shoenfeld). Elsevier Publ Amsterdam, The Netherlands: 355-364, 1999.

 

784. Harats D, George J, Levy Y, Khamashta M.A., Hughes G.R.V, Shoenfeld Y. Atheroma: links with antiphospholipid, antibodies Hughes syndrome and lupus. Q J Med 92: 57-59, 1999.

 

785. Goldstein G, Levy Y, Shoenfeld Y. The X-ANCA-immunological aspects and clinical significance. Harefuah, 136: 280-282, 1999.

 

786. Mendelovic S, Doron A, Shoenfeld Y . Depression and the immune system. Harefuah, 136: 288-190, 1999.

 

787. George J, Gilburd B, Shoenfeld Y. Autoantibody spread may explain multiple antibodies. The Immunologist 7/6; 189-193., 1999.

 

788. Ben-Ari T, Bar-Dayan Y, Shoenfeld Y. Low cholesterol, depression and unexplained deaths - the link and the mystery. Harefuah, 136: 82-85, 1999

 

789. Sherer Y, Shoenfeld Y. The Antiphospholipid (Hughes') Syndrome: An Entity to Be Expanded. AJRI Am J of Reproductive Immunol, 41:113-116, 1999.

 

790. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, Kopolovic J, Wick G, Harats D. Enhanced Fatty Streak Formation in C57BL/6J Mice by Immunization With Heat Shock Protein-65. Arterioscler Thromb Vasc Biol, 19: 505-510, 1999.

 

791. Renaudineau Y, Revelen R, Levy Y, Gilburd B, Shoenfeld Y, Youinou P. Anti-endothelial cell antibodies in systemic sclerosis. Clin Dian Lab Immunol, 6: 150-60, 1999.

 

792. Amital H, Langevitz P, Leby Y, Afek A, Goldberg I, Pras M, Livneh A, Shoenfeld Y. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease [In Process Citation]. Clin Exp Rheumatol, 17: 99-102, 1999.

 

793. George J, Gilburd B, Langevitz P, Levy Y, Nezlin R, Harats D, Shoenfeld Y. Beta(2) glycoprotein I containing immune-complexes in Lupus patients: association with thrombocytopenia and lipoprotein (a) levels. Lupus 8: 116-120, 1999.

 

794. Chapman J, Cohen-Armon M, Shoenfeld Y. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8: 127-133, 1999.

 

795. Levy Y, Portugese S, Amital H, Shoenfeld Y. Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol 21: 813-816, 1998 - reply. Clin Cardiol 22: 158-158, 1999.

 

796. Sherer Y, Levy Y, Shahar A, Leibovich L, Konen E, Shoenfeld Y. Survival without surgical repair of acute rupture of the right ventricular free wall. Clin Cardiol 22: 319-320, 1999.

 

797. Sherer Y, Shoenfeld Y. A malignancy work-up in patients with cancer-associated (paraneoplastic) autoimmune diseases: pemphigus and myasthenic syndromes as cases in point (Review). Oncol Rep, 6: 665-668, 1999.

 

798. Shoenfeld Y, Sherer Y. Blood and marrow transplantation in autoimmune diseases reported at 25th annual meeting of European Group for Blood and Marrow Transplantation. http//www.rheuma 21st.com/archives, 21/4/99.

 

799. Levy Y, George J, Fabbrizzi F, Rotman P, Paz Y, Shoenfeld Y. Marked improvement of Churg-Strauss Vasculitis with intravenous gammaglobulins. South Med J 92: 412-4, 1999.

 

800. Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Nat Acad Sci (USA) 96: 5164-5168, 1999.

801. Quaranta S, Shulman H, Ahmed A, Shoenfeld Y, Peter J, McDonald GB, de Water JV, Coppel R, Ostlund C, Worman HJ, Rizzetto M, Tsuneyama K, Nakanuma Y, Ansari A, Locatelli F, Pagenin S, Rosina F, Manns M, Gershwin ME. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol 91: 106-16, 1999.

 

802. Amital H, Shoenfeld Y. Microchimeras - the secret path that leads to immunity? Harefuah 1999; 136: 618-619.

 

803. George J, Harats D, Gilburd B, Levy Y, Langevitz P, Shoenfeld Y. Atherosclerosis - related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis. Lupus 8: 220-226, 1999.

 

804. Sherer Y, Levy Y, Langevitz P, Lorber M, Fabrizzi F, Shoenfeld Y. Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin. Clin Rheumatol 18: 170-173, 1999.

 

805. Saraux A, Jouquan J, Le Goff P, Youinou P, Levy Y, Piette J-C, Guillevin L, Semana G, Salmon D, Viard J-P, Bach J-F, Shoenfeld Y. Environment factors may modulate antiphospholipid antibody production in familial members of patients with systemic lupus erythematosus. Arthritis & Rhematism 42: 1062-1063, 1999.

 

806. Abu Shakra M, Buskila D, Shoenfeld Y. Molecular mimicry between host and pathogen: examples from parasites and implication. Immunology Letters 67: 147-152, 1999.

 

807. George J, Harats D, Gilbourd B, Afek A, Levy Y, Schneiderman J, Barshack I, Kopolovic J, Shoenfeld Y. Immunolocalization of beta2-Glycoprotein I (Apolipoprotein H) to human atherosclerosis plaques: potential implications for lesion progression. Circulation 99: 2227-2230, 1999.

 

808. Shoenfeld Y. European forum on antiphospholipid antibodies. http:// www.rheuma21st com/archives/euro_antiphos.html : 1-8, 1999.

 

809. Sherer Y, Levy Y, Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18: 238-240, 1999.

 

810. Shoenfeld Y, Sherer Y. Cancer and antibodies to p53. Harefuah, 136: 868-869, 1999.

 

811. Edelson G, Levy Y, Shoenfeld Y. Relapse of sarcoidosis after alternative medical treatment. Harefuah, 136: 849-850, 1999

 

812. Krause I, Blank M, Levy Y, Koike T, Barak V, Shoenfeld Y. Anti-idiotype immunomodulation of experimental anti- phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol, 117: 190-197,1999.

 

813. Blank M, Krause I, Goldkorn TZ, Praprotnik S, Livneh A, Langevitz P, Kaganovsky E, Morgenstern S, Cohen SH, Barak V, Eldor A, Weksler B, Shoenfeld Y. Monoclonal anti-endothelial cell antibodies from Takayasu arthritis activate endothelial cells from large vessels. Arthritis & Rheum, 42: 1421-32, 1999.

 

814. George J, Aron A, Levy Y, Gilburd B, Ben-David A, Renaudineau Y, Zonana-Nachach A, Youinou P, Harats D, Shoenfeld Y. Anti-cardiolipin, anti--endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: Relationship with vascular access thrombosis and thromboembolic events. Hum Antibodies 9: 125-31, 1999.

 

815. Sherer Y, Langevitz P, Levy Y, Fabrizzi F, Shoenfeld Y. Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin. Lupus 8: 324-327, 1999.

 

816. Zurgil N, Levy Y, Deutsch M, Gilburd B, George J, Harats D, Kaufman M, Shoenfeld Y. Reactivity of peripheral blood lymphocytes to oxidized low-density lipoprotein: a novel system to estimate atherosclerosis employing the cellscan. Clin Cardiol 22: 526-532, 1999.

 

817. Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dayan Y, Fabbrizzi F, Terryberry J, Peter J, Shoenfeld Y. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy and Immunol 119: 231-238, 1999.

 

818. George J, Harats D, Bakshe E, Adler T, LevyY, Gilburd B, Shoenfeld Y. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty. Immunol Lett 68: 263-266, 1999.

 

819. Kessary-Shoham H, Levy Y, Shoenfeld Y, Lorber M, Gershon H. In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration. J Autoimmunity 13: 129-135, 1999.

 

820. Shoenfeld Y, Fishman P. Gamma-globulin inhibits tumor spread in mice. Int Immunol 11: 1247-1251, 1999.

 

821. Shoenfeld Y, Mathieu A. Clinical and laboratory features of SLE: involvement of the central nervous system. Archived Reports http://www.rheuma21st.com/archives/featuresle.html (31.07.99) 1-9, 1999.

 

822. Krause I, Tomer Y, Elias D, Blank M, Gilbourd B, Cohen I.R, Shoenfeld Y. Inhibition of diabetes in NOD mice by idiotypic induction of SLE J Autoimmunity 13: 49-55, 1999.

 

823. George J, Shoenfeld Y, Haratz D. The involvement of Beta 2-Glycoprotein I (ß2GPI) in human and murine atherosclerosis. J Autoimmunity 13: 57-60, 1999.

 

824. Shapira S, Bar-Dayan Y, Gershwin M.E, Shoenfeld Y. Predicion and prevention of primary billary cirrhosis. Harefuah, 137: 39-41, 1999.

 

825. Bayer P.M, Bauerfeind S, Bienvenu J, Fabien N, Frei P.C, Gilburd B, Heide K-G, Hoier-Madsen M, Meroni P.L, Monier J.C, Monneret G, Panzeri P, Shoenfeld Y, Spertini F, Wiik A. Multicenter evaluation study on a n4ew HEp2 ANA screening enzyme immune assay. J Autoimmunity 13: 89-93, 1999.

 

826. Ehrenfeld M, Langevitz P, Shoenfeld Y. Anti-cytokine therapy in inflammatory joint diseases. Harefuah, 137 : 120-123, 1999.

 

827. Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G. DNA levels in circulating immune complexes decrease at severe SLE flares - correlation with complement component C1q. J Autoimmunity 13: 111-119, 1999.

 

828. Sherer Y, Levy Y, Fabrizzi F, Shoenfely Y. Immunomodulation of various autoimmune diseases by intravenous immunoglobulin. Drugs of Today, 35: 513-518, 1999.

 

829. Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin (IVIG) therapy in autoimmune diseases - SLE, antiphospholipid syndrome, vasculitis. What is new? http://www.rheuma21st.com/archives/cutting_edge_immunoglobulin.html (16.09.99) 1-5, 1999.

 

830. Afek A, Shoenfeld Y, Manor R, Goldberg I, Ziporen L, George J, Polak-charcon S, Amigo MC, Garcia-Torres R, Segal R, Kopolovic J. Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome. Lupus 8: 502-507, 1999.

 

831. Avdalovic M, Duhel L, Shoenfeld Y, Gershwin M.E. Physiological functions of leukocyte adhesion molecules and their implication in pathology. Semin Clin Immunol 2: 7-15, 1999.

 

832. George J, Harats D, Shoenfeld Y. Inflammatory and immune aspects of atherosclerosis. IMAJ 1: 112-116, 1999.

 

833. Krause I, Blank M, Shoenfeld Y. New treatment avenues: oral tolerance - mechanisms and applicability to human diseases. IMAJ 1: 45-49, 1999.

 

834. Shoenfeld Y, Alarcon-Segovia D, Buskila D, Abu-Shakra M, Lorber M, Sherer Y, Berden J, Meroni PL, Valesini G, Koike T, Alarcon-Riquelme M.E.; Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, Aptil 20-25, 1998. Sem Ar & Rheum Vol 29, No. 2: 112 - 130, Oct19 99.

 

835. George J, Shoenfeld Y . Accelerated atherosclerosis in the antiphospholipid syndrome secondary to SLE: is there a role for anti-beta2GPI antibodies? Rheumat 21st com/archives/cutting_ edge_ atherosclerosis.html, 4.10.1999.

 

836. Tomer Y, Barak V, Gilbourd B, Shoenfeld Y . Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. Clin Exp Rheumatol; 17: 521-6, 1999.

 

837. Levy Y, Sherer Y, George J, Fabbrizzi F, Shoenfeld Y. Use of intravenous immunoglobulin in idiopathic membranous nephropathy. Int Med 38; 11: 917, 1999.

 

838. Levy Y, George J, Langevitz P, Harats D, Doolman R, Sela B-A, Shoenfeld Y. Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatology; 26: 2383-2385, 1999.

 

839. Bar-Dayan T, Barshack I, Blank M, Goldberg I, Levy Y, Kopolovic J, Fishman P, Shoenfeld Y. Antibodies to the cytoplasm, cell membrane and nuclear membrane of malignant neoplasms in pooled normal human polyspecific immunoglobulin G. Int J Oncol 15: 1091-1096, 1999.

 

840. Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, Terryberry J, Meissner M, Lorber M, Peter JB, Shoenfeld Y. A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response. Lupus 8: 705-712, 1999.

 

841. Blank M, Waisman A, Mozes E, Koike T, Shoenfeld Y. Characteristics and pathogenic role of anti-b2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome. Int Immunol 12: 1917-1926, 1999.

 

842. Sherer Y, Levy Y, Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18: 238-240, 1999.

 

843. Shoenfeld Y, Avisar R, Tomsic M, Bombardieri S. Archived reports: VII international symposium of Sjogren's Syndrome. Venice, Italy, December 1-4, 1999. http/www.rheuma21st.com/archives/Sjogren99.html., 25.12.1999 : 1-13.

 

844. Adler Y, George J, Shoenfeld Y, Fink N, Herz I, Mager A, Assali A, Harats D, Sagie A. Association between mitral annulus calcification and anti b2-glycoprotein I antibody levels. J Noninvasive Cardiol III: 111-115, 1999.

 

845. Ram R, Levy Y, Shoenfeld Y. Prostacyclin-a new hope: its function and indications for therapeutic use. Harefuah, 138: 54-58, 2000.

 

846. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - 'Vaccinosis': a dangerous liaison? J Autoimmunity, 14: 1-10, 2000.

 

847. Landau Y.E., Shoenfeld Y. Appur si muove - an autoimmune disease: auto-antibodies to tissue transglutaminase in celiac disease. Harefuah. 138: 122-126, 2000.

 

848. Krause I, Blank M, Shoenfeld Y. Peptide immunotherapy: lessons from experimental models of systemic lupus erythematosus and antiphospholipid syndrome. http/www.rheuma21st.com/archives…ng_edge_Peptideimmunotherapy.html, 1.2.2000 1-5.

 

849. Asherson Ronald A, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome - molecular mimicry? J Rheumatol, 27: 1: 12-14, 2000.

 

850. Sherer Y, Shaish A, Levkovitz H, Keren P, Janackovic Z, Shoenfeld Y, Harats D. Magnesium fortification of drinking water suppresses atherogenesis in male LDL-receptor - deficient mice. Pathobiology, 67: 207-213, 1999.

 

851. Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus - like syndrome in MRL-lpr / lpr mice. Eur J Immunol, 30: 438-447, 2000.

 

852. Rotenberg M, Levy Y, Shoenfeld Y, Almog S, Ezra D. Effect of azathioprine on the anticoagulant activity of warfarin. Ann Pharmacother 34: 120-2, 2000.

 

853. Adler Y, Finkelstein Y, Guindo J, Rodriguez De La Serna A, Bayes -Genis A, Bayes De Luna A, Shoenfeld Y, Sagie A, Spodick DH. Recurrent peicarditis as a manifestation of familial mediteranean fever. Circulation 101: E71-72, 2000.

 

854. Afek A, George J, Gilburd B, Rauova L, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun, 14: 115-121, 2000.

 

855. George J, Shoenfeld Y. Autoimmunerkrankungen: Mosaiksteine der pathogenese, autoimmune faktoren bei der entstehung der atherosklerose. Aspekte, 8-15,12/99.

 

856. Shoenfeld Y. The internal medicine subspeciality in the third millenium - where do we go? I accuse! Harefuah, 138: 407-409, 2000.

 

857. Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, Lindor KD. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 32: 182-7, 2000.

 

858. Sherer Y, Livneh A, Levy Y, Shoenfeld Y, Langevitz P. Dermatomyositis and polymyositis associated with the antiphospholipid syndrome - a novel overlap syndrome. Lupus 9: 42-46, 2000.

 

859. Aharon-Maor A, Shoenfeld Y. The good, the bad and the ugly of vaccination. IMAJ 2: 225-227, 2000.

 

860. George J, Shoenfeld Y. Introduction: The immune system, the autoimmune state and autoimmune disease. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 1-18, 2000.

 

861. Abu-Shakra M, Buskila D, Shoenfeld Y. Rheumatoid arthritis and cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 19-30, 2000.

 

862. Abu-Shakra M, Buskila D, Shoenfeld Y. SLE and Cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 31-40, 2000.

 

863. Aron-Maor A, Shoenfeld Y. PSS (Scleroderma) and Cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 45-48, 2000.

 

864. Tishler M, Shoenfeld Y. Paraneoplastic Syndromes. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 121-132, 2000.

 

865. Tomer Y, Shoenfeld Y. Autoantibodies, autoimmunity and cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 141-150, 2000.

 

866. Sherer Y, Shoenfeld Y. Thymoma and autoimmune diseases. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 249-252, 2000.

 

867. Buskila D, Sikuler E, Shoenfeld Y. Hepatitis C virus, autoimmunity and cancer. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 285-298, 2000.

 

868. George J, Shoenfeld Y. The smoking - cancer - autoimmunity connection. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 309-316, 2000.

 

869. Buskila D, Abu-Shakra M, Shoenfeld Y. Anti-idiotypic in autoimmunity. In: Cancer and Autoimmunity. (Eds: Shoenfeld Y, Gershwin Eric M.) Elsevier Publ. Amsterdam, The Netherlands: 365-378, 2000.

 

870. Shoenfeld Y. Is the physician like the pilot? Lessons learned from two professions demanding great responsibility. Eur J Int Med 11: 127-129, 2000.

 

871. George J, Afek A, Gilburd B, Harats D, Shoenfeld Y. Autoimmunity in atherosclerosis: lessons from experimental models. Lupus 9: 223-227, 2000.

 

872. Krause I, Blank M, Shoenfeld Y. Immunomodulation of experimental autoimmune diseases via oral tolerance. Crit Rev Immunol; 20: 1-16, 2000.

 

873. Bar-Dayan Y, Kaveri SV, Kazatchkine MD, Shoenfeld Y. Is cancer an autoimmune process dependent on anti-apoptotic autoantibodies? Med Hypotheses, 55: 103-108, 2000.

 

874. Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin therapy in antiphospholipid syndrome. Rheumatology (Oxford), 39: 421-426, 2000.

 

875. Sherer Y, Levy Y, Fabrizio Fabbrizzi, Shoenfeld Y. Treatment of hematologic disorders other than immune thrombocytopenic purpura with intravenous immunoglobulin (IVIG) - report of seven cases and review of the literature. Eur J Int Med 11: 85-88, 2000.

 

876. Levy Y, Sherer Y, George J, Rovensky J, Ludac J, Rauova L, Poprac P, Langevitz P, Fabbrizzi F, Shoenfeld Y. Intravenous Immunoglobulin Treatment of Lupus Nephritis. Sem Arthritis Rheumatism 29: 321-327, 2000.

 

877. Cohen SH.B., Goldenberg M, Rabinovici J, Lidor A.L, Dulitzky M, Gilburd B, Shoenfeld Y, Schiff E. Anti-cardiolipin antibodies in feltal blood and amniotic fluit derived from patients with the anti-phospholipid syndrome. Eur. Soc Hum Reprod Embryol.15:1170-1172,2000.

 

878. Shoenfeld Y, Kallenberg C. GM, 9th International vasculitis/ANCA workshop. Archived Reports http://www.rheuma21st.com/archives/VASCULITIS ANCA_WORKSHOP.html (27.4.2000) 1-5.

 

879. Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol 18: 181-184, 2000.

 

880. Krause I, Blank M, Shoenfeld Y. The induction of experimental vascular diseases by immunization with pathogenic autoantibodies. Clin Exp Rheumatol : 18: 257-261, 2000.

 

881. Rauova L, Rovensky J, Shoenfeld Y. High dose intravenous immuoglobulins: a new step in the treatment of systemic lupus erythematosus. IMAJ 2: 388-392, 2000.

 

882. Levy Y, Sherer Y, Langevitz P, Lorber M, Rotman P, Fabrizzi F, Shoenfeld Y. Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - a preliminary report. Clin Rheumatol 19: 207-211,2000.

 

883. Sherer Y, Shoenfeld Y. Idiotypic network dysregulation: a common etiopathogenesis of diverse autoimmune diseases. Appl Biochem Biotechnol 83: 155-62; discussion 297-313, 2000.

 

884. Blank M, Krause I, Shoenfeld Y. The contribution of experimental models to our understanding of etiology, pathogenesis and novel therapies in the antiphospholipid syndrome. In book: "Hughes Syndrome Antiphospholipid syndrome" (Ed: M.A. Khamashta) Springer Publ : 379-385, 2000

 

885. Bar-Meir E, Amital H, Levy Y, Kneller A, Bar-Daya Y, Shoenfeld Y. Mycoplasma-pneumoniae- induced thrombotic thrombocytopenic purpura. Acta Haematologica. 103: 112-115, 2000.

 

886. George J, Ahmed A, Patnaik M, Aadler Y, Levy Y, Harats D, Gilburd B, Terrybery J, Shen G-Q, Sagie A, Herz I, Snow P, Brandt J. Peter J, Shoenfeld Y. The prediction of coronary atherosclerosis employing artificial neural networks. Clin Cardiol 23: 453-456, 2000.

 

887. Meroni P.L., Del Papa N, Gilburd B, Raschi E, Panzeri P, Borghi M.O, Lindsey N, Shoenfeld Y. The story of the murine antiendothelial monoclonal antibody BGM: from patients' bedside to laboratory bench and from animal models to patients. Clin Rev Allergy & Immunol. 18: 3-10, 2000.

 

888. Lorber M, Shoenfeld Y. Hidden autoantibodies. Clin Rev Allergy & Immunol. 18: 3-10, 2000.

 

889. George J, Harats D, Shoenfeld Y. Autoimmunity in atherosclerosis: The role of autoantigens. Clin Rev Allergy & Immunol. 18: 73-86, 2000. 80

 

890. Krause I, Blank M, Shoenfeld Y. Peptide immunotherapy in autoimmune diseases. Drug News & Perspectives 13: 78-84, 2000

 

891. Shoenfeld Y. VI International Congress of Immunorehabilitation, Eilat, Israel, May 3-6, 2000. http/www.rheuma21st.com/archives/immunorehab_shoenfeld..html, 26.6.2000 1-7.

 

892. Shovman O, Shoenfeld Y. Smoking, sex hormones and rheumatoid arthritis. Harefuah, 138; 949-951, 2000.

 

893. Shovman O, Gilbourd B, Langevitz P, Shoenfeld Y. Immunological and clinical aspects of anti-RA33 antibodies in various autoimmune diseases. Harefuah 138: 1043-1045, 2000.

 

894. George J, Shoenfeld Y, Gilbourd B, Afek A, Shaish A, Harats D. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or mycobacterium tuberculosis. Circ Res 86: 1203-1210, 2000.

 

895. Shoenfeld Y, Sherer Y, Jacob J, Harats D. Autoantibodies associated with atherosclerosis. Ann Med 32: 37-40, 2000.

 

896. Gur H., Bar-Dayan Y., Shoenfeld Y. Anti-P53 autoantibodies as diagnostic or prognostic markers of cancer. Sem Clin Immunol 1, 339-44, 2000.

 

897. Zandman-Goddard G, Shoenfeld Y. Novel approaches to therapy for systemic lupus erythematosus. Eur J Int Med 11 130-134, 2000.

 

898. Sherer Y, Shoenfeld Y, Shaish A, Levkovitz H, Bitzur R, Harats D. Suppression of atherogenesis in female-low-density lipoprotein receptor knokout mice following magnesium fortification of drinknig water: the importance of diet. Pathobiology 68: 93-98, 2000.

 

899. Amital H, Levy Y, Shoenfeld Y. Use of intravenous immunoglobulin in livedo vasculitis. Clin Exp Rheumatol, 18: 404-406, 2000.

 

900. Shoenfeld Y. Atherosclerosis and the immune system: is atherosclerosis an autoimmune disease? Sem Clin Immunol 1 : 5-6, 2000.

 

901. Kornberg A, Renaudineau Y, Blank M, Youinou P, Shoenfeld Y. Anti-beta2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue pactor in endothelial cells. IMAJ - Isr Med Ass J 2: 27-31, 2000.

 

902. Terryberry J.F., Shoenfeld Y, Sherer Y, Levy Y, Fabrizio F, Ahmed A, Peter J.B. Detection of antibodies to gangliosides and glycolipids in various Intravenous Immunoglobulin (IVIg) preparations. Immunol Invest 29: 337-347, 2000.

 

903. Levy Y, Sherer Y, Mathieu A, Cauli A, Passiu G, Sann G, Janackovic Z, Blank M, Shoenfeld Y. Anti-cardiolipin antibody from a patient with antiphospholipid syndrome recognizes only an epitope expressed by cardiolipin/ ß2-glycoprotein-I (ß2GPI) complex and induces APS. Clin Exp Rheum 18:479-84, 2000.

 

904. Shoenfeld Y, Blank M, Krause I. The relationship of anti-phospholipid antibodies to infections - do they bind to infecting agents or may they even be induced by them? Clin Exp Rheum 18: 431-2, 2000.

 

905. Blank M, Krause I, Shoenfeld Y. Molecular Mimicry: lessons from experimental models of systemic lupus erythematosus and antiphospholipid syndrome. (Chap. 16) in: Molecular Mimicry, Microbes, and Autoimmunity. Editors: M.W.Cunningham, R.S. Fujinami, 2000, ASM Press, Washington, D.C. pp. 223-233, 2000.

 

906. George J, Meroni P.L., Gilbord B, Raschi E, Harats D, Shoenfeld Y. Anti-endothelial cell antibodies in patients with coronary atherosclerosis. Immunol Letters 73: 23-27, 2000.

 

907. Shoenfeld Y. The revolution in medicine toward the third millenium: from a lecture to medical students on their first exposure to clinical medicine. Harefuah, 139: 109-110, 2000.

 

908. Shoenfeld Y, Haratz D, Jacob G. Heat shock protein 60/50, beta2-glycoprotein I and Oxidized LDL as players in murine atherosclerosis. J Autoimmunity 15: 199-202, 2000.

 

909. Sherer Y, Shoenfeld Y. Antiphospholipid syndrome: insights from animal models. Curr Opin Hematol. 7: 321-4, 2000.

 

910. Meissner M, Sherer Y, Levy Y. Chwalinska H, Langevitz P, Shoenfeld Y. Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis. Rheumatol Int 19:199-201, 2000.

 

911. Levy Y, Sherer Y, Ahmed A, Fabbrizzi F, Terryberry J, Qiu Shen G, Peter J.B., Shoenfeld Y Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment. Nat Immun (1998) 16: 207-214, 2000.

 

912. Praprotnik S, Rozman B, Blank M, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. Wien Klin Wochenschr. 112/ 15-16: 660-664, 2000.

 

913.Sherer Y, Shoenfeld Y. The idiotypic network in antinuclear-antibody-associated diseases. Int Arch Allergy Immunol, 123: 10-15, 2000.

 

914. Shoenfeld Y. Eppur si muove (Galileo Galilei 1564- 1642): the idiotypic dysregulation of autoantibodies as part of the etiology of SLE. Lupus 9: 481 - 483, 2000.

 

915. George J, Harats D, Gilburd B, Afek A, Shaish A, Kopolovic J, Shoenfeld Y. Adoptive transfer of b2-glycoprotein I - reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102: 1822 - 1827, 2000.

 

916. Reifen R. Amital H, Blank M, Sklan D, Berkovich Z, Gershwin E, Shoenfeld Y. Linseed Oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome. J Autoimmun 15: 381-385, 2000.

 

917. Shoenfeld Y, Krause I, Matalon SH, Sheer Y. 9th Internationl Symposium on Antiphospholipid Antibodies, September 12-16, 2000, Tours, Loire Valley, France. http/www.rheuma21st.com/archives/apls_shoenfeld..html, 11.10.2000 pp: 1-10.

 

918. Sanna G, Piga M, Terriberry JW, Pelz MT, Giagheddu S, Satta L, Ahmed A, Cauli A, Montaldo C, Passiu G, Peter JB, Shoenfeld Y, Mathieu A. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus: 9: 573-83, 2000.

 

919. Aron-Maor A, Shoenfeld Y. Vaccination and arthritis revisited. http/www.rheuma21st.com/archives/apls_shoenfeld..vaccination_revisited_html, 11.9.2000 pp: 1-6.

 

920. Rozen Y, Levy Y, Shoenfeld Y. Pulmonary adenocarcinoma in myasthenia gravis - autoimmunity and late development of malignancy. Harefuah; 139, 354-355, 2000.

 

921. Shoenfeld Y. Editorial: Changing of the Guard - tribute to Ya'acov Rotem. Harefuah; 138: 359, 2000.

 

922. Shoenfeld Y, Conrad K. Autoantigens and autoantibodies: diagnostic tools and clues to understanding autoimmunity. http/www.rheuma21st.com/archives/shoenfeld_dresden.html, 9.11.2000 pp: 1-11.

 

923. Leibovitch L, Amital H, Levy Y, Langevitz P, Shoenfeld Y. Isotretinoin-induced adult onset Still's disease. Clin Exp Rheumatol; 18: 616-8, 2000.

 

924. Savion S, Blank M, Shepshelovich J, Fishman P, Shoenfeld Y. Ciprofloxacin afects pregnancy loss in CBA/JxDBA/2J mice possibly via elevation of interleukin-3 and granulocyte macrophage-colony stimulating factor production. AJRI 44: 293-298, 2000.

 

925. Shoenfeld Y. Are the research physicians an endangered species? Harefuah 139: 441-442, 2000.

 

926. Sherer Y, Shemesh J, Tenenbaum A, Praprotnik S, Harats D, Fisman E Z, Blank M, Motro M, Shoenfeld Y. Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain. Am J Cardiol 86: 1206-1311, 2000.

 

927. Shoenfeld Y, Pavelka K. 32nd Rheumatologic Scientivic Conference of the Institute of Rheumatology and the Medical Faculty of Charles Zuniversity, Prague, Czech Republic, 3rd November 2000. File:////Shoenfeld/public/reprints…Shoenfeld - Prague - Rheumat21.htm, 2000, 1-4.

 

928. Levy Y, Sherer Y, Shoenfeld Y. Iloprost treatment of finger gangrene in a patient with Raynaud's Syndrome. IMAJ 2: 960-962, 2000.

 

929. Shro S, Chapman J, Shoenfeld Y. Central nervous system involvement in antiphospholipid syndrome. Harefuah, 140: 40-43, 2000.

 

930. Praprotnik S, Blank M, Levy Y, Tavor S, Boffa M-C, Weksler B, Eldor A, Shoenfeld Y. Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells. Int Immunol 13: 203-210, 2000.

 

931. Matalon SH, Blank M, Ornoy A, Shoenfeld Y. The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol Microbiol 45: 72-77, 2001.

 

932. Shoenfeld Y, Sherer Y, George Y, Harats D. Mexico-Israel Symposium: beta2-glycoprotein I in human and murine atherosclerosis. IMAJ 3: 85-87, 2001.

 

933. Leibe A, Shoenfeld Y. Association between periodontitis, gingivitis and atherosclerosis. Harefuah. 140: 126-128, 2001.

 

934. Sherer Y, Tenenbaum A, Blank M, Shemesh J, Harats D, Fisman E Z, Praprotnik S, Motro M, Shoenfeld Y. Autoantibodies to oxidized low-density lipoprotein in coronary artery disease. Am J Hypertension 14: 149-154, 2001.

 

935. Ehrenfeld M, Shoenfeld Y. Malignancies and autoimmune rheumatic diseases. J Clin Rheumatol. 7: 47-49, 2001.

 

936. Shoenfeld Y. Eppur si muove (Galileo Galilei 1564-1642): the idiotypic dysregulation of autoantibodies as part of the etiology of SLE. Harefuah, 140: 227-229, 2001.

 

937. Shoenfeld Y. Mass casualty events during night shifts in the internal medicine departments. Harefuah, 140: 230-231, 2001.

 

938. Cabral Antonio R, Shoenfeld Y. Highlights of the XXIX meeting of the Mexican Society of Rheumatology, February 9-13, 2001. http/www.rheuma21st.com/archives/highlights29mexmeet.html,

 

939. Sherer Y, Shoenfeld Y. Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis. Curr Atheroscler Rep. 3: 328-33, 2001.

 

940. Fishman P, Shoenfeld Y. Intravenous immunoglobulin (IVIg) as an inhibitor of tumor growth: from autoimmunity to cancer. (Chap. 13 ) in: Old Herborn University Seminar Monograph. Editors: Peter J. Heidt Volker D. Rusch; Dirk Van Der Waaij, 2001, Herborn Litterae, pp:93-107.

 

941. Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin (IVIg) in autoimmune diseases - expanding indications and increasing specificity. (Chap. 13 ) in: Old Herborn University Seminar Monograph. Editors: Peter J. Heidt Volker D. Rusch; Dirk Van Der Waaij, 2001, Herborn Litterae, pp:85-91.

 

942. Abu Shakra M, Shoenfeld Y. Azathioprie therapy for patients with systemic lupus erythematosus. Lupus 10: 152-153, 2001.

 

943. Rauva L, Lukac J, Levy Y, Rovensky J, Shoenfeld Y. High-dose intravenous immunoglobulins for lupus nephritis - a salvage immunomodulation. Lupus 10: 209-213, 2001

 

944. Arom-Maor A, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 10: 237-240, 2001

 

945. Leiba A, Amital H, Gershwin ME, Shoenfeld Y. Diet and lupus. Lupus 10: 246-248, 2001

 

946. Sherer Y, Levy Y, Langevitz P, Rauova L, Fabrizzi F, Shoenfeld Y. Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacology 62: 133-137, 2001.

 

947. Asherson RA, Shoenfeld Y. The catastrophic antiphospholipid syndrome - a review of 115 patients and possible clues to pathogenesis and treatment. http/www.rheuma21st.com/archives/cutting_asherson_caps.html, 2001, 1-16.

 

948. Sherer Y, Shoenfeld Y. Report on the European Atherosclerosis Society workship on the immune system in atherosclerosis. http/www.rheuma21st.com/archives/shoenfeld_immune_sys_atherosclerosis%10.html, 2001, 1-4.

 

949. Leibe A, Levy Y, Shoenfeld Y. Intravenus immunoglobulins treatment of patients with Graves' opthalmopathy. Harefuah; 140: 392-394, 2001.

 

950. Gordon PA, George J, Khamashta M, Harats D, Hughes G, Shoenfeld Y. Atherosclerosis and autoimmunity. Lupus 10: 249-252, 2001

 

951. Shoenfeld Y, Krause Irit, Krause Ilan, Evelyn V. hess. 6th International Lupus Conference Barcelona 26-28, March 2001. http/www.rheuma21st.com/archives/shoenfeld ….html, 2001, 1-11

 

952. Shoenfeld Y, Aron-Maor A, Tanai A, Ehrenfeld M. BCG and autoimmunity: another two-edged sword. JAI 16: 235-240, 2001.

 

953. Abu Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 60: 433-440, 2001.

 

954. Shemer Y, Shoenfeld Y. HAREFUAH peer review. Harefuah; 140: 403-405, 2001.

 

955. Rahamim-Cohen D, Shoenfeld Y. The mosaic of autoimmunity. A classical case of inhalation of a polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases. IMAJ 3: 381-382, 2001.

 

956. Shoenfeld Y, Sherer Y, Haratz D. Atherosclerosis as an infectious, inflammatory and autoimmune disease. TRENDS in Immunol 22: 293-295, 2001.

 

957. Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman E.Z, Harats D, George J, Levy Y, Peter J.B, Motro M, Shoenfeld Y. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, Beta-2-glycoprotein-I, and oxidized LDL antibodies. Cardiology 95: 20-24, 2001.

 

958. Leder AN, Flansbaum B, Zandman-Goddard G, Asherson R, Shoenfeld Y. Antiphospholipid syndrome induced by HIV. Lupus 10: 370-374, 2001.

 

959. Marai I, Levy Y, Goddard G, Shoenfeld Y. Following up of 90 patients with anti-phospholipid syndrome: manifestations of the disease, follow-up of antibodies titers and correlations with clinical manifestations in the Israeli population - patients in the Sheba medical center, Tel-Hashomer. Harefuah, 140: 495-500, 2001.

 

960. Von-Landenberg P, Shoenfeld Y. New approaches in the diagnosis of sepsis. IMAJ 3: 439-442, 2001.

 

961. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y, The dual association between lymphoma and autoimmunity. http/www.rheuma21st.com/archives…report_shoenfeld_duallyphoma.html, 2001, 1-7. Blood Cells Mol Dis. 2001; 27: 750-6.

 

962. Ryhal B, DeMera RS, Shoenfeld Y, Peter JB, Gershwin ME. Are autoantibodies present in patients with subacute and chronic urticaria. J Investing Allergol Clin Immunol, 11: 16-20, 2001.

 

963. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. Arthritis & Rheum 44: 1484-1494, 2001.

 

964. Zandman-Goddard G, Shoenfeld Y. HIV and Autoimmunity. http/www.rheuma21st.com/archives file:////Shoenfeld/public/REPRINT…report_zandmann_shoenfeld_hiv.html, 2001, 1-11.

 

965. Renaudineau Y, Grunebaum E, Krause I, Praprotnik S, Revelen R, Youinou P, Blank M, Gilburd B, Sherer Y, Luderschmidt C, Eldor A, Weksler B, Gershwin EM, Shoenfeld Y. Anti-endothelial cell antibodies (AECA) in systemic sclerosis - increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 33: 171-179, 2001.

 

966. Shoenfeld Y, Blank M, Sherer Y. Induction and treatment of the antiphospholipid syndrome - lessons from models. Eur J Clin Invest 31: 736-40, 2001.

 

967. Aron-Maor A, Soenfeld Y. Editorial: Alternative therapies in rheumatic diseases – pros and cons. Lupus 10: 453-456, 2001.

 

968. Katzav A, Pick CG, Korezyn AD, Oest E, Blank M, Soenfeld Y, Chapman J. Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus 10: 496-499, 2001.

 

969. Shoenfeld Y. Atherosclerosis as an autoimmune condition. Harefuah 140: 720-722, 2001.

 

970. Shoenfeld Y, Krause I, Krause I, Khamashta M, Hughes G. The Sixth International Lupus Conference, Barcelona 24-28 March 2001. Lupus 10: 580-587, 2001.

 

971. Sherer Y, Wu R, Krause I, Peter JB, Shoenfeld Y. Antiphospholipid antibody levels in intravenous immunoglobulin (IVIG) preparations. Lupus 10: 568-570, 2001.

 

972. George J, Afek A, Gilburd B, Shoenfeld Y, Harats D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-deficient mice. J Am Coll Cardiol 38: 900-905, 2001.

 

973. Ehrenfeld M, Abu Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells Molec Dis 27: 750-756, 2001.

 

974. Shoenfeld Y, Levy Y, Fishman P. Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment. IMAJ 3: 698-699, 2001.

 

975. George J, Haratz D, Shoenfeld Y. Accelerated atheroma antiphospholipid antibodies, and the antiphospholipid syndrome. Rheum Dis Clin North Am. 27: 603-610, 2001.

 

976. Shoenfeld Y, Sidi Y, Ezra D. The department of internal medicine – returned to its formal glory. Harefuah; 140: 835-6, 2001.

 

977. Ehrenfeld M, Blank M, Shoenfeld Y, Hidvegi M. AVEMAR (a new benzoquinone-containing natural product) administration interferes with the The response in experimental SLE and promotes amelioration of the disease. Lupus 10: 622-627, 2001.

 

978. Amital H, Levy Y, Davidson C, Lundberg I, Harju A, Kosach Y, Asherson RA, Shoenfeld Y. Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases. Semin Arth Rheum 31: 127-132, 2001.

 

979. Segal E, Shoenfeld Y. IVIG therapy in sepsis. Harefuah, 140: 955-958, 2001.

 

980. Carp HJ, Toder V, Gazit E, Ahiron R, Torchinski A, Mashiach S, Shoenfeld Y. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis. Am J Reprod Immunol 46: 268-73, 2001.

 

981. Shoenfeld Y,, Takasaki Y, Yamamoto K, Koike T. Report: 7th International Workshop on Autoantibodies ans Autoimmunity. http/www/rheuma21st.com/archives///report_shoenfeld….html

 

982. Sherer Y, Wu R, Krause I, Gershwin A, Levy Y, Peter JB, Shoenfeld Y. Cytokyne levels in various intravenous immunoglobulin (IVIG) preparations. Hum Antibodies 10: 51-53, 2001.

 

983. Sherer Y, Bizur R, Cohen H, Shaish A, Varon D, Shoenfeld Y, Harats D. Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model. Magnes Res 14: 173-179, 2001.

 

984. Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, Lim E, Lau TC, Gurjal A, Jedryka-Goral A, Chwalinska-Sadowska H, Dibner RJ, Rojas-Rodriguez J, Garcia-Carrasco M, Grandone JT, Parke AAL, Narbosa P, Vasconcelos C, Ramos-Casals M, Font J, Ingelmo M. Catastrophic antiphospholipid syndrome: Clue to the pathogenesis from series of of 80 patients. Medicine (Baltimore) 80: 355-377, 2001.

 

985. Brickman CM, Shoenfeld Y. The mosaic of autoimmunity. Scand J Clin Lab Invest 61: 3-15, 2001.

 

986. Rauova L, Chapman J, Shoenfeld Y. Brain vasculitis and antiphospholipid syndrome. A chapter in book: Brain disease therapeutic strategies and repair. Publication: Martin Dunitz; pp: 193-200, 2001.

 

987. Gorshtein A, Shoenfeld Y. The mosaic of pemphigus. Harefuah 140: 1049-111053, 2001.

 

988. Shovman O, Levy Y, Gilburd B, Shoenfeld Y. Anti- inflammatory and immunomodulatory properties of statins. http/www/rheuma21st.com/archives///report_shoenfeld_antiinfl_statins.html

 

989. Katzav A, Kloog Y, Korczyn AD, Niv H, Karussis DM, Wang N, Rabinowitz R, Blank M, Shoenfeld Y, Chapman J. Treatment of MRL/1pr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin Exp Immunol, 126: 570-577, 2001.

 

990. Carp H, Asherson R.A., Shoenfeld Y. Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome: what is its role? J Clin Rheumatol 7:291-294, 2001.

 

991. Marai Y, Levi Y, Shoenfeld Y. Morbidity and mortality in systemic lupus erythematosus. Harefuah, 140: 1177-1180, 2001.

 

992. Shemer Y, Shoenfeld Y. A new reality - epidemiology of terror. Harefuah, 140: 994-996, 2001.

 

993. Sherer Y, Shoenfeld Y. Atherosclerosis: Is Atherosclerosis a cellular or humoral mediated outoimmune disease? Ann Rheum Dis.; 61: 97-99, 2002.

 

994. Zan-Bar T, Aron A, Shoenfeld Y. Acupuncture therapy fo r rheumatoid arthritis. http/www/rheuma21st.com/archives/cutting_shoenfeld_acupuncture.html, 2002.

 

995. Zurgil N, Levy Y, Gilburd B, Trubiankov E, Deutch M, Shagran Y, Shoenfeld Y. Detection of cellular activity in atherosclerosis by the novel cellscan system. In: Atherosclerosis and Autoimmunity; (Eds: Shoenfeld Y, Harats D. and Wick G.) Elsevier Publ. Amsterdam, The Netherlands: pp. 191-200, 2001.

 

996. Blank M, Shoenfeld Y, Tavor S, Praprotnik S, Boffa MC, Weksler B, Walenga MJ, Amiral J, Eldor A. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of of microvascular endothelial cells. Int Immunol 14: 121-122, 2002.

 

997. Lev S, Shoenfeld Y. The family of metalloproteinases and their immunomodulatory significance. Harefuah, 141, 118-110, 2002.

 

998. Rauova L, Rovensky J, Shoenfeld Y. Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins. Springer Semin Immunopathol 23: 447-57, 2001

 

999. Fajka-Boja R, Hidvegi M, Shoenfeld Y, Ion G, Demydenko D, Tomoskozi-Farkas R, Vizler C, Telekes A, Resetar A, Monostori E. Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumor T and B cell lines. Int J Oncol 20: 563-570, 2002. 

 

1000. Marai I, Shoenfeld Y. Lupus-like syndrome due to minocycline. Harefuah 141: 151-152, 2002. 

1001. Sherer Y, Shoenfeld Y. Immunomodulation for treatment and prevention of atherosclerosis. Autoimmunity Rev 1: 21-27, 2002.

 

1002. Merimsky O, Meller I, Inber M, Bar-Yehuda S, Shoenfeld Y, Fishman P. A possible role for IVIG in the treatment of soft tissue sarcoma: a clinical case and an experimental model. Int J Oncol 20: 839-43, 2002.

 

1003. Lev S. Gilburd B, Lahat N, Shoenfeld Y. Prevention of tumor spread by matrix metalloproteinase-9 inhibon: old drugs, new concept. Eur J Intern Med 13: 101-103, 2002.

 

1004. Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman EZ, Motro M, Shoenfeld Y. Autoantibodies to cardiolipin and Beta -2 -Glycoprotein-I in coronary artery disease patients with and without hypertension. Cardiology 97: 2-5, 2002.

 

1005. Bar-Dayan Y, Kaveri SV, Bar-Dayan Y, Pashov A, Shoenfeld Y, Kazatchkine MD. Anti-inflammatory effects of intravenous immunoglobulin (IVIG) in symposium in Immunology. VII Eibl, M. and Huber H. ed. Springer - Verlag. Herlag. Heidelberg. pp. 171-184.

 

1006. Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y. Bacterial I induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 109: 797-804, 2002.

 

1007. Sherer Y, Dulitzki M, Levy Y, Livneh A, Shoenfeld Y, Langevitz P. Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome. Ann Hematol 81: 161-163, 2002.2002.

 

1008. Sherer Y, Molina V, Shoenfeld Y. Novel aspects in autoimmunity and autoimmune diseases: Summary of 3rd International Congress on Autoimmunity Geneva Switzerland, Feb. 20-24, 2002. http/www/rheuma21st.com/archives/shoenfeld_3int_cong_autoimmun.html, 2002

 

1009. Cervera R, Piette J-C, Font J, Khamashta M, Shoenfeld Y, Champs M.T., Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derkson R.H.W.M, dr Groot P.G.,Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Groc J-C, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa M-C, Hughes G.R.V, Ongelmo M. Antiphospholipid syndrome. Clinical and immunologica manifestations and patterns of disease expression in a cohort of 1,000 patients. Arth Rheum 46: 1019-1027, 2002.

 

1010. Grunebaum E, Levy Y, Shoenfeld Y. Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment. IMAJ 4: 288-289, 2002.

 

1011. Abu Shakra M, Ehrenfeld M, Shoenfeld Y. Systemic lupus erythematosus and cancer: associated or not? Lupus 11: 137-44, 2000.

 

1012. Lerner A, Shoenfeld Y. Serological markers in inflammatory bowel disease: the pros and cons. Eur J Gastroenterol Hepatol 14: 103-105, 2002.

 

1013. Rauova L, Gilburd B, zZurgil N, Blank M, Guegas LL, Brickman CM, Cebecauer L, Deutsch M, Wiik A, Shoenfeld Y. Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes. Clin immunol 103: 69-78, 2002.

 

1014. Krause I, Wu R, Sherer Y, Patanik M, Peter J, Shoenfeld Y. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations - a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med 12: 133-139, 2002.

 

1015. Shoenfeld Y. Infection and atherosclerosis - impact on autoimmune rheumatic disease, Washington D.C., USA 29-30 April 2002 - Report. http/www/rheuma21st.com/archives/report_infection_atherosclerosis.html, 2002

 

1016. Shovman O, Levy Y, Gilburd B, Shoenfeld Y. Antiinflammatory and immunomodulatory properties of statins. Immunologic Research 25: 271-286, 2002.

 

1017. Shoenfeld Y. The 10th International Vasculitis and ANCA Workshop, 25-28 April 2002, Cleveland, Ohio, USA. - Report. http/www/rheuma21st.com/archives/report_10th _intern_vasculitis_part2.html, 2002.

 

1018. Shoenfeld Y, Sherer Y, Kalden JR. The expanding world of autoimmunity. Trends Immunol. 23: 278-279, 2002.

 

1019. Tincani A, Gilburd B, Abu-Shakra M, Blank M, Allegri F, Ottaviani R, Riboni M, Meroni P.L., Balestrieri G, Shoenfeld Y. Immunization of Naive BALB/c mice with human b2Glycoprotein-I breaks tolerance to the murine molecule. Arth Rheum 46: 1399-1404, 2002.

 

1020. Assolin-Dayan Y, Leong A, Shoenfeld Y, Gershwin ME. Studies of sick building syndrome. IV Mycotoxicosis. J Asthma 39: 191-201, 2002.

 

1021. Blank M, Levy Y, Amital H, Shoenfeld Y, Pines M, Genina O. Concise communication: The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice. Arth Rheumat 46: 1689-1690, 2002.

 

1022. Shoenfeld Y. Fading into extinction. Harefuah, 141: 442-443, 2002.

 

1023. Marai I, Bornstein Y, Shoenfeld Y. Medicine and intercessory prayer. Harefuah, 141: 527-529, 2002.

 

1024. Sherer Y, Hassin Y, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P. Transverse myelitis in patients with antiphospholipid antibodies - the importance of early diagnosis and treatment. Clin Rheumatol 21: 207-210, 2002.

 

1025. Grunebaum E, Blank M, Youinou P, Shoenfeld Y. The pathogenic role of anti-endothelial cell antibodies. http/www/rheuma21st.com/archives/cutting_edge_grunebaum_antiendo.html, 2002.

 

1026. Shoenfeld Y, Meroni P.L. International Meeting on Autoimmunity and Pregnancy Loss. 8 June, 2002, Park hotel Villa Fiorita, Italy. http/www/rheuma21st.com/archives/report_schoenfeld_pregnancy.html, 2002.

 

1027. Chapman J, Shoenfeld Y. Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome. ANNALS of the New York Academy of Sciences. 966: 415-424, 2002.

 

1028. Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Clev Clin J Med,69 SII: 65-68, 2002.

 

1029. Matsuura E, Kazuko K, Junko K,Tatsuji Y, Hirofumi M, Koike T, Shoenfeld Y. Anti-b2-Glycoprotein I autoantibodies and atherosclerosis. Intern Rev Immunol 21: 51-66, 2002.

 

1030. Sherer Y, Levy Y, Shoenfeld Y. IVIG in autoimmunity and cancer-efficacy versus safety. Expert Opin Drug Saf. I(2): 153-158, 2002.

 

1031. Steiner G, Shovman O, Skriner K, Gilburd B, Langevitz P, Miholits M, Hoet R, Levy Y, Zandman-Goddard G, Hoefler E, Smolen JS, Shoenfeld Y. Induction of anti-RA33 hnRNP autoantibodies and transient spreadto U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice. Clin Exp Rheumatol. 20: 517-24, 2002.

 

1032. Krause I, He XS, Gershwin ME, Shoenfeld Y. Brief report: immune factors in autism: a critical review. J Autism Dev Disord. 32: 337-45, 2002.

 

1033. Fishman P, Bar-Yehuda S, Shoenfeld Y. IVIG to prevent tumor metastases (review). Int J Oncol 21: 875-80, 2002.

 

1034. Shoenfeld Y, Blank M, Conrad K. 6th Dresden Symposium on Autoantibodies 4-7 September 2002. http/www/rheuma21st.com/archives/report_6th_dresden_symposium_shoenfeld.html, 2002.

 

1035. Grunebaum E, Blank M, Cohen S, Afek A, Kopolovic J, Meroni PL, Youinou P, Shoenfeld Y. The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro ant in vivo studies. Clin Exp Immunol 130: 233-240, 2002.

 

1036. Schwarz A, Furman G, Cohen G, Gilutz H, Brill S, Schily M, Gurevitch B, Shoenfeld Y. Association between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis. Eur. J Int Med 13: 434-438, 2002.

 

1037. Harats D, Yacov N, Gilburd B, Shoenfeld Y, George J. Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis - induced and high-fat-diet-driven atherosclerotic lesions. J Am Col Cardiol 7: 1333-8, 2002.

 

1038. Matalon S, Shoenfeld Y, Blank M, Yacobi S, Blumenfeld Z, Ornoy A. The effects of IgG purified from women with SLE and associated pregnancy loss on rat embryos in culture. Am J Reproduct Immunol 48: 296-304, 2002.

 

1039. Lev Sh, Shoenfeld Y. Cardiac valvulopathy in the antiphospholipid syndrome. Clin Rev Allergy Immunol, 23: 341-348, 2002.

 

1040. Shoenfeld Y, Rauova L, Gilburd B, Kvapil F, Goldberg I, Kopolovic J, Rovensky J, Blank M. Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus. Int Immunol 14: 1303-1311, 2002.

 

1041. Shapiro S, Shoenfeld Y, Gilburd B, Sobel E, Lahat N. Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages. Cancer 95: 2032 - 2037, 2002.

 

1042. Shoenfeld Y, Orbach H. Blank M, Zandman-Goddard G, Gilburd B, Krause I, Chapman J, Sherer Y. Summary of the 10th International Congress on Antiphospholipid Antibodies. http/www/rheuma21st.com/archives/report, 26.11.2002.

 

1043. Orbach H, Gilburd B, Brickman CM, Gerli R, Shoenfeld Y. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease. IMAJ 4, 892-893, 2002.

 

1044. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmunity Rev 1/6: 329-337, 2002.

 

1045. Matsuura E, Kobayashi K, Koike T, Shoenfeld Y. Autoantibody-mediated atherosclerosis. Autoimmunity Rev 1/6: 348- 353, 2002.

 

1046. Assolin-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin E. Pathogenesis and natural history of osteonecrosis. Sem Arth Rheum 32: 94-124, 2002.

 

1047. Krause I, Blank M, Sherer Y, Gilburd B, Kvapil F, Shoenfeld Y. Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins. Eur J Immunol 32: 3414-3424, 2002.

 

1048. Molina V, Blank M, Shoenfeld Y. Fibrotic diseases. Harefuah, 141: 973-978, 2002.

 

1049. Krauze I, Shoenfeld Y. Autoimmune aspects of cytokines and anti-cytokine therapies. http/www/rheuma21st.com/archives/report, 25.11.2002.

 

1050. Short S, Katzav A, Korczyn AD, Litvinijuk Y, Hersherson R, CG Pick, Blank M, Zaech J, Shoenfeld Y, Sirota P, Chapman J. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11: 736-743, 2002.

 

1051. Gorshtein A, Levy Y, Shoenfeld Y. Air flights and venous thromboembolism - a preventable condition. IMAJ 4 1080 - 1081, 2002,

 

1052. Rottem M, Gershwin ME, Shoenfeld Y. Allergic disease and autoimmune effectors pathways. Developmental Immunology 9: 161-167, 2002.

 

1053. Shoenfeld Y. Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unreaveled. Trends in Immunology 24: 2-4, 2003.

 

1054. Siekmann JH, Allen LA, Watnik MR, Nestel P, Neumann CG, Shoenfeld Y, Peter JB, Patnik M, Ansari AA, Coppel RL, Gershwin ME. Titers of antibody to common pathogens: relation to food-based interventions in rural Kenyan schoolchildren. Am J Clin Nutr. 77: 242-9, 2003.

 

1055. Amital H, Rewald E, Levy Y, Bar-Dayan Y, Manthorpe R, Engervall P, Sherer Y, Langevitz P, Shoenfeld Y. Fibrosis regression induced by intravenous gammaglobulin treatment. Ann Rheum Dis 62: 175-177, 2003.

 

1056. Borchers AT, Keen CL, Shoenfeld Y, Silva J Jr, Gershwin ME. Vaccines, viruses and voodoo. J Invest Allergol Clin Immunol 12:155-68, 2002.

 

1057. Guejes L, Zurgil N, Deutsch M, Gilburd B, Shoenfeld Y. The influence of different cultivating conditions on polymorphonuclear leukocyte apoptotic precesses in vitro, I: the morphological characteristics of PMN spontaneous apoptosis. Ultrastruct Pathol 27: 23-32, 2003.

 

1058. Asherson RA, Shoenfeld Y. Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheum 30: 214-219, 2003.

 

1059. Shovman O, Levy Y, Tal S, Shoenfeld Y. Omental Cake in a Male. IMAJ 5 73-74, 2003.

 

1060. Zandman-Goddard G, Levy Y, Weiss P, Shoenfeld Y, Langevitz P. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheum 21: 111-113, 2003.

 

1061. Aron-Maor A, Shoenfeld Y. BCG immunization and the 'Trojan Horse' phenomenon. Clin Rheum 22: 6-7, 2003.

 

1062. Von-Landenberg P, Matthias T, Zaech J, Schultz M, Lorber M, Blank M, Shoenfeld Y. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol (AJRI) 49:51-56, 2003.

 

1063. Ingaki J, Sugiura-Ogasawara M, Nomizu M, Nakatsuka M, Ikuta K, Suzuki N, Kaihara K, Kobayashi K, Yasuda T, Shoenfeld Y, Aoki K, Matsuura E. An association of igG anti-laminin-1 autoantibodies with endometriosis in infertile patients. Human Reprod 18: 544-549, 2003.

 

1064. Wu R, Shoenfeld Y, Sherer Y, Patnaik M, Matsuura E, Gilburd B, Koike T, Peter JB. Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations – possible immunomodulation of atherosclerosis. Autoimmunity 36: 91-97, 2003.

 

1065. Rottem M, Shoenfeld Y. Allergy and autoimmunity. http://www.Rheum 21st.com.

 

1066. Katzav A, KloogY, Lprczum A.D., Molina V, Blank M, Shoenfeld Y, Chapman J. Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphopholipid syndrome. Immunobiol 207: 47-50, 2003.

 

1067. Matsuura E, Kobayashi K, Koike T, Shoenfeld Y, Khamashta MA, Hughes G.RV. Atherogenic autoantigen: oxidized LDL complexes with β2-glycoprotein I. Immunobiol 207: 17-22, 2003.

 

1068. Sherer Y, Shoenfeld Y. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Immunobiol 207: 13-16, 2003.

 

1069. Zandman-Goddard G, Blank M, Sherer Y, Ehrenfeld M, Chapman J, Orbach H, Gilburd B, Krause I, Shoenfeld Y. 10th International Congress on antiphospholipid antibodies – summary. Autoimmunity Rev 2: 79-85, 2003.

 

1070. Espinosa G, Cervera R, Font J, Shoenfeld Y. Antiphospholipid syndrome: pathogenic mechanisms. . Autoimmunity Rev 2: 86-93, 2003.

 

1071. Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R, Harats D. Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water. Biological Trace Element Research 90: 251-260, 2002.

 

1072. Orbach H, Shoenfeld Y. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis. Harefuah,142: 182-165, 2003.

 

1073. Shoenfeld Y, Cutolo M. The glucocorticoid induced osteoporosis (GIO) international congress, March 2003, Turin, Italy. http/www/rheuma21st.com/archives/report_gio_int_cong_shoenfeld_cutolo.html. April 3, 2003.

 

1074. Sherer Y, Shoenfeld Y. Summary of an expert conference on the use of IVIG. 14-15 February 2003, Berne. http/www/rheuma21st.com/archives/report_expert_ivig_shoenfeld_sherer.html. 27 March, 2003.

 

1075. Sherer Y, Tartakover-Matalon S, Blank M, Matsuura E, Shoenfeld Y. Multiple autoantibodies associated with autoimmune reproductive failure. J Assisted Rep & Genetics 20: 53-57, 2003.

 

1076. Shoenfeld Y. 23rd European Workshop for Rheumatology Research Marseille France 27/2-2/3, 23-3-2003. http/www/rheuma21st.com/archives/report 11.4.3004 pp: 1-6.

 

1077. Tartakover-matalon S, Blank M, Levy Y, Carp H.J.A., Arad A, Burek L, Grunebaum E, Sherer Y, Ornoy A, Refetoff S, Weiss R.E, Rose N.R, Shoenfeld Y. The pathogenic fole of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Human Reproduct 18: 1094-1099, 2003.

 

1078. Haj-Yahja S, Sherer Y, Blank M, Kaetsu H, Smolinski A, Shoenfeld Y. Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model. Lupus 12: 364-369, 2003.

 

1079. Shamir R, Shoenfeld Y, Blank M, Eliakim R, Lahat N, Sobel E, Shinar E, Lerner A. The prevalence of celiac disease antibodies in patients with the antiphospholipid syndrome. Lupus 12: 394-399, 2003

 

1080. Conrad K, Sack U, Shoenfeld Y. From proteomics to molecular epidemiology: relevance of autoantibodies. Autoimmunity Rev. 2: 165-169, 2003.

 

1081. Rotman - Pikielny P, Levy Y, Eyal A, Shoenfeld Y. Pyomyositis or "injectiositis" – staphylococcus aureus multiple abscesses following intramuscular injections. IMAJ 5: 295-296, 2003.

 

1082. Shoenfeld Y, Shemer J. Why viral (SARS, Ebola and AIDS) epidemics now? Harefuah, 142: 324-325, 2003.

 

1083. Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, Pick CG, Leider-Trejo L, Kalashnikova L, Blank M, Chapman J. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. LUPUS 12, 436-442, 2003.

 

1084. Tartakover - Matalon S, Blank M, Matsuura E, Inagaki J, Nomizu M, Levy Y, Koike T, Sherer Y, Ornoy A, Shoenfeld Y. Immuniation of naïve mice with mouse laminin-1 affected pregnancy outcome in a mouse model. Am J Reprod Immunol (AJRI) 50: 159-165, 2003.

 

1085. Abu Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy & Immunol 25: 13-24, 2003.

 

1086. Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy & Immunol 25: 29-40, 2003.

 

1087. Severin M.C., Levy Y, Shoenfeld Y. Systemic lupus erythematosus and parvovirus B-19. Casual coincidence or causative culprit? Clin Rev Allergy & Immunol 25: 41-48, 2003.

 

1088. Jara LJ, Medina G, Vera-Lastra O, Shoenfeld Y. Atherosclerosis and antiphospholipid syndrome. Clin Rev Allergy & Immunol 25: 79-88, 2003.

 

1089. Zandman-Goddard G, Shoenfeld Y. Novel approaches to therapy for SLE. Clin Rev Allergy & Immunol 25: 105-111, 2003.

 

1090. Shoenfeld Y. Systemic antiphospholipid syndrome. LUPUS 12, 497-498, 2003.

 

1091. Alarcon-Segovia D, Boffa MC, Branch W, Tincani A, Arnout JMMC, koike T, Piette J-C, Khamashta MA, Shoenfeld Y. Prophylaxis of the antiphospholipid syndrome: a consensus report. LUPUS 12, 499-503, 2003.

 

1092. Meroni PL, Moia M, Derksen RHWM, Tincani A, McIntyre JA, Koike T, Piette J-c, Khamashta MA, Shoenfeld Y. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis. LUPUS 12, 504-507, 2003.

 

1093. Brey RL, Chapman J, Levine SR, Ruiz-Irastorza G, Derksen RHWM, Khamashta M, Shoenfeld Y. Stroke and the antippholpholipid syndrome: consensus meeting Taormina 2002. LUPUS 12, 508-513, 2003.

 

1094. Chapman J, RAQND jh, Brey RL, Levine SR, Khamashta MA, Shoenfeld Y. Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. LUPUS 12, 514-517, 2003.

 

1095. Lockshin M, Tenedios F, Petri M, McCarty G, Forastiero R, Krilis S, Tincani A, Erkan D, Khamashta MA, Shoenfeld Y. Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. LUPUS 12, 518-5523, 2003.

 

1096. Tincani A, Branch W, Levt RA, Piette JC, Carp H, Khamashta MA, Shoenfeld Y. Treatment of pregnant patients with antiphospholipid syndrome. LUPUS 12, 524-529, 2003.

 

1097. Asherson RA, Cervera R, De Groot PG, Erkan D, Boffa M-C, Piette J-C, Khamashta MA, Shoenfeld Y. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. LUPUS 12, 530-534, 2003.

 

1098. Blank M, Krause I, Wildbaum G, Karin N, Shoenfeld Y. TNFa DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome. LUPUS 12, 546-549, 2003.

 

1099. Matsuura E, Kobayashi K, Koike T, Shoenfeld Y, Khamashta MA, Hughew GRV. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. LUPUS 12, 550-554, 2003.

 

1100. Ornoy A, Yacobi S, Tartakover-Matalon S, Blank M, Blumenfeld Z, Miller RK, Shoenfeld Y. The effects of antiphospholipid antibodies obtaind from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. LUPUS 12, 573-578, 2003.

 

1101. Ferro D, Saliola M, Meroni PL, Valesini G, Caroselli C, Pratico D, Fitzgerald GA, Shoenfeld Y, Violi F. Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost 1: 523-531, 2003.

 

1102. Jakab F, Shoenfeld Y, Balogh A, Michelatti M, Hoffmann A, Kahan Z, Lapis K, Mayer A, Sapy P, Szentpetery F, Telekes A, Thurzo L, Vagvolgyi A, Hidvegi M. A medical nutriment has supportive value in the treatment of colorectal cancer. British J of Cancer 89: 465-469, 2003.

 

1103. Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease – a comprehensive review. Autoimmunity 36: 193-197, 2003.

 

1104. Nicoletti F, Di Marco R, Papaccio G, Conget I, Gomis R, Bernardini R, Sims JE, Shoenfeld Y, -Bendtzen K. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiplw low-doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18 – binding protein: Fc construct. Eur J Immunol 33: 2278 – 2286, 2003.

 

1105. Rosman Y, Shoenfeld Y. The importance of the Cochrane Collaboration. Harefuah, 142: 674-676, 2003.

 

1106. Krause I, Valisini G, Scrivo R, Shoenfeld Y. Autoimmune aspects of cytokine and anticytokine therapies. Am J of Med 115: 390 – 397, 2003.

 

1107. Shoenfeld Y, Toubi E, Hiepe F. Eighth International Workshop on Autoantibodies and Autoimmunity Berlin, Germany, 10- 13, September 2003. Autoimmunity Rev 3; 77-84, 2004.

 

1108. Shoenfeld Y, Krause I, Kvapil F, Sulkes J, Lev S, Von Landenberg P, KFont J, Zaech J, Cervera R, Piette JC, Boffa MC, Khamashta MA, Bertolaccini ML, Hughes GRV, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jonsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Vriezman VB, Blank M. Prevalence and clinical correlations of antibodies against six b2-Glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol 23: 377-383, 2003.

 

1109. Levy Roger A, Galarza C, Shoenfeld Y. I Latin American Congress of Immunology, Galapagos - September 15 – 18, 2003. Autoimmunity Rev 3: 76-87, 2004

 

1110. Piette JC, Cervera R, Levy RA, Nasonov EL, Triplett DA, Shoenfeld Y. The Catastrophic Antiphospholipid Syndrome – Asherson's Syndrome. Ann Med Interne, 154: 195-196, 2003.

 

1111. Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, Gilburd B, Corbanese S, Patnaik M, Zampieri S, Favaretto E, Laccarino L, Sherer Y, Todesco S, Pauletto P. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62: 1071-1077, 2003.

 

1112. Mari A, Zandman-Goddard G, Shoenfeld Y. Apoptosis in systemic lupus erythematosuss. Harefuah; 142: 844-847, 2003.

 

1113. Amital H, Gilburd B, Shoenfeld Y. Intelligent nutrision: health-promoting mechanisms of probiotics. IMAJ 5: 812-813, 2003.

 

1114. Levy Y, Uziel Y, Zandman-Goddard G, Amital H, Sherer Y, Langevitz P, Goldman B, Shoenfeld Y. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 62: 1221-1223, 2003.

 

1115. Rottem M. Shoenfeld Y. Asthma as a paradigm for autoimmune disease. Int Arch Allergy Immunol 32: 210-214, 2003.

 

1116. Marai I, Gilburd B, Blank M, Shoenfeld Y. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. Hum Antibodies 12:57-62, 2003.

 

1117. Bujanover Sh, Levy Y, Katz M, Leitner Y, Vinograd I, Shoenfeld Y. Lack of association between anti-phospholipid antibodies (APLA) and attention deficit/hyperactivity disorder (ADHD) in children. Clin & Developmental Immunol; 10: 105-109, 2003.

 

1118. Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63: 31-35, 2004.

 

1119. Shoenfeld Y. The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies. Nature Med 10: 17-18, 2004.

 

1120. Zandman-Goddard G, Shoenfeld Y. Therapy with biologic agents in SLE. APLAR J Rheum 7:79-82, 2004.

 

1121. Asherson RA, Shoenfeld Y, Jacobs P, Bosman C. An unusually complicated case of primary sjogren's syndrome: development of transient "Lupus-type" autoantibodies following silicone implant rejection. J Rheumatol 31: 196-7, 2004.

 

1122. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus 12, 903-907, 2003.

 

1123. Tartakover-Matalon S, Shoenfeld Y, Blank M, Yacobi S, von-Landenberg P, Ornoy A. Antiphosphatidylserine antibodies affect rat yolk sacs in culture: a mechanism for fetal loss in antiphopholipid syndrome. Am J Reproduct Immunol (AJRI) 51: 144-151, 2004.

 

1124. Toubi E, Shoenfeld Y. BLyS/BAFF: a potential target in the treatment of active systemic lupus erythematosus. IMAJ 6: 99-102, 2004.

 

1125. Marai I, Carp H, Shai S, Shabo R, Fishman G, Shoenfeld Y. Autoantibody panel screening in recurrent miscarriages. Am J of Reproduct Immunol (AJRI) 51: 235-240, 2004.

 

1126. Blank M, Asherson R.A., Cervera R, Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol 24: 12-23, 2004.

 

1127. Blank M, Shoenfeld Y. B-Cell targeted therapy in autoimmunity. http://www.rheuma21st.com/archives/cutting_edge_b_cell_targeted_therapy_shoenfeld_html. 08/03/2004.

 

1128. Levy Y, Amital H, Langevitz P, Nacci F, Righi A, Conforti L, Generini S, Cerinic MM, Shoenfeld Y. Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. Arthritis & Rheum 50: 1005-1007, 2004.

 

1129. Shoenfeld Y, Krause I. IVIG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients. J Clin Immunol 24: 107-114, 2004.

 

1130. Pierangeli S.S., Blank M, Liu X, Espinola R, Fridkin M, Ostertag MV, Roye-Green K, Harris EN, Shoenfeld Y. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo. J Autoimmun 22: 217-225, 2004.

 

1131. Doria A, Shoenfeld Y, Pauletto P. Premature coronary disease in systemic lupus. New Engl J Med 350:1571-5, 2004.

 

1132. Doria A, Puttini PCS, Shoenfeld Y. A meeting review: Heart, rheumatism and autoimmunity. Milan, Italy February 5-7, 2004. Autoimmunity Rev 3:337-354, 2004.

 

1133. Gilburd B, Abu Shakra M, Shoenfeld Y, Giordano A, Bartoloni Bocci E, delle Monache F, Gerli R. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluagtion – a homogeneous multiplexed system. Clin & Develop Immunol, 11: 53-56, 2004.

 

1134. Ziporen L, Polak-Charcon S, Korczyn AD, Goldberg I, Afek A, Kopolovic U, Chapman J, Shoenfeld Y. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin & Develop Immunol 11: 67-75., 2004.

 

1135. Zurgil N, Solodeev I, Gilburd B, Shafran Y, Afrimzon E, Avtalion R, Shoenfeld Y, Deutsch M. Monitoring the apoptotic process induced by oxidized low-density lipoprotein in Jurkat T-lymphoblast and U937 monocytic human cell lines. Cell Biochemistry & Biophysics 40: 97-113, 2004.

 

1136. Shoenfeld Y. 5th International symposium on IVIG: IVIG in the third millennium, 25-27 September 2003, Interlaken, Switzerland. Autoimmunity Rev 3: 234-241, 2004.

 

1137. Marai I, Shoenfeld Y, Bizzaro N, Villalta D, Doria A, Tonutti E, Tozzoli R. IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus. LUPUS 13: 241-244, 2004.

 

1138. Shlyakhov E, Shoenfeld Y, Gilburd B, Rubinstein E. Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity. Clin Microbiol Infect 10: 421-424, 2004.

 

1139. Zan-Bar T, Aron Maor A, Shoenfeld Y. Acupuncture therapy for rheumatoid arthritis. http://www.rheuma21st.com/archives/cutting_main_html. 27/04/2004.

 

1140. Amital H, Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. In: Systemic LUPUS Erythematosus 4th edition. Robert G. Lahita (Editor), Elsevier Publication, Amsterdam, The Netherlands) pp. 3-27, 2004.

 

1141. Gilburd B, Shovman O, Zandman-Goddard G, Schiffenbauer Y, Trubniykov E, Severin M, Shoenfeld Y. Autoantigen cell activation for rapid diagnosis of different autoimmune disordersL comparison of proliferation assays with a static cytometer (CellsScan). Clin Application Immunol 3: 316-323, 2004.

 

1142. Amital H, Rubinow A, Langevitz P, Shoenfeld Y. Refractory leg infection as an inducer of the catastrophic antiphospholipid syndrome. Ann Rheum Dis . 63: 1004, 2004 .

 

1143. Rottem M, Shoenfeld Y. Vaccination and allergy. Current Opinion in Otolaryngology

 

1144. Gerli R, Schillaci G, Giordano A, Bartoloni Bocci E,Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E. CD4+ CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109: 2744-2748, 2004.

 

1145. George J, Yacov N, Breitbart E, Bangio L, Shaish A, Gilburd B, Shoenfeld Y. Harats D. Suppression of early atherosclerosis in LDL-recptor deficient mice by oral tolerance with β2-glycoprotein I. Cardiovascular Research 62: 603-609, 2004.

 

1146. Shoenfeld Y. Anti-phospholipid syndrome from a systemic disease toward the infectious etiology. La Revue de medicine interne 25: 10-11, 2004.

 

1147. Amital H, Shoenfeld Y. The etiopathogenesis of autoimmunity. Chapter in book "Stem cell therapy for autoimmune disease". Eds: Richard K. Brut & Alberto M. Marmont. Laandes Bioschience Georgetown, Texas, USA, pp: 106-112, 2004.

 

1148. Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, Von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jonsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Chapman J, Van-Breda-Vriezman PJ, Damoiseaux J. Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol 31: 1344-8, 2004.

 

1149. Blank M, Shoenfeld Y. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 112: 190-199, 2004.

 

1150. Veres K, Lakos G, Kerenyi A, Szekanecz Z, Szegedi G, Shoenfeld Y, Soltesz P. Antiphospholipid antibodies in acute coronary syndrome. Lupus 13: 423-427, 2004.

 

1151. Tishler M, Shoenfeld Y. Vaccination may be associated with autoimmune diseases. IMAJ 6: 430-432, 2004.

 

1152. Toubi E, Shoenfeld Y. Toll-like receptors and their role in the development of autoimmune diseases. Autoimmunity, 37: 183-188, 2004.

 

1153. Shoenfeld Y, Blank M. The infectious etiology of the antiphospholipid syndrome (APS). Autoimmunity Rev 3 Suppl. 1: 532-34, 2004.

 

1154. Erkan D, Asherson R, Shoenfeld Y. Intravenous immunoglobulin and antiphospholipid syndrome. Arthritis & Rheum 50: 2711-2712, 2004.

 

1155. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmunity Rev. 3: 423-53, 2004.

 

1156. Shoenfeld Y, Blank M. Autoantibodies associated with reproductive failure. Lupus 13: 643-648, 2004.

 

1157. Levy Y, Shovman O, Granit Ch, Luria D, Gurevitz O, Bar-Lev D, Eldar M, Shoenfeld Y, Glikson M. Pericarditis following permanent pacemaker insertion. IMAJ 2004; 6: 599-602.

 

1158. Blank M, Shoenfeld Y. Antiphosphatidylserine antibodies and reproductive failure. Lupus 13: 661-665, 2004.

 

1159. Kuhna A, Rondinoneb R, Doria A, Shoenfeld Y. 1st International Conference on Cutaneous Lupus Erythematosus: a meeting review. http://www.Rheuma21st.com/archives/report_cutaneous_lupus_shoenfeld_2004.html

 

1160. Achiron A, Mandel M, Shoenfeld Y. Multiple sclerosis and anti-phospholipid syndrome - one or two diseases? Harefuah 143: 724-726, 2004.

 

1161. Shoenfeld Y, Wu R, Dearing LD, Matsuura E. Are anti-Oxidized Low-Density Lipoprotein antibodies pathogenic or protective? Circulation 110:2552-2558, 2004.

 

1162. Wu R, Shoenfeld Y, Cerinic R, Gerli R, Gilburd B, Perfetto F, Shen G, Lehrhoff L, Morris R. Leptin. anti-HSP60, anti-HSP65 and anti-oxLDL in autoimmune rheumatic diseases. 12th International Congress of Immunology and 4 Annual Conference of FOCIS, Immunology 315 - 324, 2004..

 

1163. Blank M, Shani A, Goldberg I, Kopolovic J, Amigo MC, Magrini L, Shoenfeld Y. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. Thrombosis Research 114: 589-592, 2004.

 

1164. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Sem Arth Rheum 34: 501-537, 2004.

 

1165. Inagaki J, Kondo A, Lopez LR, Shoenfeld Y, Matsuura E. Anti-laminin-1 autoantibodies, pregnancy loss and endometriosis. Clin Dev Immunol. 11:261-6,2004

 

1166. Shoenfeld Y, Blank M, Achiron A, Chapman J, Gilburd B, Molina V, Toubi E. 4th International Congress on Autoimmunity. http://www.Rheuma21st.com/archives/report_all_29Nov2004.html.

 

1167. Marai I, Zandman-Goddard G, Shoenfeld Y. The systemic nature of the antiphospholipid syndrome. Scand J Rheumatol 33: 365-372, 2004.

 

1168. Toloza S.M.A, Uribe A.G, McGwin G Jr., Alarcon G.S., Fessler B.J., Bastian H.M., Vila L.M., Wu R, Shoenfeld Y, Roseman J.M., Reveille J.D. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). Baseline predictors of vascular events. Arthritis & Rheum 50: 3947-3957, 2004.

 

1169. Zan-Bar Tal, Aron A, Shoenfeld Y. Acupuncture therapy for rheumatoid arthritis. APLAR J of Rheumatol 7: 207-214, 2004.

 

1170. Orbach H, Tishler M, Shoenfeld Y. Intravenous immunoglobulin and the kidney - a two-edged sword. Semin Arthritis Rheum 34: 593-601, 2004.

 

1171. Krause I, Shoenfeld Y. Intravenous immunoglobulin treatment for fibrosis, atherosclerosis and malignant conditions. In: Adoptive Immunotherapy Methods and Protocols. Burkhard Ludewig & Matthias W. Hoffmann (Editors). Humana Press, Totowa, New Jersey, pp: 403-408, 2004.

 

1172. Pras E, Neumann R, Zandman-Goddard G, Levy Y, Assia E.I., Shoenfeld Y, Langevitz P. Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum 34: 602-609, 2004.